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Summary 
Bovine tuberculosis is a chronic disease, caused by M. bovis, mycobacteria 
which belongs to the mycobacterium tuberculosis complex; it is notable for having 
one of the broadest spectrum of hosts. The preferred host of M. bovis is cattle, but it 
has the ability to infect humans and a wide range of domestic animals. 
In Morocco, cattle production is one of the most important components of the 
agricultural economy; a sector which contributes heavily to the development of the 
Moroccan economy. The development of this sector is faced by many problems, like 
poor infrastructure, lack of services and climate change, in addition to infectious 
diseases like bovine tuberculosis 
Bovine tuberculosis is a zoonosis which affects the livestock industry, the 
public health sector and wildlife reservoirs. BTB has also effects like international 
trade restrictions for countries where BTB is endemic. Tourism and other areas of 
public and private interest could also be affected indirectly by BTB infection.  
The respiratory route is considered to be the primary mode of infection 
between cattle. In addition, M. bovis is largely transmitted to humans through 
consumption of unpasteurized milk, but there is also the possibility of inhalation of 
aerosols due to contact with cattle. 
Bovine tuberculosis in endemic in Morocco, the prevalence in Moroccan cattle 
is estimated at 18% (95% CI: 16.5%-20.3%), and 33% (95% CI: 31%-35%) at the 
individual and the herd level respectively, but the human burden needs further 
clarification. 
A prevalence study have been conducted in Sidi Kacem province in Morocco 
in 2012, 1201 cattle were screened using single comparative intradermal tuberculin 
skin test, the apparent prevalence was 20.4% and 57.7% in the individual and herd 
level respectively. The individual prevalence found in the present study is in line with 
the last national survey conducted in 2004 in collaboration with the FAO in Morocco. 
Consequently, Morocco is in an endemic stable state, similarly to other African 
countries. 
The livestock production sector in Morocco is continuously growing, due to the 
ambitious “plan Maroc Vert” launched in 2008, and also to the increasing demand of 
animal protein in Morocco. Consequently, livestock production system in Morocco is 
moving to intensified and irrigation rearing systems. Those factors in Sidi Kacem 
have been shown to be associated with higher risk of BTB compared to the extensive 
livestock system. 
In order to investigate BTB molecular epidemiology in Morocco. Bovine 
tuberculosis samples were collected from two slaughterhouses in Morocco, Rabat 
7 
 
and El Jadida, 8658 animals were examined, 3.7% of them showed gross visible 
lesions suggesting bovine tuberculosis. However this prevalence reflects the 
prevalence in young bulls and old cows rather than the prevalence in the whole cattle 
population.  
Molecular characterization of the samples collected from the previously 
reported slaughterhouses has shown grown cultures in 225 isolates, 63.6% (n=143) 
have been confirmed to be M. bovis (absence of the RD4).  
From 134 samples analyzed using spoligotyping, 43 different spoligotypes 
were found; ten of them were new patterns (23%), they were submitted to the 
M.bovis database and they were given new reference numbers. The most prevalent 
spoligotypes were SB0121, SB0265, and SB0120, which were already reported in 
many other countries, mainly in Algeria, Spain, Tunisia, and also in the United States 
and Argentina.  
Spoligotypes of African 1 and African 2 clonal complexes were not reported 
among the characterized isolates. Considering the localization of Af 1 and Af 2 in 
West Central Africa and East Africa respectively, we could consider Sahara as a 
potential efficient barrier preventing the introduction of BTB to Morocco from West 
Central and East Africa. 
More molecular characterization is needed to investigate the strains circulating 
in the south and the north of Morocco. In order to investigate more deeply 
transmission dynamics of BTB in Africa, an overall study using whole genome 
sequencing and including several African countries is needed. 
The present thesis presents the first cattle to cattle and cattle to human 
compartmental deterministic mathematic model. Bovine tuberculosis reproductive 
number was consequently calculated, it was found to be equal to 1.375, in the range 
of both low and high risk areas. 
The sensitivity analysis of the model showed that the birth rate and the 
sensitivity of the single comparative intradermal tuberculin skin test are the most 
sensitive parameters of the model for the total cost and the time to elimination 
respectively. High birth rate values lead to an increased cattle population yielding 
higher costs for elimination. In the other hand, low test sensitivity cases low detection 
of infected animals and therefore less culling which leads to a longer time to 
elimination. 
Simulation of test and slaughter interventions led to a decline of BTB 
prevalence depending on the proportion of testing (p). Using a severe cut off (2mm) 
for the SICTT, the time of freedom from BTB ranged from 75 years for p=20% to 25 
years for p=50%. The cumulated cost was largely stable ranging from 1.47*10^9 
(p=100%, time to disease freedom of 12 years) to 1.87*10^9 (p=20%, time to disease 
freedom of 12 years). 
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Deterministic and matrix models were used to develop a demographic model of 
Moroccan cattle population based on real data. The cost of bovine tuberculosis was 
consequently calculated using the established model.  
The productivity losses triggered by BTB (5%) were estimated for 18 years, 
applying Leslie matrix with and without BTB. Cattle Moroccan population was 
compared with and without the disease, and the loss in term of animal numbers was 
then calculated. Considering the productivity loss, the asset value of the living 
animals lost due to BTB in year 18 is 98 Million Euro. 
The present thesis informs Moroccan stakeholders involved in bovine 
tuberculosis regarding the updated prevalence in Sidi Kacem Area, molecular 
epidemiology of BTB among slaughtered cattle, the time frame, and range of cost 
and levels of intervention, in addition to the cost of BTB considering productivity 
losses.  
Further research is needed in Morocco, in one hand, investigations of the 
molecular epidemiology of BTB in the north and the south of the country will give 
more insight about the dynamics of BTB in Morocco, a broader investigation using 
whole genome sequencing including several African countries could be even more 
efficient. In the other hand a herd based transmission model will provide a more 
realistic cost estimation of BTB intervention in Morocco. 
Elimination of bovine tuberculosis is a costly and long process, the 
achievement of BTB control of Morocco will need the commitment of the different 
stakeholders involved. In addition, public-private collaborations could be helpful in 
order to achieve a sustainable control intervention of BTB in Morocco. 
Keywords: Morocco, Bovine tuberculosis, Transmission dynamics, Molecular 
characterization, Cost analysis. 
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I. Introduction: Bovine tuberculosis in animal health in Morocco 
A. Etiology,	pathogenesis	and	transmission	
1. Etiology	
a) Responsible agent 
Bovine tuberculosis is caused by M. bovis, a member of the mycobacterium 
tuberculosis complex (MTBC). To date, 175 Mycobacteria species exist (1). In 
addition to M. bovis, the other most important members are M. tuberculosis, M. 
canettii, M. africanum, M. caprae, M. microti, M. pinnipedii, and M. mungi (2–5). 
MTBC members have different cultural characteristics and requirements and vary in 
their pathogenicity. 
MTBC members are characterized by a very complex cell wall envelope which 
impacts the cell permeability and allows for the differential staining procedure (Ziehl 
Neelsen), due to the existence of a long chain of α-alkyl and β-hydroxy fatty acids. 
Mycobacteria are divided into two groups based on the growth rate. M. bovis is 
part of the slow growing group, together with M. tuberculosis and M. leprae. 
However, M. smegmatis is a fast-growing mycobacteria (6). The capsular structure of 
the mycobacteria is thought to be involved in the permeability barrier of the cell 
envelope and contribute to protect the mycobacteria from the microbicidal activities of 
host macrophages (7). 
b) Morphology 
The mycobacterial cell wall has been described as having three layers, an outer 
layer of lipopolysaccharide (LPS), an intermediate layer of LPS-lipid-protein complex, 
and an inner layer of LPS muco-peptide (8). The disposition and composition of the 
mycobacterial cell wall contributes to the intracellular survival of the bacteria and its 
immune modulating abilities. These are key elements to consider in developing 
potential new drugs and treatment strategies as they impact drug resistance. In 
addition, they contribute to initial host responsiveness (9). 
c) Hosts  
M. bovis is notable for having one of the broadest host spectrum. The preferred 
host of M. bovis is cattle, but it has the ability to infect humans and a wide range of 
domestic animals. M. tuberculosis infects preferably humans, but has also been 
isolated in many settings from cattle. M. africanum and M. canettii can also infect 
humans. M. caprae is usually isolated from goats (6), but has been described in 
cattle and humans (10), while M. microti is a rodent pathogen (6). 
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d) Pathogenicity  
Mycobacteria lack toxins, a typical element in other bacterial pathogens. 
However, MTBC species have several virulence genes, which mostly encode for 
enzymes of several lipid pathways, cell surface proteins, regulators, or proteins of the 
signal transduction system. Another group of genes of relevance for mycobacterial 
pathogenicity are the genes involved in mycobacterial survival inside the aggressive 
micro environment of the host macrophages. Many of the MTBC virulence genes are 
also conserved by non-pathologic mycobacteria. 
The virulence determinants have been reviewed by Forrelad et al. (6) and 
categorized into the following groups based on their function, molecular features or 
cellular localization:  
 Lipid and fatty acid metabolism, including catabolism of cholesterol,  
 Cell envelope proteins: including cell wall proteins, lipoproteins and secretion 
systems,  
 Proteins inhibiting antimicrobial effectors of the macrophage, including those 
involved in responses to oxidative and nitrosative stresses, phagosome arrest 
and inhibition of apoptosis,  
 Protein kinases, 
 Proteases, including metalloproteases, 
 Metal-transporter proteins, divided into importer and exporters, 
 Gene expression regulators, including two component systems, sigma factors 
and other transcriptional regulators,  
 Proteins of unknown function, including PE and PE_PGRS(Polymorphic CG-
repetitive sequences) families, 
 Other virulence proteins.  
B. Pathogenesis 
MTBC strains infect mammalian hosts primarily in the lungs, where the 
mycobacteria are engulfed within alveolar macrophages. Inside of the macrophage, 
the bacteria are contained in endocytic compartments. MTBC species have several 
mechanisms to circumvent the hostile environment of the macrophage, including by 
inhibiting the phagosome-lysosome fusion and by escaping the acidic environment 
inside the phagolysosome (11).  
Infection by an MTBC strain is normally contained in the lungs through formation 
of granulomas due to the activated macrophages and other immune cells which 
surround the site of infection to limit tissue damage and restrict microbial 
dissemination. Within the granuloma, the mycobacteria may remain dormant for 
decades without any clinical disease (latent tuberculosis). Subsequent immune 
suppression  could allow activation of the dormant bacteria, followed by replication 
and spread into the lungs and other tissue (12,13).  
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C. Transmission 
1. Animal to animal transmission 
The respiratory route is considered to be the primary mode of infection between 
cattle (14). Most lesions in tuberculous animals are found in the upper and lower 
respiratory tract and the associated lymph nodes (15). 
Cattle to cattle transmission plays an important role in introducing infection into 
negative herds, through purchased infected animals with contiguous spread. 
After mycobacteria infect cattle, a variable period of latency occurs before the 
animal excretes the pathogen, generally from 8 up to 65 days. However, this period 
could be as long as 7 years. Barlow et al used a period of 6 to 20 months to construct 
a simulation model for the spread of bovine tuberculosis within New Zealand cattle 
herds(16). In addition, transmission of M. bovis from cows with tuberculous mastitis 
to calves via milking has been reported (17).  
2. Animal to human transmission 
M. bovis is largely transmitted to humans through consumption of unpasteurized 
milk, but there is also the possibility of inhalation of aerosols due to contact with cattle 
(18). In order to decrease the transmission risk of M. bovis from cattle to humans, a 
strict milk pasteurization policy should be applied, in addition to application of strict 
safety measures to protect populations with high risk of BTB transmission (livestock 
keepers, abattoir workers, veterinarians) (19). 
3. Human to human transmission 
Human to human transmission of M. bovis occurs less commonly than animal to 
human transmission, although it has been described between immune deficient TB 
patients in the UK and Spain (20,21). In addition, human to human transmission of M. 
bovis between immune-competent patients has been described in the United 
Kingdom (UK), United States of America(USA) and France (22–24). 
D. Diagnostic	tools	
1. Ante	mortem	diagnostic	tools	
Bovine tuberculosis diagnosis is still a challenge, and the available tools have 
sensitivity (se) and specificity (sp) limitations. Type III hyper sensibility immunological 
response in BTB infected cattle is cellular immunity based on T-cells (25). Cattle in 
late stages of infection develop M. bovis antibodies (26). Consequently, ante-mortem 
tests based on cellular immunity can identify cattle infected with BTB earlier than 
other tests (27). The most used ante-mortem diagnostic tools are the single and 
comparative intradermal tuberculin tests (SIT and SCITT), in the cervical area in 
Europe and in the caudal region in Australia, New Zealand and the USA (28). 
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The intradermal test has some important advantages, including low cost and 
the technique is well documented. On the other hand, the intradermal test also has 
significant disadvantages, such as requiring a second visit to read the reaction, as 
well as difficulties in test administration and interpretation of results (27). The use of 
the intradermal test requires trained personnel.  
The interferon (IFN) gamma assay has been approved by several national 
control programs in the European Union, Australia, New Zealand and the USA. This 
test is employed to enhance sensitivity in parallel testing with the intradermal skin test 
or to enhance specificity when used for serial testing. One of the advantages of the 
IFN gamma test is that the animals only need to be handled once because no 
second visit is required (29). The European Food Safety Authority indicated that the 
IFN gamma assay has a comparable performance to the intradermal skin test; 
however, under some conditions, the specificity of the IFN gamma test might be 
lower than that of the tuberculin skin test (30). 
The IFN gamma is analogous to the intradermal skin test, but is an in vitro 
laboratory based assay which detects specific cell mediated immune response from 
circulating lymphocytes. The assay consists of incubation of heparinized blood with 
purified protein derivative (PPD) or specific antigens. This antigenic simulation results 
in the release of IFN gamma by T lymphocytes. Subsequently, the released IFN 
gamma in the plasma is quantified using a sandwich enzyme-linked immunosorbent 
assay (ELISA). 
The median sensitivity and specificity of the IFN gamma assay are 87.6 % and 
96.6 %, respectively. The assay sensitivity has been demonstrated to be higher than 
that of the intradermal skin test, but the specificity is problematic. Many elements 
contained in the PPDs are present in non-pathogenic environmental mycobacteria 
(31) which could explain the decreased specificity. A cocktail composed of peptide 
derived from the mycobacterial antigens ESAT-6, CFP-10, and Rv3615c has been 
shown to increase the specificity of the IFN gamma assay. The addition of the 
antigen Rv3020c improves the diagnostic sensitivity of the assay (32). An “in-tube” or 
“in-plate” device for rapid stimulation of lymphocytes after blood collection might 
overcome one of the biggest disadvantages of this diagnostic test, making the IFN 
gamma assay more practical (33). 
Serological tests for BTB diagnosis have been studied in the last 15 years, as 
new methods have shown that M. bovis antibodies are produced soon after infection. 
The serological antibody based assays have the advantages of requiring little time, 
with good cost effectiveness and flexibility of use (34). In 2000, a panel of 
mycobacterial antigens was tested using antigen specific lymphocyte proliferation 
and cytokine responses. The two antigens PPD-M and ESAT-6 were the only ones to 
show positive responses throughout the infection period, whereas for the other 
antigens the response was not constant. Therefore, it was recommended to use a 
cocktail of antigens for BTB serological diagnostic (35). In addition, ELISA using the 
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recombinant proteins ESAT-6, MPB70 and MPB83 has shown satisfactory 
agreement with the SCITT, while also discriminating between BTB positive and 
negative cattle prior to tuberculin skin test (36). More recently, an ethanol vortex 
ELISA (EVELISA) was used to detect anti M.bovis antibodies in the sera of cattle 
using MPB83 antigen. EVELISA showed a positive potential for BTB diagnosis but 
needs to be studied further (37). Serological antibody based assays for BTB 
diagnostics need more studies prior to recommendation as standalone tests. 
2. Post	mortem	diagnostic	tools	
Bovine tuberculosis can be diagnosed after the death or slaughtering of cattle 
by histopathology, bacteriology, and molecular techniques. Animals which have gross 
visible lesions at slaughter are condemned, and the lesions showing characteristic 
histological changes (caseous necrosis, mineralization, epithelioid cells, 
multinucleated giant cells and macrophages) may be sampled for further analysis. A 
bacteriological examination can first be performed using Ziehl-Neelsen (ZN) 
coloration and microscopy observation. The observation of acid-fast bacilli provides 
presumptive confirmation of the presence of mycobacteria. However, microscopic 
examination does not allow for characterization of the mycobacteria. Isolation of the 
mycobacteria may be performed after a decontamination of the sample using solid 
egg based culture media for the primary culture (29). Additionally, pyruvate 
supplementation has been shown to enhance M. bovis growth, while glycerol inhibits 
M. bovis growth (38).  
Culture is a reliable diagnosis method, but it is time consuming because 
mycobacteria grow slowly. In addition, sampling of BTB suspicious lesions and their 
handling in the laboratory should be performed using the required biosafety level 3 
measures (39). PCR (Polymerase chain reaction) based techniques, like RD typing 
(Region of Deletion) are a good alternative for culture, as they need less time; 
however, a well-equipped laboratory with trained personnel are necessary, and PCR 
is expensive compared to the other post mortem diagnostic methods (40).  
Variable Number Tandem Repeat (VNTR) typing and spoligotyping, either alone 
or together, have shown good results in molecular characterization of MTBC, 
although VNTR provides better discrimination than spoligotyping (41). 
E. M.bovis	in	the	mycobacterium	tuberculosis	complex	
The DNA (Deoxyribonucleic acid) of the MTB complex is 99.9% similar, in 
addition to having virtually identical 16S rRNA sequences, cited by (42). The whole 
genome sequencing for M. bovis was performed for the first time in 2003 (43). Smith 
et al suggested in 2009 (44) that M. bovis evolved from M. tuberculosis, supporting 
the hypothesis addressed by Brosch in 2002 (45) 
Differential hybridization arrays identified 14 regions of difference in the MTBC, in 
addition to H37Rv related deletions (RvD 1-5), and the M. tuberculosis specific 
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deletion TbD1 (46). M. bovis is the most recent member of MTBC lineage, presenting 
the largest number of deletions, as shown in the figure 1. It has been suggested by 
Brosch that the common ancestor of the tubercle bacilli resembled M. tuberculosis or 
M. canetti, and was likely to already be a human pathogen, in contrast to the 
hypothesis previously presented that M. tuberculosis emerged from M. bovis (45). 
 
Figure I.1. Phylogeny of MTBC 
So far, four clonal complexes of M. bovis have been identified. The first one is 
African 1, which is characterized by the chromosomal deletion RDAf1, in addition to 
the absence of spacer 30 in the spoligotype pattern. The second one is African 2, 
which has the RDAf2 deletion and the absence of spacer 3 to 7 in the standard 
spoligotyping scheme. The third clonal complex is European 1, which is 
characterized by the RDEu1 deletion. The African 1 clonal complex is geographically 
localized in Mali, Cameroon, Nigeria and Chad, while the African 2 is localized in 
East Africa. The European 1 complex is rare or absent in African countries, with the 
exception of South Africa, being found in European countries (e.g., France, Portugal, 
Spain), as well as the USA, Canada, Australia, and New Zealand (47–49). The fourth 
clonal complex of M. bovis, European 2 complex, was identified in the Iberian 
Peninsula and is characterized by the absence of spacer 21 from the spoligotype 
pattern, in addition to the presence of a specific SNP (Single-nucleotide 
polymorphism) in gene guaA. This clonal complex was isolated in low frequency in 
France and Italy (50). 
Before 2000, data about the molecular epidemiology of M. bovis were scarce, 
since no well-established molecular typing system was available (51). The first 
molecular typing technique used for M. bovis was restriction endonuclease analysis 
(REA) (52) in the late 1980s and early 1990s in New Zealand (53) and Ireland (54). 
However, REA is technically demanding (55).  
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While REA deals with many small fragments of DNA, PFGE (Pulsed-field Gel 
Electrophoresis) separates a few large fragments (51). This typing technique was first 
developed by Shwatz et al for the differentiation of yeast chromosomes (56). The 
PFGE was then adapted for bacteria and used for M. tuberculosis (57), before it was 
utilized for M. bovis typing and differentiation between M. bovis and M. bovis BCG 
(57,58). 
Both REA and PFGE are whole genome techniques (51). Later, partial 
genomic techniques were developed, such as restriction fragment length 
polymorphism (RFLP). This technique initially used radioactive labeled probes, and it 
was not recommended due to safety concerns until these were replaced by chemi-
luminescent systems (59). 
Restriction fragment length polymorphism using insertion sequence 6110 
(IS6110) is a technique which was widely used, mostly for M. tuberculosis, as the 
genome carries several copies of IS6110, which results in a high discriminatory 
power. Consequently, IS6110-RFLP was long considered as a gold standard in the 
molecular epidemiology of human TB (51). This technique has less often been used 
for M. bovis molecular typing, because of the low number of copies which exist in the 
genome of M. bovis. However, some studies showed that the number of copies of the 
IS610 in M. bovis is variable depending on the host and the specificities of the local 
strains (60,61). In fact, IS6110-RFLP is highly discriminatory for M. tuberculosis, as 
the genome has up to 20 copies of IS6110. However, the discriminatory power 
decreases when the genome has one or only a few copies of IS6110 (62). It has 
been recommended to combine IS6110-RFLP with another molecular technique for 
M. bovis molecular typing (59).  
Even though RFLP has a high discriminatory power, it has many limitations; 
most importantly, it is technically demanding and requires a large amount of DNA, 
which makes its application directly on clinical specimens difficult (63). These 
limitations were a strong motivation for the development of more rapid and 
automated techniques, like PCR based molecular techniques (51). 
PCR based methods are used in most cases as a confirmatory tool to culture, 
which is a gold standard, or to differentiate MTBC members. For this purpose, 
different genes, insertions or deletions are targeted. In order to differentiate between 
tuberculous and non tuberculous mycobacteria, the duplex MrpoB PCR is usually 
used (64). On the other hand, PCR amplification and DNA sequencing of 16s rRNA 
are used for samples confirmed to not be a mycobacteria (65).  
In order to differentiate between the members of MTBC, a large number of 
deletions /insertions are available so far, which are used separately to identify M. 
tuberculosis or M. bovis, or in multiplex PCR (66–68). Amongst the most important 
PCR based techniques are Mixed linked PCR (ML-PCR)(69), Ligation-mediated PCR 
(LM-PCR) (70), and Fast ligation-mediated PCR (Flip)(71). The discriminatory 
potential of those three PCR based techniques is good but somewhat lower than 
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IS6110-RFLP analysis (71,72). Deletion typing using the regions of differences (RD) 
is also usually used for the discrimination between the MTBC members (45). 
Currently, the most used PCR based techniques for the molecular identification 
of M. bovis are spoligotyping (73) and variable number tandem repeat analysis 
(VNTR) (74). 
F. Molecular	typing	methods	used	for	M.	bovis	
Spoligotyping is based on polymorphism of one specific genomic region, called 
direct repeat (DR) locus. The DR locus is composed of a series of well-conserved 
direct repeats (DRs) interspersed with a unique, non-repetitive spacer sequence, 
identified first by Hermans et al in 1991 (75). 
Spoligotyping is a fast, robust and cost effective technique, which can be used to 
differentiate M. tuberculosis and M. bovis. However, the discriminatory power of this 
technique is lower than IS6110-RFLP (73). Spoligotyping targets only a single 
genetic locus, covering less than 0.1% of MTBC, which is the cause of the lower 
discriminatory power of the technique. However, spoligotyping remains a useful tool 
for differentiation of MTBC strains with a low number of copies of IS6110 (76,77). 
Two large databases are available online which list all of the previously reported 
spoligotype patterns, and new patterns can be submitted (SITVIT and mbovis 
databases) (78,79). M. tuberculosis lacks spacers 33 to 36, and M. bovis lacks 
spacers 39 to 43 (80). 
From human gene mapping, forensic analysis and paternity testing, genetic loci 
containing variable numbers of tandem repeats (VNTR loci) were then used for the 
characterization of bacterial species, including MTBC species (51,63). VNTR consists 
of the amplification of the DNA containing variable numbers of tandem repeat 
sequences and the determination of the size of the products by gel electrophoresis 
(51) or fluorescence (74). In 1998, Frothingham and Meeker-O'Connell identified one 
major polymorphic tandem repeat (MPTR) loci and six exact tandem repeat (ETR) 
loci (ETR-A to F) relevant for MTBC typing (81).  
First VNTR typing ETR A to F was found to be less discriminatory than 
spoligotyping used alone or IS6110-RFLP typing (81,82). Consequently, a set of 
mycobacterial interspersed repetitive units (MIRU-VNTR) has been proposed 
(74,83,84). A 15 locus system was first proposed as a standard for routine 
epidemiological discrimination of M. tuberculosis isolates, while the 24-locus system 
was proposed as a high-resolution tool for phylogenetic studies (83). However, for M. 
bovis, six loci (ETR A, ETR B, ETR-D, QUB 3232, QUB 11a, QUB 11b) were shown 
to result in a high discriminatory power (74,85–87) and were recommended for typing 
M. bovis by the Veterinary Network of Laboratories Researching into Improved 
Diagnosis and Epidemiology of Mycobacterial Diseases (VENoMYC) Consortium (EU 
Coordination Action SSPE-CT-2004-501903 (88). It has been recommended that a 
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definition of an appropriate combination of heterogenic loci for each country and 
MTBC panel studied is necessary(84), although different sets of the most 
discriminatory loci for M. bovis are available for many settings (84,85,89,90). 
G. International	situation	of	bovine	tuberculosis:	focus	on	Africa	and	
Morocco	
BTB is listed by the OIE (World organization for animal health) as a cattle 
infection in list B and as having an economic and public health burden, in addition to 
being a significant element in international trade of animals and animal products (91).  
 
Figure I.2. Bovine tuberculosis distribution map (92) 
Bovine tuberculosis is present worldwide. After the introduction of control 
measures and milk pasteurization in developed countries, the prevalence of BTB 
dropped drastically. Currently, bovine tuberculosis is mostly present in Africa and in 
South America. Many countries on these two continents have no data available on 
this infectious disease. In North America, most of Asia and Europe, BTB is absent or 
limited to one or few regions.  
BTB has been eliminated from several countries (e.g., Switzerland, Australia, 
New Zealand). The countries where BTB has been eliminated have the absence of a 
wildlife reservoir in common. In countries like the UK, which have a wildlife reservoir 
for BTB, elimination of the disease is ongoing, with low prevalence level of BTB in 
cattle but still a big problem in the wildlife. 
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Table I.1. Bovine tuberculosis prevalence in some countries using a cut off 
recommended by the OIE (positive when the difference is >4 mm) 
Country Nb. 
Tested 
animals 
Diagnostic 
tool(s) used 
Year Individual 
prevalence 
(%) 
Reference  
Morocco 13021 SCITT 2004 18 (92) 
Mozambique 1136 SCITT 2004 39.6 (93) 
Tanzania _ SCITT 2.4 (94) 
Eritrea 15354 SCITT 2011 21.5 (95) 
Ecuador 1446 CITT 2008 8.4 (96) 
Ethiopia 2550 CITT 2015 5.5 (97) 
Pakistan 556 SCITT 2015 5.75 (98) 
Brazil 22990 SCITT 2015 0.81 (99) 
Niger 393 SCITT 2009 3.6 (100) 
Zambia 944 SCITT 2004 49.8 (101) 
Cameroun 807 SCITT 2010 3.5 (102) 
H. Control	strategies	for	bovine	tuberculosis	in	developed	countries	and	
lessons	learned	
Australia was one of the first countries which eliminated BTB. A joint BTB and 
brucellosis eradication program started in 1970, and Australia was declared free of 
BTB by 1997. Australia was fortunate as no feral host for M. bovis was present (103). 
However, the wildlife reservoir represents a cause of reemergence of BTB in many 
countries (104). In Ireland, badgers are a reservoir for M. bovis, and prevention of the 
transmission of BTB from badgers to cattle is one of the challenges faced in order to 
move forward in the control of BTB (105). In addition, New Zealand used a strategy 
based on the control of the wild host, which resulted in decrease of the infected cattle 
herds to less than 100 by 2014 (106). 
While the problem of BTB eradication in the developed world is mainly the wildlife 
reservoir, in Africa, as a developing continent, the control of zoonoses like BTB are 
affected by political and economic factors, the lack of efficient organization of 
veterinary services and inadequate communication networks (107). However, wildlife 
reservoirs are an additional obstacle for BTB elimination for some African countries 
(feral baboons in Kenya (108) and warthog and buffalo in Uganda (109), and African 
buffalo (Syncerus caffer) in the Kruger National Park in South Africa (110)). Bovine 
tuberculosis constitutes a neglected problem in developing countries, where the few 
human and financial resources are mainly engaged in the control of other acute and 
fatal diseases and parasitic diseases (107). 
Strong industry and government support in funding and policy development are 
important factors for the success of a zoonosis eradication campaign, as confirmed 
by the Australian experience. Other factors could affect success of disease control 
22 
 
and eradication programs, like extreme rigor in the application of the selected 
strategy, in addition to the implication of the process for the owners(111). 
Trust between all the stakeholders, especially the industry, the government and 
the owners, is a very important component which contributed to the success of BTB 
control program in Australia. In addition, animal traceability and abattoir surveillance 
were applied from the early years of the control program in Australia (112). While in 
the US, the application of animal traceability was a challenging element for abattoir 
surveillance and needed more effort to achieve an effective elimination of BTB (113). 
Correct application of livestock biosafety, early diagnosis of the disease, application 
of quarantine, and animal movement control are other parameters which markedly 
affect the success of a control campaign (114).  
I. Current	control	approaches	in	developing	countries	
In Nigeria, reporting of BTB is not mandatory, and there is no active TB 
surveillance program (115). Like in Nigeria and other African countries, the control of 
BTB is challenging in Cameroon as well due to the high cost of surveillance and the 
limited veterinary and public health infrastructure (116).In Burkina Faso, there is no 
BTB control strategies (117). 
In 1967, Iran initiated a compulsory test and slaughter program for BTB in all 
cattle, and this control program, although having several weaknesses, has been 
successful, decreasing the prevalence from 28% to less than 0.5% (118). 
The control strategy shown to be effective to control and eliminate BTB in 
developed countries is test and slaughter, but such intervention remains unaffordable 
for low and middle income countries with large cattle populations (107). A test and 
slaughter strategy could be applied in developing countries when logistically and 
financially feasible, but it should be integrated with many other actions, like abattoir 
surveillance, a national animal identification system, and promotion of milk 
pasteurization at local and national levels (119). A trans-disciplinary approach is 
potentially the best way to apply a successful BTB control intervention. Considering 
that an increased awareness and knowledge of the disease is an important step in 
the development of control measures, health communication is a tool which has been 
proven to be cost effective (119). Awareness could contribute to a better acceptance 
of a potential control intervention by the population; in addition, it is a crucial element 
for the sustainability and the effective implementation of the control strategy(120).  
A preliminary investigation of the important key risk factors which could influence 
the success of BTB control interventions should be performed, as done in Zambia, 
where the livestock production system and grazing strategy have been determined as 
important risk factors to be considered (101).  
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This chapter is focused in the economics of bovine tuberculosis (TB), taking 
into consideration the burden of this disease for livestock and also for human health, 
with a stong emphasis in One Health (OH) as a control approach. The current 
chapter starts with an overview of One Health, followed by a review of the economics 
of bovine TB as an OH issue, through a summary of One Health and its added value 
for bovine TB and human TB control.  
A. One Health  
OH can be defined as the added value of closer cooperation between human and 
animal health in terms of better health of humans and animals, financial savings and 
improved ecosystem services (121). OH is part of the broader consideration of 
ecology and health. It contributes to improve health by engaging different institutions 
and disciplines in a closer way by improved communication, closer collaboration and 
better information sharing based on the recognition that human and animal health are 
mutually dependent. 
Obstacles of the broad acceptance of the benefits gained from an OH approach 
are mostly economic. In fact, it is critical for the establishment of an OH approach to 
demonstrate that public and private stakeholders may save money from a closer 
cooperation (122). 
Veterinary attention should be drawn to many sectors related directly or indirectly 
to the animal health, such as international trade and travel, global climate changes, 
habitat destruction, overpopulation, ecotourism and food safety, and all those sectors 
should be aware of the positive impact of the collaboration with other disciplines. 
However, the establishment of an OH initiative and setup of its principles should be 
performed at the academic level; in addition to the creation of specialized Masters’ in 
OH (123), the academic training of OH should be adapted to different countries and 
contexts in order to be most efficient. Still, the OH approach should be embraced 
also by several institutions and organizations outside academia, such as industrial 
firms, especially those that will benefit from addressing the challenges posed by 
bovine TB using an OH approach (e.g. the milk and meat industries). 
Public health schools remain among the biggest institutions that deploy 
considerable efforts to educate global health experts and prepare them to confront 
the global burden diseases. One of the strengths of public health schools is their 
multidisciplinary orientation and their aspiration to develop, test and validate new 
approaches, technologies and systems in order to reach the global health needs, 
especially in developing countries (124). Moreover, OH courses are available in 
many universities, non-governmental organizations and government agencies, for 
example, the University of Edinburgh, London School of Hygiene and Tropical 
Medicine, Swiss Tropical and Public Health Institute, and many other universities and 
institutes. 
Examples of OH approaches include a vaccination campaign in Chad for both 
pastoralists (vaccination against diphtheria, whooping cough, tetanus and against 
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polio) and their livestock (vaccination against anthrax, pasteurellosis, blackleg and 
contagious bovine pleuropneumonia), in addition to the delivery of health care. This 
was a successful intervention integrating human and animal health workers, where 
this joint action allowed to reduce costs by 15% compared to a separate campaign 
(125,126). 
Moreover, it has been validated in a prevalence study performed in Chad for 
brucellosis and Q-fever that using an OH approach in prevalence investigations of a 
zoonosis could decrease the detection time when sampling humans and animals in 
parallel (127). However, this joint investigation should be justified with a higher 
incremental knowledge, and more importantly, no concessions should be made in the 
quality of the methods (128). 
Zinsstag et al. (2007) demonstrated, using brucellosis, rabies and avian influenza 
examples, that interventions against zoonoses become cost saving when considered 
from a societal perspective. An intervention may become highly cost effective when 
costs are shared between different sectors in proportion to their benefits (130). In 
contrast to developed countries, many zoonoses are still endemic in many 
developing countries, as financial and organizational resources cannot be focused on 
the animal reservoir (131). 
B. Human Tuberculosis: The International Epidemiological Situation and 
Control Strategy 
According to the World Health Organization (WHO), in 2015, TB caused 1.8 
million deaths worldwide, which puts human TB as a leading cause of death. In 
addition, 12% of all TB cases are co-infected with HIV. The estimated number of new 
cases of human TB in the world for 2015 is 10.4 million. The incidence of TB is 
variable from one region to another; Southeast Asia and the Western Pacific 
accounts for 58% of all TB cases. Africa has 28% of worldwide TB cases, but has the 
most severe burden relative to population (132). 
On the other hand, Western Europe and North America showed a low incidence 
of human TB compared to the most populous countries of Asia, where human TB is 
very prevalent (e.g. Bangladesh, India, China, Indonesia, and Pakistan) (133). In 
addition, in some developing countries, an increase in new TB cases has been 
observed within the last 20 years, and this could be explained, among other reasons, 
by better data management and diagnostic rates (132). 
In May 2014, the End TB strategy was established with the goals of reducing the 
number of TB deaths by 90% by 2030 (compared to 2015 rates) and reducing the 
number of new TB cases by 80% (132).  
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C. The Economic and Public Health Burden of bovine Tuberculosis 
Bovine TB affects the national economy of the countries where this disease is 
endemic by causing a decrease in productivity, condemnation of meat in the abattoirs 
and an influence on the international trade of animal products (134) Ongoing bovine 
TB transmission also has important effects on ecosystems by affecting wildlife (135). 
Bovine TB is more difficult to eliminate from wildlife than from cattle. This is currently 
an obstacle for the eradication of bovine TB in some developed countries, for 
example, badgers in the United Kingdom (UK)  and Ireland (136,137), the brushtail 
possum in New Zealand (138), wild boar (Sus scrofa) in the Iberian Peninsula (139) 
and  white-tailed deer (Odocoileus virginianus) in Michigan, USA (140). 
The public health burden of zoonotic TB in industrialized countries is low because 
of the pasteurization of milk and/or its effective elimination in cattle. Rare cases are 
contracted abroad (141). For example, in Australia Mycobacterium bovis represented 
0.2% of all human TB cases in 2010, and M. bovis infection is linked with 
employment in the livestock industry and immigration from countries in which bovine 
TB is endemic (142). In the United States (US), between 1995 and 2005, the majority 
of human M. bovis patients was born outside of the US and could have contracted 
zoonotic TB abroad. In addition, the consumption of fresh cheese (‘queso fresco’) 
produced from unpasteurized milk in Mexico has been described to be a potential 
source of M. bovis in the US (143). Mexico is a country where bovine TB has a high 
prevalence in cattle, and studies have found high prevalence in humans (144–146). 
A recent study described a prevalence of 26.2% of M. bovis among human TB 
patients (n = 1165) in Mexico. However, this high proportion of M. bovis among 
human TB patients has been explained by the authors as potentially linked to 
immunosuppressed patients; in addition, isolates obtained from HIV-infected patients 
accounted for 19.2% of the local samples in the same study (147). 
Bovine TB has been previously classified by the WHO to be a neglected zoonosis 
in developing countries, where the public health burden of bovine TB is high and 
many risk factors linked to the transmission and persistence of M. bovis are present, 
for example, consumption of unpasteurized milk (107). Moreover, neglected 
zoonoses such as bovine TB in developing countries are associated with poverty 
(148). The quantified burden of zoonotic TB on public health is still not well known in 
developing countries. A recent review of M. bovis among humans in Africa reported a 
mean prevalence of 2.8% of M. bovis among human TB patients. Considering an 
incidence rate of 264/100 000 population/year, this review resulted in a crude 
estimate of 7 zoonotic TB cases/100 000 population per year (149); however, more 
studies are needed to better investigate the public health burden of bovine TB in 
developing countries. In June 2016, the WHO included zoonotic TB as a priority and 
it is now endorsed by the Strategic and Technical Advisory Group (STAG). In order to 
follow this development, OH approaches are needed to continue improve the 
situation. 
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1. Livestock 
Bovine TB causes economic losses to the livestock industry, as it increases 
mortality and reduces milk and meat production. It also results in condemnation of 
organs and carcasses in the slaughterhouses when animals show gross visible 
lesions suggestive of bovine TB infection (150). To date no study has been 
performed in Africa to estimate the productivity losses in terms of meat and milk 
caused by bovine TB.  
In Ireland, a study showed that bovine TB infection caused a decrease of milk 
production by 0.5% to 14.6%; however, decreased milk production has been shown 
to be a risk factor for bovine TB (151). These findings are in line with earlier 
estimates of milk production losses of 10% among tuberculin-positive animals in the 
former East Germany (152). In Bangladesh, a study showed bovine TB to be 
responsible for 18% of milk losses (153). In addition, annual calving rates are 
reduced by 5% among bovine TB-positive animals, thus affecting the fertility and 
demographic composition of the herd  (154). Overall, the cost of bovine TB to the 
Ethiopian livestock production systems was estimated at 1% of the net present value 
in the rural and 4% to 6% in urban areas (155). 
2. Human health 
The emergence of drug-resistant M. bovis is an important public health problem 
that affects the success of TB control programs in many developing countries, for 
instance in Mexico (156). Consequently, it causes an increased illness burden and 
financial losses due to relapses considering the resistance of M. bovis to a first-line 
drug (pyrazinamide) used in human TB treatment (157–159)  
In most developing countries, no microbiological identification of TB causative 
agents is made before the administration of treatment. Considering the natural 
resistance of M. bovis to pyrazinamide, in addition to the re-emerging mutations in M. 
bovis genome, which cause resistance to other TB drugs (158), a human infection 
with M. bovis could be considered as one the causes contributing to the relapse of 
TB patients. Consequently, there is an urgent need to quantify the exact burden of 
zoonotic TB among human TB patients in developing countries and, more 
importantly, among the groups that are the most at risk to contact M. bovis from 
cattle. 
D. Bovine Tuberculosis: Transmission and Risk Factors for Cattle and 
Humans  
Bovine TB is a zoonosis caused by M. bovis, a Gram-positive bacteria belonging 
to the Mycobacterium tuberculosis complex (MTBC). The most important host for M. 
bovis is cattle (160); however, this species infects a wide range of domestic and wild 
animals as well as humans (139,161). 
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A brief description of factors impacting transmission of M. bovis among cattle and 
to and between humans is presented in this section to highlight the need of an OH 
approach to control bovine and zoonotic TB. Several risk factors are linked with 
bovine TB infection in cattle. The risk of bovine TB infection has been described to 
increase with age (162), while local breeds have been linked with lower prevalence of 
bovine TB (163). The risk of bovine TB infection regarding gender has been observed 
to be linked to livestock management practices and cultural behavioral habits related 
to each country (164). In developing African countries, imported cattle are usually 
kept under intensive conditions, a factor that has been previously described as a risk 
factor for bovine TB infection (165). In addition, intensive breeding is usually 
practiced in larger herds, a factor that has been shown to increase the risk of bovine 
TB infection (164). The type of production could also be a risk factor for bovine TB, 
as described in a cohort study in New Zealand from 1980 to 2004, where dairy herds 
were observed to have a higher risk of infection compared to fattening schemes 
(166). 
Two routes of transmission have been described in humans: for adult and older 
patients, airborne transmission is the most common route causing pulmonary TB, 
while in younger patients, foodborne transmission occurs more often, which may lead 
to extra-pulmonary tuberculosis (143). Consumption of unpasteurized milk has been 
recognized as to be a major risk factor (167). However, the transmission of M. bovis 
to humans can be enhanced by other factors, such as HIV co-infection (143,168). 
Person-to-person transmission of M. bovis has been previously reported in immune-
deficient patients (169,170), as well as in immune-competent patients as described in 
France in 2009 (Sunder et al., 2009). The transmission of M. bovis between animals 
and humans depends on many risk factors, which vary from one epidemiological 
context to another. In developing countries, the livestock management system is a 
very important risk factor for bovine TB transmission. As the economy of a country 
grows, the livestock keepers tend to move from more extensive pastoral systems to 
more intensive livestock management for dairy production. In such systems, animals 
are closer together in less ventilated spaces and with less sunlight. Such intensified 
production systems provide a more favorable environment for the persistence of the 
disease, as M. bovis is more easily transmitted (165,171). 
Moreover, human TB due to M. bovis has been suggested as an occupational 
hazard after the isolation of M. bovis from 5 abattoir workers among 3000 abattoir 
workers during a 2-year period in Australia (172). In Pakistan, human TB caused by 
M. bovis was found in livestock keepers and abattoir workers. Almost all of these 
workers do not work safely and they do not protect themselves (173). These facts 
suggest that biosafety measures should be applied for workers in direct contact with 
M. bovis hazards from livestock to abattoirs, and strict routine surveillance for bovine 
TB gross visible lesions should be applied in order to protect the consumer from M. 
bovis exposure. 
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E. The Cost of Bovine Tuberculosis  
The economics of bovine TB have been summarized by  Zinsstag et al. (2006). 
The authors emphasized the multifaceted and multi-sector nature of bovine TB with 
costs to livestock production and animal health, in addition to wildlife and human 
health. However most of the time economic analyses of bovine TB focused only in 
one sector: the cost to livestock production. In areas where cattle are the only 
reservoir host, the control of bovine TB is possible with a test and slaughter policy, 
whereas in countries with wildlife reservoirs it is more difficult and increases the cost 
of efforts to control bovine TB. The cost for the control of bovine TB in the UK 
decreased from an average of GB£92 million annually from 2003 to 2005 (174)) to 
GB£74 million in 2006 (136) and increased again to GB£99 million pounds in 2013 
(175). A total of GB£66 million has been directed for operational, policy and lab work 
performed by the animal health services and the veterinary laboratories agency; in 
addition to the payment for private veterinarians for TB testing, GB£23.5 million of the 
total amount is for cattle compensation costs (176). In Turkey, the annual socio-
economic impact of bovine TB to the agriculture and health sectors is estimated to 
range from US$15 to US$59 million (177), while in Argentina, the losses due to 
bovine TB has been estimated to be US$63 million  as reported by Cosivi et al. (167). 
Very few cost estimates are available for bovine TB in developing countries. As 
one of the first, in Ethiopia the cost of this disease was estimated using a livestock 
demographic model (LDPS2, Food and Agriculture Organization) with some 
modifications to allow the stochastic simulation of parameters. It was shown that the 
cost of bovine TB in the peri-urban dairy production system in areas of Addis Ababa 
(where the disease has a higher prevalence, and the present value of livestock 
products is US$13.9 million) was found to range from US$0.5 to US$4.9 million in 
2005 and in 2011, respectively, whereas in the rural areas, where bovine TB has a 
lower prevalence, with a present value of livestock products of US$7.5 billion, the 
cost of bovine TB ranged from US$75.2 million in 2005 to US$358 million in 2011 
(155). This cost analysis in Ethiopia concluded that the intervention to control bovine 
TB in the country would not be cost effective and was not possible within the current 
economic situation of Ethiopia (155). 
 
In addition, a recent review in Ethiopia identified the test and slaughter control 
strategy to be financially and logistically unfeasible for bovine TB. This review also 
highlighted the need to explore alternative control options such as milk 
pasteurization, meat condemnation in the abattoirs and animal movement control 
(179).  
The above analysis was not multi-sectorial in the sense that it considered that the 
estimation of the full societal cost of a bovine TB should take into account the social 
and private sectors, direct and indirect losses to livestock production, and animal and 
human health.  
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Table II.1 summarizes the different losses triggered by bovine TB in humans and 
animal sectors. The human health sector losses could be estimated considering the 
burden of M. bovis on human TB cases.  
Table II.1. Direct and indirect economic losses associated with BTB in human and 
animal sectors. 
                 Animal                           Human 
Direct  Condemned meat in 
slaughterhouses 
 Diminution of the 
animal value 
 Diagnostic and hospitalization 
(ministry of health) 
 Out-of-pocket expenses for 
health care (contribution of the 
patient) 
Indirect  Diminution of milk 
production 
 Diminution of fertility 
 Change of herd 
demographic composition 
 DALY’s lost 
 Transport costs (travel 
expenses) 
 Expenses related to the 
patient visitors and accompanying 
person. 
 Jobs lost (change in the 
household income) 
Bovine TB is not a disease that receives the most attention in developing 
countries, as many other infectious diseases in animal health given higher 
prioritization (e.g. foot and mouth disease and peste des petits ruminants). In 
addition, as the burden of bovine TB has not yet been estimated in most of the 
countries, the stakeholders are not aware of the real burden of this disease, 
especially for human health. In many developing countries, physicians are not 
convinced of the added value of working closer with the animal health sector in order 
to control this disease, as they assume the proportion of M. bovis among human TB 
patients to be very low, although this is not yet estimated in many developing 
countries (e.g. Morocco), and that M. bovis has not been officially considered or 
investigated as the causal agent of human TB. In countries where bovine TB has a 
high prevalence in cattle, and where no prevention control measures are applied 
(e.g. mandatory milk pasteurization), the proportion of M. bovis infections among 
human patients could potentially be higher than expected.  
F. One Health Economics of Bovine Tuberculosis  
OH approaches to control zoonoses have been applied in developing countries, 
mainly in epidemiological investigations. Examples include human and animal 
seroprevalence studies performed in Kyrkyzstan (180,181) and in Mangolia (182). 
Moreover, OH showed a great potential in the contribution to rabies elimination in 
Africa as explained by (183). 
To apply an OH approach to bovine TB, the first step to be undertaken is to 
investigate the burden of M. bovis among human TB patients. This information could 
be used in order to start a dialogue between the human and animal health sectors. 
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Before an integrated approach to control human TB and bovine TB can be 
developed, an economic study assessing the cost of the control of human TB using a 
OH approach should be performed, in addition to the evaluation of the added value of 
this approach. Potential savings achievable through the implementation of OH 
concept in 139 World Bank client countries have been estimated to range from 0% to 
40% depending on the task considered (184). 
The adequate resources needed to achieve this collaboration should be available; 
in addition, the persons involved in OH interventions should be trained in order to 
have the necessary skills needed for a better management of the intervention (186). 
Decision makers are a key stakeholder in bovine TB control strategy, and they 
should be involved in the process from the beginning. The economic and societal 
impact of each approach suggested must be communicated to the decision makers, 
in addition to a time line for intervention and a cost-effectiveness analysis (186). 
Interventions to control a zoonosis should be performed in parallel with a health 
education campaign, as this will contribute to a better acceptance of the control 
program by the local population and its sustainability (187). 
G. Bovine Tuberculosis as a One Health Issue 
The burden of M. bovis for public health is very low for developed countries, 
where the disease in cattle has a low prevalence or has been eradicated. In 
developing countries, the burden of M. bovis in humans is known for only a few 
countries. In a systematic review and meta-analysis, (149) reported an average 
prevalence of M. bovis among humans of about 2.8% (7 zoonotic TB cases/100,000 
population per year) in Africa, based on information from African countries for which 
data is available. However, no data are available for quantifying the number of 
human TB patients infected with M. bovis in many other developing countries in 
Africa and elsewhere. This could be due to a weak communication between human 
and veterinary health systems, which calls for an OH approach. In addition to a lack 
of awareness of a potential high burden of M. bovis among humans, in settings 
where bovine TB has a high prevalence among cattle and several risk factors for 
transmission of bovine TB to humans are present (e.g. consumption of unpasteurized 
milk, close contact between human and cattle), the burden of M. bovis should be 
urgently considered.  
Morocco is a developing country where the prevalence of bovine TB among cattle 
is 18% (188), and 40% of the population live in rural areas (189) in close contact with 
cattle. The burden of M. bovis among human TB cases should be investigated, as the 
risk factors for zoonotic TB transmission from animals to humans are present. In this 
context, an OH approach should be introduced where the human health and 
veterinary efforts are integrated in order to investigate the real burden of M. bovis in 
humans in such settings, but such collaboration needs an improved communication 
between both sectors. 
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A recent transmission model (Figure. II.1) of bovine TB in Morocco showed that 
the disease could be controlled within 20 years, if 60% of Moroccan cattle were 
tested annually and infected animals were slaughtered. This 20-year campaign is 
projected to cost €1.53 billion (190). Further analyses on the profitability and cost 
effectiveness are ongoing. The transmission model used to estimate the cost of 
bovine TB elimination in Morocco considered three categories for cattle (susceptible, 
exposed with latent TB, and infected with active TB). The human population was 
divided into four categories (susceptible, exposed with latent zoonotic TB, infected 
with active TB, and recovered from TB). In order to represent the human burden of 
bovine TB, a transmission from infected cattle to exposed humans was considered in 
the model (190). 
 
Figure II.1. Schematic diagram of the bovine TB cattle-human transmission 
model for Morocco (Abakar et al., 2016) 
H. Towards the Control and Elimination of Bovine Tuberculosis in 
Developing Countries 
In Japan, the tuberculin skin test was introduced in 1948, and the test and 
slaughter strategy was applied, followed by an annual examination. Consequently, 
bovine TB prevalence dropped quickly and the disease was nearly eliminated from 
cattle in Japan (191). Several developed countries were able to eliminate bovine TB 
using the test and slaughter strategy, and the success of this strategy was supported 
by the absence of a wildlife reservoir (192). Switzerland is one of the success stories 
of bovine TB eradication, where the test and slaughter strategy was applied for 10 
years followed by 20 years of surveillance campaign (193). Australia also 
successfully controlled bovine TB using a mandatory test and slaughter strategy 
(103). Test and slaughter is the only control strategy that shows success for the 
control and elimination of bovine TB; however, this strategy remains unaffordable for 
developing countries, primarily because of the compensation needed for the 
slaughtered cattle (107). 
In order to control a particular disease, a clear understanding of the biology and 
epidemiology of the causal agent is an important starting point that allows for the 
identification of all the realistic intervention points and the design of control strategies 
that are in line with the economic situation of the country. The implementation of a 
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control strategy should be done in a way that allows progressive adjustments. 
Epidemiological surveillance procedures and tools should be used to monitor the 
progress of the control strategy and adjust it if necessary (194). According to Morris 
(2015), the most problematic point in dealing with the control of a disease is the fact 
that the previously explained points are marginalized. Disease control could be 
achieved in a more efficient way by integrating suitable management tools by the 
appropriate stakeholders (195). Bovine TB control should be motivated by both the 
public health implications of M. bovis and the economic losses triggered (160). 
Transdisciplinary research using participatory stakeholder involvement could be used 
in order to contribute to the control of bovine TB from developing countries, like 
Morocco, where there is very little or almost no dialogue between the different 
stakeholders (veterinarians, medical doctors, decision makers and farmers).  
The importance of an OH-integrated approach including livestock, wildlife and 
public health sectors was identified as a key element in bovine TB control in Ethiopia 
(179). In developing countries, the control of bovine TB must begin with many 
transdisciplinary workshops in order to set a dialogue between the different 
stakeholders, as well as create a trust environment between these sectors. In this 
process, farmers and decision makers will be informed by the scientists about the 
economic losses caused by bovine TB and about the different ways or actions that 
could be undertaken in order to control this disease. The needs of all the 
stakeholders involved in controlling bovine TB should be considered, as this will 
ensure their engagement in the application of control strategies and contribute to its 
sustainability.  
In developing countries, bovine TB control strategy should be focused on many 
levels. Good management of the resources that will be involved in the campaign is 
required, in addition to training the teams that will participate in the intervention. In 
parallel, an awareness campaign should be launched in order to make the local 
population aware of the effectiveness of the control strategy and its positive effect on 
the long term. Sustainability of the control strategy is essential for the success in 
controlling of bovine TB and its elimination in the long term. The integration of all the 
stakeholders in all the processes from the formulation to the application of the control 
strategy and including the monitoring is crucial to ensure the achievement of the 
interventions. 
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III. Research rationale 
1. Goals 
One health approach has been increasingly popular in the past years, and 
showed positive results regarding zoonosis control. In Morocco, OH has been 
introduced first in 2009 with the launching of the European Union project ICONZ 
(Integrated Control Of Neglected Zoonosis). ICONZ project was dealing with dog 
transmitted zoonosis and bacterial zoonosis. One of the bacterial zoonosis is Bovine 
tuberculosis; this chronic disease is endemic in Morocco.  
M. bovis, the causative agent of BTB could be transmitted to humans, as 
reported so far, M. bovis is responsible for a respectively small proportion of human 
TB cases; Muller et al reported a proportion of 3.1 % of M. bovis among human TB 
cases in Africa. However, in many developing countries, where BTB is highly 
prevalent, there is no estimation yet of the proportion of M. bovis among human TB 
patients. 
Actually, in Morocco the human burden of M. bovis is not yet known, in the 
absence of any collaboration between the human and animal health services, this 
data is difficult to investigate. 
The application of OH approach for bovine tuberculosis is a long term process, 
as BTB is currently not a priority for veterinary services in Morocco. In addition the 
burden of M. bovis on human health is not fully recognized by the human TB experts 
in Morocco. Trans-disciplinary process could be an efficient tool in bringing all the 
stakeholders together in order to discuss and design adapted solutions BTB problem 
in Morocco. 
The goal of the present thesis is to contribute on the understanding of bovine 
tuberculosis problem in Morocco, to identify the key points to consider for a future 
BTB control strategy. In addition to provide advocacy elements, this could be used to 
set up stakeholders meetings between human and animal health sectors.  
2. Objectives 
 
 Investigation of the prevalence of bovine tuberculosis in Sidi Kacem area in 
Morocco, and analyze the respective risk factors 
 Molecular characterization the strains responsible of bovine tuberculosis in two 
Moroccan slaughterhouses. 
 Realization a mathematical model of BTB transmission from cattle to cattle to 
human in Morocco 
 Realization of a demographic model for cattle population in population 
 Assessment of the societal cost of BTB for the human and the animal health 
sectors.  
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Abstract 
Bovine tuberculosis (BTB) and brucellosis are major endemic zoonoses in ruminants 
in Morocco that impact on both human and human health. This study presents an 
assessment of the epidemiological and socioeconomic burden of bacterial zoonoses 
in Sidi Kacem Province in Northern Morocco from a cross- sectional survey of 125 
cattle and/or small ruminant-owning households. In total, 1082 sheep and goats were 
examined from 81 households. The single intradermal comparative cervical test to 
screen for bovine tuberculosis was undertaken on 1194 cattle from 123 households 
and all cattle were blood sampled. Cattle and small ruminant blood samples were 
tested for brucellosis using the standard Rose Bengal Test (sRBT). Bacteriology was 
performed on 21 milk samples obtained from cattle that were seropositive for 
brucellosis for isolation and phenotyping of circulating Brucella strains. 
Individual and herd prevalence for BTB in cattle of 20.4% (95% CI [18%-23%]) and 
57.7% ([95% CI [48%-66%]) respectively were observed in this study. The 
prevalence of Brucellosis in cattle, at individual and herd level in cattle was 1.9% 
(95% CI [1.2%-2.8%]) and 9% (95% CI [4.5%-1.5%]) respectively. Brucella 
pathogens were isolated from three cattle milk samples and were identified as 
Brucella abortus using Bruceladder ® multiplex PCR and Brucella abortus biovar 1 
from application of classical phenotyping. All small ruminants were seronegative to 
sRBT, two were positive to mRBT.. 
A higher risk of BTB and brucellosis was observed in cattle in intensive livestock 
systems, in imported and crossed breeds and in animals from larger herds  (>15). 
The three risk factors were usually present in the same herds, leading to higher 
transmission risk and persistence of both zoonoses. 
These results highlight the importance of implementing control strategies for both 
BTB and brucellosis to reduce productivity losses in ruminants and reduce the risk of 
transmission to humans. Prioritising control for BTB and brucellosis in intensive 
livestock production systems is essential for human and animal health.  
 
Keywords: Morocco, Bovine tuberculosis, Brucellosis, Ruminants, Prevalence, 
Risk factors. 
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Introduction 
Bovine tuberculosis (BTB) and brucellosis are bacterial zoonoses that are endemic in 
ruminant cattle and small ruminants (for brucellosis) populations in Morocco. These 
diseases are prioritized in Moroccan veterinary legislation (1,2), but remain poorly 
controlled. Infectious diseases impose a heavy financial burden on the livestock 
sector (3) and zoonoses have a dual impact through human disease burden and 
productivity losses of livestock, on which rural families depend for their livelihoods 
(4). While Brucellosis and BTB have been controlled and/or eliminated in many 
developed countries (5,6),  in developing nations, these diseases are neglected (7) 
with WHO considering control of zoonotic TB to be a major priority (8). Rapid growth 
and intensification of livestock systems is expected to result in an increase in 
prevalence of both brucellosis and BTB (19). 
The infectious agent of Bovine tuberculosis (BTB) is Mycobacterium bovis, a member 
of the Mycobacterium tuberculosis complex. Despite a host preference for cattle (9), 
M. bovis can infect a wide range of domestic and wild animals (10,11). Cattle to cattle 
transmission occurs via direct contact (aerosols) and depends on a number of factors 
including the number of bacilli excreted and herd density (12). Transmission of BTB 
to humans is mainly through consumption of infected raw milk, although direct 
transmission can occur (13). In Morocco BTB is still highly prevalent. A national 
tuberculosis survey in cattle in 2004 using the single intradermal tuberculin test 
showed individual and herd prevalence of 18% (n= 13,021) and 33% (n=2263) 
respectively (14). BTB is responsible for meat losses due to carcass condemnation 
and causes a decrease in herd productivity and milk yields (15). 
In Morocco, Government BTB control initiatives include tuberculin testing and the 
slaughtering of any positive animals (reactors). At national level, the mandatory BTB 
control strategy is for test and slaughter but legislation is poorly enforced and no 
programme of systematic BTB screening of cattle is in place (2,16).  
Brucellosis is caused by gram-negative bacteria of the genus Brucella which includes 
eleven species (17). B. melitensis and B. abortus are the most economically 
important for Morocco and cause disease in small ruminants and cattle respectively 
(18). In West Africa B. abortus infection in small ruminants is noted to occur in areas 
where the animals are in contact with cattle and where B. melitensis is absent (19). 
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Brucellosis is spread through contact with abortion products and vaginal fluids, from 
milk feeding or as a venereal disease. Contact with infected animals and 
consumption of raw dairy products is the most common source of transmission (20). 
Brucellosis causes economic losses in livestock due to abortions and prolonged 
calving to conception intervals.  
National epidemiological surveys for brucellosis in Morocco in 1996 and 2010 
showed that bovine brucellosis is more prevalent in the north-west coastal and 
central zones where the cattle density is the highest, with a mean individual and herd 
prevalence of 2.1 % (n=8991) and 4.9 % (n=1168) respectively (Government survey, 
2010). Herd seroprevalences have remained at a similar level to those reported in 
1977 (4.6%) and in 1988 (4.9%) (19).  
Initiatives to control brucellosis in Morocco have had varied success. A national 
vaccination campaign using S19 vaccine that ran from 1989 to 1994 showed little 
impact on herd prevalence (21) 
By contrast, a public-private initiative (2007) to roll out RB51 and/or S19 vaccination 
to farms that are members of professional associations or cooperatives reduced 
brucellosis prevalence from 40% to 0.4% in member farms (22). In total 81230 cattle 
were serologically tested for brucellosis, 55869 were vaccinated and 2901 were 
culled at a cost of $US 2.6 million. A large bacterio(23–25)logical study comprising 
500 samples from 357 cattle isolated B. abortus biovar 1 and 3 in the 1980s (26).   
Brucellosis in small ruminants is a recognized problem across the northern 
Mediterranean zone of Morocco and in inland mountainous areas where sheep and 
goat populations dominate. In the mid-1990s, small ruminant brucellosis emerged in 
in the Oriental region where Morocco shares a border with Algeria and prompted a 
program of mass vaccination with Rev 1 (FULL NAME) via the conjunctival route of 
small ruminants in the zone between 1997 and 2003.  A premature closure of the 
vaccination campaign resulted in disease re-emergence and between 2009 and 
2013, 48 individual case reports of small ruminant brucellosis were reported in the 
Northeastern region. A National survey in 2006 testing 11,609 small ruminants, 
yielded 8 sero-positives, 5 of which from the Oriental region (19). Bacteriological 
evidence of brucellosis in small ruminants in Morocco is limited to only three studies 
reporting isolation of B. melitensis biovar 3 (23–25). 
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This study aimed to estimate the prevalence of bovine tuberculosis in cattle and the 
seroprevalence of brucellosis in cattle, sheep and goats; to identify Brucella strains 
circulating in Sidi Kacem province and to assess BTB and brucellosis risk factors in 
this epidemiological context.  
Material and methods 
Study area  
 
 
Figure IV.1. Location of Sidi Kacem, North West Morocco (27) 
Sidi Kacem province (figure 4.1) comprises 29 communes, and is sub-divided into 
two agro-hydrologic zones: “rain-fed” (bour) in the northeast and “irrigated” in the 
southwest (figure 4.2). The irrigated zone is characterized by low-lying plains, in 
contrast to the rain-fed zone, which is mountainous (altitude from 150 to 500 m). The 
number of cattle in the rain-fed zone is 40% of the total number in the province with 
an average herd size of 5 cattle; by contrast, average herd size in the irrigated region 
is 15 cattle (28). The irrigated zone is dominated by an intensive mode of livestock 
rearing characterized by a larger herd size and European dairy breeds (Holstein-
Friesian, Montbeliarde, Tarentaise) or cross-bred cattle. The livestock production 
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system in the rainfed zone is more extensive, with dominance of local cattle breeds 
and smaller herd size.   
Sampling 
Sample size was determined using standard formulae for cluster surveys(29). 
assuming the following parameters, i) a BTB prevalence of 18% (national survey 
2004 (14)), ii) a mean number of cattle per household of 9, iii) an average number of 
2 households selected per cluster and iv) an intra-class correlation coefficient of 0.2 
(30). An average of 62 villages (douars) and 124 households are required to estimate 
the prevalence with a precision (defined as one half-length of the 95% CI) of 5%-
points. Clusters were randomly selected based on the official village lists available for 
Sidi Kacem province. Two households per village were randomly selected based on 
livestock-owning households provided by the chief of the commune upon arrival in 
each village; all cattle in cattle owning households were sampled. As small ruminant 
flock numbers were high, not all sheep and goats were sampled in small-ruminant 
owning households; a minimum of 20 animals were sampled for households that 
owned more than 20 sheep or goats.   
Herd and animal level data  
At herd level, GPS coordinates (Figure 4.2), livestock production system, grazing 
system and herd size were recorded.  
Most sampled households owned cattle, in contrast to small ruminants. Table 4.1 
shows the number of households and the species present within the household.  For 
every animal, age, gender, breed and body condition score (BCS) was recorded.  
Table IV.1. Number of sampled households in terms of present species 
Species owned by household Number of households 
Cattle only 44
Sheep only 2
Goats only 0
Cattle sheep and goats 4
Cattle and sheep 75
Cattle and goats 0
Sheep and goats 0
TOTAL 125
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Diagnosis of bovine tuberculosis.  
The single intradermal comparative cervical skin test (SICCT) was used following 
OIE terrestrial manual standards for BTB screening. Briefly, injection sites were 
clipped and cleaned; a fold of skin within each clipped area was measured with 
calipers and 0.2 ml each of bovine and avian PPD with 25’000 IU/ml was injected in 
the left neck region. Injections were performed using a separate intradermal gun for 
each PPD in two spots separated by approximately 15 cm. The skin-fold thickness at 
each injection site was re-measured 72 hours after injection by the same individual. 
Any exudate, edema and pain observed in the injection sites were recorded. The 
SICTT was interpreted using the OIE recommended cut off and an animal was 
considered positive if the increase in skin thickness in the Bovine PPD injection site 
was superior to the skin thickness in the Avian PPD injection site by at a minimum of 
4 mm. The reaction was considered inconclusive if the difference was between 1 and 
4 mm and if the increase in the skin thickness was the same in the bovine PPD and 
avian PPD injection sites, the reaction was considered negative (31). 
Brucellosis sero-diagnosis and bacteriology 
Blood from 1194 cattle and 1082 small ruminants across 125 households was 
collected (Figure 2) and all sera were stored in cool boxes before processing. After 
24h storage at 4°C to allow serum separation, the tubes were centrifuged and sera 
extracted and aliquoted. One aliquot was used for immediate screening of both cattle 
and small ruminant sera using the modified Rose Bengal Test (mRBT), 75 μl serum 
and 25 μl antigen.  
The initial screening aimed to collect milk samples from seropositive lactating 
females for bacteriological investigations, and using mRBT increased the diagnostic 
sensitivity thereby maximising the number of milk samples collected. A second 
aliquot was stored at -18 C and sent to the Instituto de Salud Tropical y Depto. 
Microbiología y Parasitología, Universidad de Navarra (UNAV) for screening. Cattle 
samples were screened using sRBT. Small ruminant samples were screened using 
sRBT and mRBT in parallel.  
The antigen used in RBT was a suspension of fully smooth B. abortus 1119 
standardized according to international guidelines (31) and controlled for quality 
using a panel of brucellosis positive and negative serum samples (32).  
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Bacteriology was undertaken on milk samples obtained from 21 seropositive cattle 
(three CITA and three Farrell’s selective media plates for each sample). After 
incubation for 4-7 days 37ºC (5-10% CO2 atmosphere), suspicious colonies were re-
plated on the same media for preliminary identification. Isolates were considered 
presumptive for brucella by means of the staphylococcus co-agglutination, oxidase 
and urease tests (33). Colonies found to be suspicious based on morphological 
evaluation were stored at -20ºC in vials of Triptic Soy Broth (TSB) with 5%DMSO for 
further typing at the WHO and OIE collaborating centres for the diagnosis of animal 
and human brucellosis at the University of Navarra (UNAV) and Centro de 
Investigación y Tecnología Agroalimentaria de Aragón (CITA) in Spain. 
Isolates were confirmed as Brucella species and typed at species level using 
Bruceladder ® multiplex PCR (34) and, at biovar level, using classical phenotyping 
methods (33), i.e. oxidase and urease tests, CO2 requirement, agglutination with 
monospecific anti-A / anti-M sera, lysis with phages (Tb, Wb, Iz1 and R/C), sensitivity 
to dyes (fucsine, thionin and saphranine) and Crystal Violet exclusion test (to assess 
absence of dissociation).  
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Figure IV.2. Sidi Kacem rainfed and the irrigated regions and geo-
localisation of the households screened 
Statistical analyses 
Data was entered in Access 2012 and analysed using Generalized Estimating 
Equation models in Stata 12.1, to account for clustering at household level. 
Prevalence and individual and herd risk factors for BTB and brucellosis were 
investigated. 
Using diagnostic sensitivity (51,1%) and specificity (98.9%) values (previously 
reported by Müller et al. from Chadian cattle using SICTT (42)) and apparent 
prevalence estimated in our study, the true prevalence of BTB was calculated using 
the formula proposed by Morgan et al. (35): {True prevalence= (Apparent 
prevalence+sp-1)/(sp+se-1)}. Given the high sensitivity and specificity of sRBT 
apparent prevalence is close to  true prevalence (24, 28). 
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Analysis showed that most of the within-cluster correlation occurred at household 
rather than at village level and so household was selected as the cluster level for 
analysis. Sensitivity analysis used villages as clusters.   
Results 
Cattle characteristics  
In total, 1201 bovines from 125 farms in 62 villages were examined of which 78.4% 
(n = 938) were female, 85% were crossbreeds (n = 1016). Almost all of the cattle 
(96%, n = 1150) had a BCS equal to or less than 3. Most cattle (78%) (n = 936) were 
over 12 months. Cattle were almost equally distributed between the rain fed and the 
irrigated area, most from semi intensive herds (82.8%, n  = 994) and only a few (n = 
20) from extensive farming systems. Most herd sizes were below 15 (Table 4.2). 
Table IV.2. Basic characteristics of 1201 cattle sampled in Sidi Kacem, Morroco. 
Characteristics Classes N (%) 
Herd level  
Livestock production system 
 
Intensive 15 (12.2)
Semi-intensive 105 (85.4)
Extensive 3 (2.4)
Grazing system Irrigated 67 (53.6)
Rainfed 58 (46.4)
Herd size 1-15 92 (74.8)
>15 31 (25.2)
Animal level 
Livestock Production System 
 
Intensive 187 (15.6)
Semi-intensive 994 (82.8)
Extensive 20 (1.6)
Grazing system Rainfed 596 (49.6)
Irrigated 605 (50.4)
Age 0-12 265 (22.1)
13-36 397 (33.1)
>36 539 (44.8)
Sex Male 258 (21.6)
Female 938 (78.4)
Breed Crossed 1016 (84.9)
Imported 100 (8.4)
Local 81 (6.7)
Body Condition score 
 
1-2 (including 2) 366 (30.5)
2-3 (including 3) 784 (65.3)
3-4 15 (1.3)
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Prevalence for BTB 
Tuberculin skin test results were derived for 1194 cattle, 107 animals were found 
inconclusive for BTB using the OIE interpretation criteria of the SICCT and were not 
included in the analysis. An individual apparent BTB prevalence of 20.4% (95% CI 
18%-23%) and a herd prevalence of 57.7% (95% CI 48%-67%) were found.  
Considering a sensitivity of 51% and specificity of 99% as reported in Müller B et al 
(37), a true individual BTB prevalence of 38.2% was estimated. 
Brucellosis results using sRBT diagnostic protocols were available for 1179 cattle. 
Prevalence of bovine brucellosis was 1.9% (95% CI 1%-3%) at individual level and 
9% (95% CI 5%-15%) at herd level. None of the 1044 sheep or 51 goats screened 
was sRBT positive and only 2/1044 sheep were mRBT positive. 
Risk factors analysis 
a. Bovine tuberculosis 
The univariate and multivariate analysis of BTB risk factors are shown in Table 4.3. 
Local breeds were observed to have a lower risk of BTB compared to crossbreds 
(9% vs 21%, OR: 0.5, 95% CI 0.2-1.3). Male animals showed a significantly higher 
risk of BTB compared to female animals (12% vs 22.7%, OR: 0.3, 95% CI 0.4-4.8). 
Age of 12-36 months and higher than 36 months was associated with a significantly 
higher risk of BTB compared to a lower age (14.4% and 28.2% vs 13.7% OR:1.4, 
95% CI 0.8-2.5, and 3.9, 95% CI 2.3-6.6). BCS higher than 2 showed a significantly 
lower risk of BTB compared to lower BCS score (16.7% and 15.4% vs 29.5%, OR: 
0.6, 95% CI 0.4-0.8). 
At herd level, semi-Intensive and extensive livestock production system showed a 
lower risk of BTB than intensive rearing (18.1% and 5.3% vs 34.7% OR: 0.4, 95% CI 
0.1-0.9). Irrigated grazing systems showed a significantly higher risk of BTB 
compared with rain fed systems (30.1% vs 11%, OR: 3.5, 95% CI 1.8-6.5). Large 
herd size showed a higher risk of BTB than small to medium herd size (26.2% vs 
15.7%, OR: 2, 95% CI 0.9-4.1).  
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Table IV.3. Individual and herd risk factors of BTB in 1087 cattle 
  
Risk factor 
 
N. Screened 
 
% (N. Pos) 
 
OR (95% CI) 
 
P value 
 
mOR (95% CI)
Individual risk factors 
B
re
ed
 
Crossed 918 21.7 (199) Ref -- -- 
Imported 96 16.7 (16) 0.3 (0.1-0.7) 0.005 0.4 (0.1-0.8) 
Local 73 9.6 (7) 0.5 (0.2-1.3) 0.14 0.5 (0.2-1.4) 
A
ge
 
0-12 241 13.7 (33) Ref -- -- 
13-36 367 14.4 (33) 1.4 (0.8-2.5) 0.3 1.2 (0.7-2.3) 
>36 475 28.2 (134) 3.9 (2.3-6.6) <0.0001 2.6 (1.4-4.8) 
Se
xe
 F 845 22.7 (192) Ref -- -- 
M 241 12.0 (29) 0.3 (0.2-0.6) <0.0001 0.8 (0.4-1.4) 
B
C
S 
1-2 
(including 2) 
325 29.5 (96) Ref -- -- 
2-4 732 16.7 (122) 0.6 (0.4-0.8) 0.003 0. 8 (0.5-1.3) 
Herd risk factors 
Li
ve
st
oc
k 
pr
od
uc
tio
n 
t
Intensive 170 34.7 (59) Ref -- -- 
 
Semi-
intensive & 
extensive 
922 17.8 (164) 0.4 (0.1-0.9) 0.023 0.5 (0.2-1.4) 
G
ra
zi
ng
 
sy
st
em
 Rain fed 550 11.0 (60) Ref -- -- 
Irrigated 544 30.1 (164) 3.5 (1.8-6.5) <0.0001 3.1 (1.6-6.2) 
H
er
d 
si
ze
 0-15 animals 
600 15.7 (94) Ref -- -- 
>15 animals 492 26.2 (129) 2.0 (0.9-4.1) 0.06 2.1 (1.0-4.3) 
mOR: multivariate analysis OR 
ref: Reference category 
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b. Brucellosis 
Univariate and multivariate analysis of risk factors for brucellosis are shown in Table 
4.4. Imported and indigenous breed animals, in addition to male sex categories, were 
negative for RBT leading to perfect prediction. A higher risk of brucellosis was 
associated with an age greater than 36 months compared with ages lower than 36 
months (3.8% vs 0.4%, OR: 6.9, 95%CI 0.8-60.4). Having a low body condition score 
of 2 to 3 showed a significant lower risk of BTB compared to BCS lower than 2 (0.7% 
vs 4.7%, OR: 0.2 (95% CI 0.05-0.7). 
Semi-intensive production systems showed a lower risk for bovine brucellosis 
compared with intensive rearing (1% vs 6.9%, OR: 0.3, 95% CI 0.05-2.02). Irrigated 
grazing showed a significantly higher risk of bovine brucellosis than rain fed grazing 
systems (3.2% vs 0.5%, OR: 4.7, 95% CI 0.8-26.7). Large herd sizes showed a 
higher risk of BTB than small to medium herds (3.16% vs 0.77%, OR: 2.8, 95% CI 
0.5-15.1) (Table 4). 
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Table IV.4. Individual and herd risk factors of bovine brucellosis in 1177 cattle 
  
Risk factor 
N. 
Screened 
%Pos 
(n) 
 
OR (95% CI) 
 
P value
 
mOR (95% CI)
Individual risk factors 
B
re
ed
 
Crossed 997 2.2 (22) Ref -- --
Imported 100 0.0 (0) Nda -- --
Local 80 0.0 (0) Nda  -- --
A
ge
 
0-12 257 0.4 (1) Ref -- --
13-36 388 0.3 (1) 0.5 (0.02-8.5) 0.6 0.4 (0.02-7.41)
>36 527 3.8 (20) 6.9 (0.8-60.4) 0.08 5.1 (0.6-45.6)
Se
xe
  F 928 2.4 (22) Ref -- --
M 248 0.0 (0) Nda -- --
B
C
S 1-2 (including 2) 
363 4.7 (17) Ref -- --
2-4 783 0.6 (5) 0.2 (0.05-0.7) 0.01 0.5 (0.1-1.8)
Herd risk factors 
Li
ve
st
oc
k 
 
pr
od
uc
tio
n 
sy
st
em
 
Intensive 187 6.9 (13) Ref -- --
Semi 
intensive & 
extensive 
994 1 (9) 0.3 (0.05-2.02) 0.2 0.6 (0.1-4.3)
G
ra
zi
ng
 
sy
st
em
 Rain fed 595 0.5 (3) Ref -- --
Irrigated 586 3.2 (19) 4.7 (0.8-26.7) 0.083 3.4 (0.6-21.0)
H
er
d 
si
ze
 
Small to 
medium 0-
15 
643 0.77 (5) Ref -- --
Large (>15) 538 3.16 (17) 2.8 (0.5-15.1) 0.2 2.3 (0.5-11.9)
a: Not determined because of perfect prediction 
mOR: multivariate analysis OR 
 
Brucellosis molecular characterization 
Three Brucella strains isolated from female cattle were confirmed as Brucella abortus 
biovar 1 through classical typing. Isolates were from cows belonging to the same 
herd, from the irrigated zone. The cows were over 72 months old; two had a history 
of abortions and BCS of less than 2. The BTB herd prevalence was 57% (12/29). 
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Discussion 
The overall BTB individual apparent prevalence in this study was 20.4%, similar to 
that reported in 2004 (18%) during national tuberculin skin testing. However, given 
the reported low sensitivity of BTB testing these estimates are likely to be 
underestimates. The BTB herd prevalence in this study of 57.7% is higher than that 
previously reported at 33% in 2004 at national level (14). The 2004 survey applied 
the single intradermal tuberculin skin test (SITT), which is less specific than the 
SICTT used in the present study.  
The BTB prevalence in the present study is far higher than that reported  in Uganda 
(6%) (38), Niger (3.6%) (39), rural Ethiopia (5.5%) (40), and Tanzania (2.4%) (41). 
The high prevelance in Morocco may be explained by more intensive dairy cattle 
farming practices. BTB prevalence in Morocco (20.4%) was lower than that reported 
in Zambia (49.8%) and Mozambique (39.6%) (42,43). 
The tuberculin skin test is the recommended OIE test for BTB diagnosis. While the 
single tuberculin skin test (SITT) may result in a high number of false positives, the 
comparative tuberculin skin test (SICTT) was shown to reduce false positives and 
cross reactions (i.e. the single test has a higher diagnostic sensitivity and the 
comparative test is more specific) (31). In Morocco, legislation stipulates SITT as the 
recommended tuberculin skin test; the SICTT is used as a confirmatory test when the 
SITT is positive (16).  
Individual apparent brucellosis prevalence found in this work (1.9%) is near the 2.1% 
reported for the national survey of 2010-2011. National statistics from 1982 to 1992 
registered a mean herd prevalence ranging from 2.1% to 4.9%, which is lower than 
brucellosis herd prevalence (9%) found in the present study (23). Individual 
brucellosis prevalence found in Sidi Kacem was also lower than those found in Egypt 
(23.8%) (44), Uganda (5%) (45), Nigeria in 2011 (4.04%) (46) and in Ethiopia in 2006 
(2.9%) (47).  
In this study only two sheep from two different herds in the irrigated area showed a 
positive mRBT result, and regrettably slaughter for collection of necropsy samples for 
bacteriological confirmation could not be performed. The mRBT positive sheep were 
from a herd found that had had several cases of brucellosis in cattle. Livestock from 
this village graze on shared pasture and the sheep may have developed 
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seropositivity due to contact with B. abortus infected cattle (as previously reported in 
Nigeria (12)). These sheep could have developed antibodies but cleared the infection 
and hence be of negative infection status or alternatively be infected and a source of 
contagion to other ruminants or humans.  
Meta-analysis of diagnostic tests for bovine brucellosis (48) shows that the standard 
RBT (sRBT) performed with diagnostic sensitivity and specificity values of 98.1% 
(96.8-99.1%, 95% CI) and 99.8% (99.7-99.8%, 95% CI), respectively, where 
vaccination is not practiced (as in this study). The modified RBT protocol was used 
for serological analysis of small ruminant sera in order to optimise sensitivity whilst 
maintaining specificity in the absence of vaccination (34, 54). In addition, mRBT has 
been shown to be useful for reducing the cost and the time of brucellosis screening in 
B. melitensis eradication campaigns implemented in Portugal  (50). As Morocco is a 
country where no brucellosis vaccination is currently practiced (thus no interference 
due to vaccine-induced antibodies), RBT can be recommended for serological 
surveys in cattle and small ruminants respectively. 
Indirect and competitive ELISA tests both show similar sensitivity and specificity to 
RBT in absence of vaccination (31), but are more expensive (48) and need to be 
validated in the target population since their diagnostic performance depends on the 
manufacturer and the selection of an adequate cut-off to discriminate positive and 
negative samples (51). 
The gold standard for brucellosis diagnosis is isolation and identification of Brucella 
spp. Bacteriological culture is cumbersome, expensive and requires skill and facilities 
rarely available in resource-poor countries and consequently, indirect testing of anti-
brucella antibodies in serum is commonly applied for brucellosis screening. There is 
no single serological test which can be applied in all settings (52). Tests most often 
used for sero-epidemiological surveys or to monitor disease once vaccination has 
been implemented include the rose Bengal test (RBT), serum agglutination test (SAT; 
not recommended by OIE for brucellosis testing for the purpose of international trade 
due to its low sensitivity), and the complement fixation test (CFT - used as a 
confirmatory test when vaccination is practiced but technically cumbersome). 
Precipitation tests with Native Hapten and related polysaccharides show good 
diagnostic specificity even in the context of vaccination, making them useful for 
eradication programs and situations when infected and vaccinated animals coexist 
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(53); they are not commercially available making their use outside of research 
projects difficult. 
This study shows that intensive livestock production systems carry a significantly 
higher risk of BTB and bovine brucellosis. Intensive systems have previously been 
shown to be linked to elevated prevalence of BTB and bovine brucellosis (47,48,49). 
Intensive dairy farming conditions within a confined environment with less access to 
sun, air flow and high humidity conditions may enhance transmission of Brucella and 
Mycobacteria between animals. The higher stocking density, larger herd sizes, and 
propensity to buy in animals together with higher calving frequency in intensive 
systems may also increase the risk of disease transmission.  
Extensive systems, where animals are grazed in lower density on communal pasture, 
may have a lower risk of transmission because of the effect on the sun and heat on 
Brucella and Mycobacteria environmental contaminants. 
Brucellosis and BTB persist in both extensive and intensive livestock farming 
systems. In pastoralist rangelands, while the proportion of infected flocks or herds 
may be high, brucellosis may persist unidentified and/or unreported. Livestock 
intensification generates abortion storms and large productivity losses. The shift to a 
more intensive livestock production observed in rapidly urbanizing developing 
countries such as Morocco, could lead to an increase of zoonotic diseases 
transmission in the absence of animal recording systems, movements control and 
strong veterinary services management.  
Indigenous animals showed a lower risk of BTB, as has been previously reported 
(43), compared with imported and crossed breed animals. This may be explained by 
their non-adaptation to local conditions. Local indigenous breeds may not be a 
protective factor, however, because in Morocco extensive herds are dominated by 
local and cross bred cattle, while intensive herds are dominated by imported breeds. 
Consequently, the breed could be a confounding factor for the production system 
(18).  
Older animals showed a higher risk of BTB and bovine brucellosis as described in 
other studies (57). All positive brucellosis cases were found to be females but the 
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sample was composed predominantly of female cattle. In Nigeria, females were 
described to be more susceptible to B. abortus infection (58).  
In the present study, a low BCS showed a significantly higher risk of BTB. BCS has 
previously been linked with BTB infection (59,60), although recent studies in Ireland 
and Tanzania showed no evidence of the association of low BCS and high BTB 
prevalence (61,62). Low BCS could be linked to clinically advanced BTB (63) but in 
this study the initial status of the sampled animals was unknown. 
The Brucella strains isolated from the three Friesian/Holstein cows belonging to the 
same herd in the irrigated zone were found to be B. abortus biovar 1. Phylogenetic 
studies (not described here) showed these strains have some homogeneity with 
Spanish strains. This is in line with a study conducted in the mid-1980s yielding 8 B. 
abortus biovar 1 and 28 B. abortus biovar 3 strains from 500 samples (26,64). A 
subsample of these Moroccan strains was examined as part of a study characterising 
B. abortus strains of African origin and found the 12 Moroccan strains to be identical 
to B. abortus biotypes isolated in Europe.  
The present study demonstrates that there is added value in investigating multiple 
zoonoses simultaneously, especially for zoonoses with a reservoir overlap. 
Undertaking brucellosis and BTB screening in parallel and in multiple hosts is 
logistically and technically feasible. The added value of an integrated approach to 
epidemiological investigations on zoonoses has been demonstrated in Chad (65). 
Morocco could consider a parallel elimination campaign for BTB and brucellosis that  
optimizes use of  human and economic resources. 
The present study concluded that bovine tuberculosis and brucellosis are prevalent in 
Sidi Kacem. Considering the economic losses caused by BTB and brucellosis, in 
addition to their public health impact, additional efforts should be deployed to design 
an integrated control strategy. Test and slaughter has been shown to be the most 
efficient elimination strategy for BTB in several countries. Many factors contribute to 
the success of a control and elimination campaign. Trust between all the 
stakeholders especially the industry, the governmental structures and the farmers is 
a very important component which contributed to the success of brucellosis and BTB 
control program. Correct application of livestock biosafety measures, early diagnosis 
of the disease, and application of movement restrictions also affect the success of a 
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control campaign (66). In Australia, animal movement controls and abattoir 
surveillance were applied from early years of the control program (67). 
In Morocco, relationships between livestock keepers, local authorities and veterinary 
services are characterized by mistrust. Solid and sustainable control cannot be 
achieved without the conviction and participation of all stakeholders. Sensitisation 
and education campaigns of all stakeholders are required to improve adherence to 
and acceptance of control programs by local populations and decision makers. 
Strong industry and government support in funding and policy development are 
important factors for the success of a zoonosis eradication campaign as shown in 
Australia. A rigorous application of the decided strategy and involvement of the 
animal owners are pivotal for the success of control and elimination programs (68). 
Wildlife reservoirs can complicate control operations. The presence of a wildlife 
reservoir (e.g. badgers in Ireland) has caused reemergence of BTB in developed 
countries (69). Wildlife reservoirs have been shown to exist in Africa (feral baboons in 
Kenya (70) and warthog and buffalo in Uganda (71)). The role of a wildlife reservoir in 
BTB transmission in Morocco is unknown, and other barriers to control are 
considered critical including: lack of efficient organization of veterinary services; 
prioritization of other highly infectious viral and parasitic diseases; limited technical 
capacity and financial constraints (72).   
The best strategy for controlling brucellosis in Morocco would be conjunctival mass 
vaccination (B. abortus S19 in female cattle and B. melitensis Rev 1 in male and 
female small ruminants) every two years just before mating or immediately after 
calving/lambing/kidding. This is the best option as prevalence is high and the 
veterinary services are not able to apply individual tagging allowing vaccination of 
young replacements only (73). However, vaccination needs to be sustained over time 
to be effective. Premature removal of S19 or Rev1, or replacement with a less 
effective vaccine e.g. RB51, has led to failure of previous attempts for control in 
Morocco (19).  
Mass vaccination has been effective for brucellosis control in other countries e,g, 
Spain, which has been able to decrease the prevalence of brucellosis in ruminants. 
However, vaccination should be associated with adequate organisation of veterinary 
services, strict control of animal movements and adequate economic compensation 
68 
 
to affected farmers (29). Veterinary services could fall back on private veterinarians 
to perform BTB testing, as for the vaccination campaigns. Stakeholder engagement 
is key to success (74). 
A BTB transition model for Morocco indicated that BTB could be controlled within 25 
years, if 50% of cattle were tested annually, and infected animals were slaughtered at 
an estimated cost of 1.55 billion Euros (75). Taking into consideration the current 
infectious diseases prioritized by Morocco (e.g: foot and mouth disease, sheep pox 
virus and Peste des Petits Ruminants (PPR)), such a control strategy is currently 
deemed unaffordable for a middle income country.  
As for all NTZs, evidence and advocacy is necessary to convince policy-makers and 
communities of the benefits of disease control (76,77).  The evaluation of the cost of 
BTB should take into account the cost of the human disease, and for this purpose an 
investigation of the prevalence of M. bovis in humans is required, as well as a 
calculation of the direct and indirect cost of a human TB case. Cross-sectorial socio-
economic analysis of the cost of both diseases is needed. In addition, support from 
private industry (e.g. the milk industry) could sustain BTB and brucellosis control 
campaigns, as they will also benefit from the control measures.  Novel methods for 
innovative financing should be examined to mobilize investment for interventions that 
contribute towards elimination of NZDs (78,79) and benefit human and animal health.  
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Abstract 
Background 
Bovine tuberculosis (BTB) is caused by Mycobacterium bovis, which belongs to the 
Mycobacterium tuberculosis complex. Mycobacterium bovis have been described to 
be responsible of most cases of bovine tuberculosis. Although M. tuberculosis, M. 
africanum and non-complex mycobacteria were isolated from cattle. 
In Morocco, so far, no molecular studies were conducted to characterize the strains 
responsible of BTB. The present study aims to characterize M. bovis in Morocco. 
The present study was conducted in slaughterhouses in Rabat and El Jadida. 
Samples were collected from 327 slaughtered animals with visible lesions suggesting 
BTB. 
Results  
A total of 225 isolates yielded cultures, 95% (n= 215) of them were acid-fast (AF). 
Sixty eight per cent of the AF positive samples were confirmed as tuberculous 
mycobacteria (n=147), 99% of these (n=146) having RD9 and among the latter, 98% 
(n=143) positive while 2% (n=3) negative for RD4 
A total of 134 samples were analyzed by spoligotyping of which 14 were in cluster 
and with 41 different spoligotypes, ten of them were new patterns (23%). The most 
prevalent spoligotypes were SB0121, SB0265, and SB0120, and were already 
identified in many other countries, such as Algeria, Spain, Tunisia, the United States 
and Argentina. 
Conclusion 
The shared borders between Algeria and Morocco, in addition to the previous 
importation of cattle from Europe and the US could explain the similarities found in M. 
bovis spoligotypes. On the other hand, the desert of Morocco could be considered as 
an efficient barrier preventing the introduction of BTB to Morocco from West Central 
and East Africa. Our findings suggest a low level endemic transmission of BTB 
similar to other African countries. However, more research is needed for further 
knowledge about the transmission patterns of BTB in Morocco. 
Keywords: Mycobacterium bovis, Bovine tuberculosis, Morocco, Cattle, 
Slaughterhouse, Spoligotype, PCR. 
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Introduction 
Bovine tuberculosis (BTB) is a chronic granulomatous caseous-necrotising 
inflammatory disease that mainly affects the lungs and their draining lymph nodes, it 
can also affect other organs, depending on the route of infection (1–3). BTB is 
caused by Mycobacterium bovis, which belongs to the Mycobacterium tuberculosis 
complex (MTBC). M. bovis has the particular ability to infect a wide range of host 
species other than cattle (livestock, wildlife and pets) and humans, (3,4), however, 
cattle remain the most important reservoir for M. bovis (5). There exist important 
wildlife reservoirs like the badger (Meles meles), the Possum (Trichosurus vulpecula) 
(4). 
M. bovis can be transmitted between animals by inhalation of aerosols and the 
ingestion of contaminated food. The transmission is enhanced by many risk factors, 
mostly related to intensive livestock system (6). The transmission of M. bovis to 
humans occurs by consumption of unpasteurized infected raw milk and by the 
contact with infected cattle (7). 
While BTB is still occurring in some developed countries in low prevalence (8–10) 
because of a wildlife reservoir (11) i.e. badgers in the UK (12), this zoonosis is 
endemic in many of the developing countries, who lack the financial resources to 
control this disease. Bovine tuberculosis is highly prevalent in many African countries 
(13,14), where it causes economic losses by its effects on animal health and 
productivity and by international trade restrictions. (15). Bovine tuberculosis is also a 
zoonosis and, consequently, considered as a public health issue (1,16,17). 
In Morocco, the agriculture sector is of key importance to the economy, representing 
approximately 14% of total gross domestic product (GDP) (75bn MAD/ €6.6bn) and 
approximately 7% of exports (2009). Livestock represents 38% of the total agriculture 
sector GDP (18). Both extensive and intensive livestock production systems exist in 
Morocco, with local, crossbred and imported breeds, mostly Holstein. Local breeds 
have been shown to be more resistant to the disease (14,19). Bovine tuberculosis is 
an endemic zoonosis in Morocco. The last national survey based on skin tuberculin 
test was conducted in 2004 and showed an individual prevalence of 18% and a herd 
prevalence of 33% (20). Furthermore, a cross-sectional tuberculin study was 
conducted in the Sidi Kacem area in Morocco in 2012 showing an individual 
prevalence of 20.4% and a herd prevalence of 57.7% (19). 
Officially, skin test and slaughter is the current control strategy applied in Morocco; 
however this strategy is not fully applied as it is not respected; in addition, there is no 
systematic BTB screening of cattle at a national level (21). 
In a review published by Muller et al in 2013, the proportion of zoonotic human 
tuberculosis (TB) among all TB cases was estimated at 1.4 % for the non-African 
countries, and at 2.8 % in Africa (22). The highest prevalence were found to be    
13.8 % and 7 % respectively in Mexico (23) and in Uganda (24). However, the World 
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Health Organization states a worldwide median prevalence of 3.1 % of M. bovis 
among human TB patients (25). Even if those prevalence values are mostly low, 
Muller et al, Pérez-Lago et al and Navarro, and García-de-Viedma highlight the major 
consequences of TB due to M. bovis on certain groups of the population, and report 
a potential underestimation of the prevalence of zoonotic human TB (22,25). 
The phylogeny of MTBC showed recently that the strains found in animals belong to 
a single lineage which showed the deletion of the “Region of Difference” 9 (RD9) 
(22,26). Indeed, M. bovis is the most recent strain in his lineage showing the deletion 
of RD4 (27). 
Molecular deletion typing had been found to be an important tool to differentiate M. 
bovis from the other strains of the MTBC (28). Pattern of presence or absence of 
these RDs would allow a discrimination among MTBC strains (28–30). 
Currently there is no data available in Morocco about the molecular characterization 
of BTB and the prevalence of MTBC among slaughtered cattle. The aim of the 
present study was to characterize the strains of MTBC which are responsible for BTB 
among the slaughtered cattle in Morocco. 
Materials and methods 
Study area and sample collection 
The study was conducted in two slaughterhouses in Morocco, one in Rabat and 
another in EL Jadida, which are two coastal cities separated by 200 km. The cattle 
slaughtered in these two slaughterhouses come from the rural areas surrounding the 
two cities and also from many other areas of the country (Figure 5.1). Individual 
information of every animal, such as gender, age, breed, and the possible origin were 
recorded in our database, as well as the date of sampling. The sample collection was 
performed in Rabat from March to July 2015 and in El Jadida from June 2014 to April 
2015. 
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Figure V.1. Geographic distribution of the origin of the sampled animals 
The samples were conveyed to the Veterinary and Agriculture Institute (IAV) in Rabat 
and stored in -20 °C until their treatment. 
Tissue preparation, culture 
Prior to treatment, samples were thawed overnight at 4°C. Subsequently, samples 
were desiccated to remove adipose tissue, and 5g of the desiccated lesions were 
mixed with sterilized sand and 10 ml of phenol red. The solution (7.5 ml) was placed 
in a 15 ml conic tube, 2.5 ml of NaOH 1N was added at room temperature for 10 
minutes, and then HCl 6N was added for sample neutralization. As a final step, the 
tube was centrifuged for 25 min at 3500 rpm. 
The supernatant was discarded and pellet was distributed in two of the four pre-
tested culture media: Lowenstein-Jensen (LJ), LJ with glycerol (LJG) or pyruvate 
(LJP) and Herrold according to the availability in the laboratory. Cultures were 
incubated for 12 weeks at 37°C and observed daily for growing colonies during the 
first week then weekly from the second week onwards. 
All the grown cultures were deactivated by adding a loopful of mycobacterium 
colonies to 1 ml of sterilized water contained in small tubes. The samples were then 
inactivated for 1h at 90°C. 
Determination of MTBC and deletion typing 
Mycobacterium molecular characterization was performed using Multiplex 
polymerase chain reaction (PCR). The PCR was performed in the TB laboratory at 
Swiss TPH. We performed first MrpoB PCR in order to differentiate MTC and NTM as 
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described earlier (35). Deletion analysis by PCR was used to differentiate M. bovis 
and M. tuberculosis from other species of the MTBC by assessing the presence or 
absence of Regions of Difference 9 and 4 (RD). The analysis was carried out as 
previously described (13,28). 
Spoligotyping 
Spoligotyping was performed as previously described (36). Spoligotyping patterns 
were defined according to the SITVIT WEB database (37) and to Mycobacterium 
bovis molecular typing database (38). All the patterns which were not found in the 
two databases were submitted as new patterns; new spoligotype numbers were 
assigned to them. 
Results 
Cattle information 
In the present study, a total number of 8658 animals were examined. Three hundred 
and twenty seven animal presented gross visible lesions (3.7%) and were cultured, 
66% (n=215) of the total sampled animals were analyzed by Ziehl-Neelsen(ZN), 68% 
(n=147) of the latter were ZN positive and heat-killed for further molecular typing. 
Figure 1 represents the geographic distribution of the samples (figure 1). While the 
age and gender distribution, in addition to the localization of the lesions sampled are 
shown in the table 5.1 and 5.2. The majority of the lesions were localized in the 
lymph nodes and the lungs (Table 5.2). 
Table V.1. Age and gender distribution of the sampled animals according to positive 
and negative cultures 
 Male Female Total 
<1 year 1-3 years >3 years <1 year 1-3 years >3 years 
Culture + 6 153 20 1 3 66 249 
Culture - 4 40 6 2 3 23 78 
Total 10 193 26 3 6 89 327 
 
The majority of the sampled animals were males between 1 and 3 years and females 
more than 3 years (Table 5.1). 
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Table V.2. Localisation of the collected lesions, in addition to the specifications of the 
animals sampled 
 
Lesion localisation 
 
n 
Gender Breed 
F M I C L 
Liver 5 1 4 0 5 0
Lungs 4 2 2 0 4 0
Lungs and diaphragm 1 0 1 0 0 0
LN 185 45 140 67 117 8
LN and diaphragm 4 1 3 1 3 0
LN and liver 4 1 3 1 3 0
LN and lungs 70 30 40 35 35 2
LN, lungs, and diaphragm 6 1 5 4 2 0
LN, lungs, and liver 18 7 11 4 14 0
LN, lungs, liver, and diaphragm 24 4 20 21 2 1
LN, lungs, liver, and kidney 2 2         0 0 2 0
LN, lungs, pleura, and pericardium 2 2           0 0 2 0
Miliary tuberculosis 2 2           0 0 2 0
Total 327 88 229 133 191 11
LN: Lymph nodes; I: Imported; C: Crossed; L: Local. 
MrpoB PCR 
A total of 68% (n=147) of the 215 samples which were AF positive were confirmed as 
MTBC strains using MrpoB PCR. Thirty two per cent (n=69) of animals were negative 
for MrpoB. 
Deletion typing 
The samples confirmed as MTBC strains were all positive to RD9 deletion typing and 
then confirmed to be not M. tuberculosis strains. A total of 144 (1.7%) of the samples 
were confirmed to be M. bovis as they were positive to the RD4 pcr. Three samples 
were negative for RD4. 
Out of the total of the confirmed M. bovis samples, 30% were female while 70% were 
male. The predominant breed in the positive animals was Crossbreed prime Holstein. 
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Spoligotyping 
A total of 136 analyzed samples were lacking spacers 39 to 43. Forty one different 
spoligopatterns were found. The most frequent patterns were SB0121, SB0265, 
SB0120, with frequencies of 24.3% (n=33). 16.9% (n=23), 9.6% (n=13) respectively. 
They were shown to belong to BOV-1 family. Two other spoligotypes were found in 9 
and 6 samples respectively, SB0125 and SB0869. Three spoligotype patterns had no 
SIT reference on the SITVIT database and were designated as orphan. Ten isolates 
presented nine undescribed spoligotypes, which were submitted to M. bovis website 
(www.mbovis.org) (Table 5.3). The discrimination power of spoligotyping, calculated 
using Hunter and Gaston’s formula was D=0.9057(39). 
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Table V.3. The different spoligotype patterns of the analysed samples and their 
relative frequencies 
Spol Nb. Frequency SIT Family SB Nb. 
■■□■■■■■□■■■■■■□■■■■□■■■■■■■■■■■■■■■■■□□□□□ 33 24.3 481 BOV_1 SB0121 
■■□■■□■■□■■■■■■□■■■■□■■■■■■■■■■■■■■■■■□□□□□ 23 16.9 684 BOV_1 SB0265 
■■□■■■■■□■■■■■■□■■■■■■■■■■■■■■■■■■■■■■□□□□□ 13 9.6 482 BOV_1 SB0120 
■■□■■■■■□■■■■■■□■■■■□■■■■■■■■■■□□■■■■■□□□□□ 9 6.6 Orphan BOV_1 SB0125 
■■□■■■■■□■■■■■■□■■■■□■■■■■■■■■■■■■□□■■□□□□□ 6 4.4 1026 BOV_1 SB0869 
■■□■■■■■□■■■■■■□■■■■■■■■■■■■■□□□■■■■■■□□□□□ 4 2.9   SB1025 
■■□■■■■■□■■■■■■□■■■■□■■■■□□□□■■■■■■■■■□□□□□ 4 2.9 696 BOV_1 SB0339 
■■□□□■■□□□■■■■■□■■■■■■■■■■■■■■■■■■■■■■□□□□□ 3 2.2 1673 BOV SB0136 
■□□□■■■■□■■■■■■□■■■■□■■■■■□■■■■□■■■■■■□□□□□ 3 2.2   SB2225 
■■□■■■■■□□■■■□□□■■■■□■■■■■■■■■■■■■■■■■□□□□□ 2 1.5   SB1269 
■■□■■■■■□■■■■■■□■■■■□■■■■■■■■■■■■■■■□■□□□□□ 2 1.5 698 BOV_1 SB0295 
□■□□□□□□□□□□□□□□■■■■■■■■■■■□■□□□□■■■■■□□□□□ 2 1.5 646 BOV_4-CAPRAE  
■■□□□□□■□■■■■■■□■■■■□■■■■□□□□■■■■■■■■■□□□□□ 2 1.5 Orphan BOV_1 SB1145 
■■□□□■■■□■■■■■■□■■■■■■■■■■■■■■■■■■■■■■□□□□□ 2 1.5 665 BOV_1 SB0134 
■■□■■■■■□■■■■■□□■■■■■■■■■■■■■■■■■■■■■■□□□□□ 1 0.7 820 BOV SB0856 
■■□■■■■■□■■■■■□□■■■■□■■■■■■■■■■■■■■■■■□□□□□ 1 0.7 695 BOV SB0119 
■■□□□■■■□■■■■■■□■■■■■□□□■■■■■■■■■■■■■■□□□□□ 1 0.7   SB1888 
■■□■■□■□□□□□■■■□■■■■■■■■■■■■■□□□□□□□■■□□□□□ 1 0.7   SB2073 
■□□□□□□□□□□□□□□□□□□□□■■■■■■■■■■■■■■■■■□□□□□ 1 0.7 980 BOV SB0152 
■■□■■■■□□□□□□■■□■■■■□■■■■■■■■■■■■■■■□■□□□□□ 1 0.7   SB1230 
■■□■■■■■□■■■■□□□■■■■■■■■■■■■■■■■■■■■■■□□□□□ 1 0.7 694 BOV SB0127 
■□□□□□□□□□□□□□□□□□□□□■■■■■■■■■■■■■■■■■□□□□□ 1 0.7 980 BOV SB0152 
■■□■□□□■□■■■■■■□■■■■□■■■■■■■■■■■■■■■■■□□□□□ 1 0.7 Orphan BOV_1 SB2271 
□■□□□□□□□□□□□□□□■■■■■■■■□□□□□□□□□□□□□□□□□□□ 1 0.7 818 BOV_4-CAPRAE SB0866 
■■□■■■□■□■■■■■■□■■■■□■■■■■■■■■■■■■■■■■□□□□□ 1 0.7   SB1361 
■■□□□■■■□■■■■■□□■■■■■■■■■■■■■■■■■■■■■■□□□□□ 1 0.7   SB1265 
■■□□□■■■□□■■■□□□■■■■■■■■■■■■■■■■■■■■■■□□□□□ 1 0.7   SB1074 
□□□□□□□■□■■■■■■□■■■■□■■■■■■■■■■■■■■■■■□□□□□ 1 0.7   SB2224 
■■□■■■■■□■■■■■■□□□■■□■■■■■■■■■■■■■■■■■□□□□□ 1 0.7   SB1993 
■□□□■■■■□■■■■■■□■■■■□■■■■■■■■■■■■■□□■■□□□□□ 1 0.7 650 BOV SB0341 
□□□□□□■■□■■■■■■□■■■■□■■■■■■■■■■■■■■■■■□□□□□ 1 0.7 Orphan BOV  
■■□■■■■■□□■■■■□□■■■■□■■■■■■■■■■■■■■■■■□□□□□ 1 0.7   SB1333 
■■□■■■■■□■■■■■■□□□□■□■■■■■■■■■■■■■■■■■□□□□□ 2 1.5  New SB2381 
■□□■□■■□□□■■■□□□■■■■□□■■■■■■■■■□□■■□■■□□□□□ 1 0.7  New SB2382 
□□□□□■□□□□□□■□□□□□□□□□□■■□■■□□□□□□□□□□□□□□□ 1 0.7  New SB2383 
■■□■■■■■□■■■■■■□□■□■□■■■■■■■■■■■■■■■■■□□□□□ 1 0.7  New SB2384 
■□□□■■■■□■■■■■■□■■■■□□□□□□□■■■■□■■■■■■□□□□□ 1 0.7  New SB2385 
■■□□□■□■□■■■■■■□■□□□□□■■■■■■■■■■■■■■■■□□□□□ 1 0.7  New SB2386 
■■□■■■■■□■■■■■□□■■■■□■■■■■■■■■■□□■■■■■□□□□□ 1 0.7  New SB2387 
■□□■□■■□□□■■■□□□■■■■□□■■■□□□□■■□□■■□■■□□□□□ 1 0.7  New SB2388 
■□□□■■■■□■■■■■■□■■■■□■■□□□□■■■■□■■■■■■□□□□□ 1 0.7  New SB2389 
Discussion 
To our knowledge, this is the first study investigating the molecular characterization 
of bovine tuberculosis among cattle in Morocco. The prevalence of the gross visible 
lesions suggesting BTB in Rabat and El Jadida slaughterhouses (3.7%) was low 
compared to the prevalence found previously using tuberculin skin test in the last 
national survey performed in 2004 (20). This prevalence was close to those observed 
in Mali (1.8 %) and in Algeria (3.6 %). 
Surprisingly, no non-tuberculous mycobacteria was found, while in the African 
context, among slaughterhouse gross visible lesions, 3.3 % in Mali (40), and 9 % in 
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Burkina Fasso (41) were confirmed as non-tuberculous mycobacteria. This was also 
observed in Chadian slaughtered cattle (33,34). 
Almost 52.4% of the overall sample size was confirmed to be M. bovis, three samples 
were negative to RD4. While two spoligotypes were typical for the caprae family, the 
third sample was a new spoligotype. Studies in other Countries (e.g. Nigeria, 
Ethiopia) found M. tuberculosis in cattle (42), whereas in Morocco, remarkably, we 
didn’t find this MTBC species in our samples. 
The most predominant spoligotype pattern found in Morocco is SB0121, belonging to 
the family BOV 1, this spoligopattern was already reported in Algeria (43), in Tunisia 
(44) and in Spain (45). The second most frequent spoligotype was SB0265 which 
was reported as the second most frequent in the United States from a set of strains 
collected between 1989 and 2013 (46), in addition, this spoligotype was isolated in 
Tunisia from a strain coming from Morocco (37), and was also reported in many 
European countries (47,48), as well as in Taiwan (49). The spoligopattern SB0120 
had the frequency of 11.7 % in our sample size and was reported previously in 
France from a sample originating from Morocco (SITVIT database), it was also 
reported in many African countries like Algeria (43), Tunisia (44) and Zambia (50) as 
well as in Argentina and Spain (45,51). Our study shows no similar spoligotype 
pattern with Mali, indicating that the Sahara desert and the long distance between 
cattle rearing areas (cattle are only kept until a Latitude of 12 degrees in Mali) seem 
to be an effective barrier for the transmission of M. bovis and/or that there is probably 
little trade of cattle between Morocco and Mali (40).  
Two spoligotypes of three samples belonged to the M. caprae family, of which one 
was found as well in M.bovis database as SB0866, this spoligotype was already 
reported in Spain from one goat, one cattle and one pig in 2011 (52). 
The similarities found in some spoligopatterns between Morocco and Algeria could 
be explained by the shared borders between the two countries, in addition some 
patterns found in Morocco were previously reported in the United States and in 
Argentina, two countries from where Morocco have previously imported cattle. 
Spoligotypes of African 1 and African 2 clonal complexes were not found among our 
characterized isolates (53,54). African 1 is localized in West and Central Africa, and 
African 2 is localized in East Africa, consequently, the desert of Morocco could be 
considered as a potential efficient barrier preventing the introduction of BTB to 
Morocco from West, Central and East Africa.  
The relatively low prevalence of proven M. bovis infection in two Moroccan abattoirs 
has to be interpreted with caution. Firstly, the abattoir prevalence reflects more the 
prevalence in young bulls and old cows rather than the whole population. Secondly, 
not all granuloma yielded a bacteriological isolate, hence the true prevalence may be 
much higher than the one observed. Overall, our findings reflect rather the 
epidemiological situation of a low level endemic transmission similar to other African 
countries rather than the one of a peri-urban intensive system (55,56). More research 
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is needed to further characterize the ongoing transmission patterns of bovine 
tuberculosis in view of the development of a locally adapted elimination strategy of 
bovine tuberculosis in Morocco (57). 
Conclusion 
This study presents the first molecular characterization of BTB isolates from 
Moroccan cattle. M. bovis represented a high amount of granulomatous lesions 
detected in the abattoirs of Rabat and El Jadida. Spoligotype suggests a link of 
Moroccan BTB to Europe, rather than to Africa, highlighting then the potential of the 
Moroccan desert barrier for BTB introduction to Morocco from sub-Saharan Africa. 
Further investigations of BTB strains using new molecular techniques such as whole 
genome sequencing are needed to clarify more the potential links between Moroccan 
BTB strains and those of Europe and other African countries. 
List of abbreviations 
BTB Bovine tuberculosis
MTBC Mycobacterium tuberculosis complex 
TB Tuberculosis 
RD Region of difference
NTM Non-tuberculous mycobacteria
LJ Lowenstein Jensen 
LJG Lowenstein Jensen with glycerol
LJP Lowenstein Jensen with pyruvate
PCR Polymerase chain reaction
ZN Ziehl-Neelsen 
 
Ethical consideration 
No ethical consideration was necessary, as the sampling work was part of routine 
work of meat inspection in the slaughterhouses. 
Consent for publication 
Not applicable 
Availability of data and materials 
The dataset supporting the conclusions of this article is included within the article, 
and its additional file(s). The data provided shows the original sample name, 
individual information, in addition to Deletion typing results for all 215 MTBC strains 
isolated from Morocco, and spoligotype pattern and number for 136 samples which 
were analyzed by spoligotyping. 
Competing interests 
The authors declare not having any conflict interest to disclose. 
87 
 
Funding  
This study was supported by the EU FP7 ICONZ program (grant agreement n° 
221948), by the local government of Basel-Stadt, Switzerland, and by the IFS 
scholarship B 5643. 
Author’s contribution  
HYA: Participated to the acquisition of a part of the funds (IFS grant), participated in 
the conception and design of the study, culture of Mycobacteria, molecular analysis, 
statistical analysis, writing of the manuscript. HA: Participated in sample collection. 
MB: Participated in the conception and design of the study, acquisition of funds, 
principle supervision in Morocco and intellectual contributions. JB: Participated in the 
conception and design of the study, Principle supervision of the laboratory work in 
Morocco (culture of mycobacteria). SR: Participated to the laboratory work in 
Morocco (culture of mycobacteria). MR: supervision of the molecular analysis in the 
tuberculosis laboratory in the Swiss TPH. SG: Supervision of the laboratory work in 
the Swiss TPH, important intellectual contribution. JF: Supervision of the molecular 
analysis in the tuberculosis laboratory in the Swiss TPH. SB: Supervision of the 
molecular analysis, and participated to the conception and the design of the study. 
JZ: Principal supervision of the project, Principle acquisition of the funds, important 
intellectual contribution. All the authors have read and approved the final version of 
the manuscript. 
 
Acknowledgements 
We would like to acknowledge the veterinarians in the two slaughterhouses of El 
Jadida and Rabat, for their help and collaboration. 
  
88 
 
References 
1.  Ayele WY, Neill SD, Zinsstag J, Weiss MG, Pavlik I. Bovine tuberculosis: an old 
disease but a new threat to Africa. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung 
Dis. 2004 Aug;8(8):924–37.  
2.  Domingo M, Vidal E, Marco A. Pathology of bovine tuberculosis. Res Vet Sci. 2014 
Oct;97 Suppl:S20-29.  
3.  Pesciaroli M, Alvarez J, Boniotti MB, Cagiola M, Di Marco V, Marianelli C, et al. 
Tuberculosis in domestic animal species. Res Vet Sci. 2014 Oct;97 Suppl:S78-85.  
4.  Palmer MV. Mycobacterium bovis: characteristics of wildlife reservoir hosts. 
Transbound Emerg Dis. 2013 Nov;60 Suppl 1:1–13.  
5.  Amanfu W. The situation of tuberculosis and tuberculosis control in animals of 
economic interest. Tuberculosis. 2006 May;86(3–4):330–5.  
6.  Goodchild AV, Clifton-Hadley RS. Cattle-to-cattle transmission of Mycobacterium 
bovis. Tuberc Edinb Scotl. 2001;81(1–2):23–41.  
7.  Dankner WM, Davis CE. Mycobacterium bovis as a significant cause of tuberculosis in 
children residing along the United States-Mexico border in the Baja California region. 
Pediatrics. 2000 Jun;105(6):E79.  
8.  Aranaz A, Liébana E, Mateos A, Dominguez L, Vidal D, Domingo M, et al. Spacer 
oligonucleotide typing of Mycobacterium bovis strains from cattle and other animals: a 
tool for studying epidemiology of tuberculosis. J Clin Microbiol. 1996 Nov;34(11):2734–
40.  
9.  Haddad N, Ostyn A, Karoui C, Masselot M, Thorel MF, Hughes SL, et al. Spoligotype 
diversity of Mycobacterium bovis strains isolated in France from 1979 to 2000. J Clin 
Microbiol. 2001 Oct;39(10):3623–32.  
10.  Smith NH, Dale J, Inwald J, Palmer S, Gordon SV, Hewinson RG, et al. The 
population structure of Mycobacterium bovis in Great Britain: clonal expansion. Proc 
Natl Acad Sci U S A. 2003 Dec 9;100(25):15271–5.  
11.  Collins JD. Tuberculosis in cattle: strategic planning for the future. Vet Microbiol. 2006 
Feb 25;112(2–4):369–81.  
12.  Delahay RJ, Walker N, Smith GC, Smith GS, Wilkinson D, Clifton-Hadley RS, et al. 
Long-term temporal trends and estimated transmission rates for Mycobacterium bovis 
infection in an undisturbed high-density badger (Meles meles) population. Epidemiol 
Infect. 2013 Jul;141(7):1445–56.  
13.  Mwakapuja RS, Makondo ZE, Malakalinga J, Moser I, Kazwala RR, Tanner M. 
Molecular characterization of Mycobacterium bovis isolates from pastoral livestock at 
Mikumi-Selous ecosystem in the eastern Tanzania. Tuberc Edinb Scotl. 2013 
Nov;93(6):668–74.  
14.  Moiane I, Machado A, Santos N, Nhambir A, Inlamea O, Hattendorf J, et al. 
Prevalence of Bovine Tuberculosis and Risk Factor Assessment in Cattle in Rural 
Livestock Areas of Govuro District in the Southeast of Mozambique. PLOS ONE. 2014 
Mar 14;9(3):e91527.  
89 
 
15.  Thoen CO, Steele JH, Gilsdorf MJ. Mycobacterium bovis Infection in Animals and 
Humans. John Wiley & Sons; 2008. 356 p.  
16.  Cosivi O, Grange JM, Daborn CJ, Raviglione MC, Fujikura T, Cousins D, et al. 
Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg 
Infect Dis. 1998 Mar;4(1):59–70.  
17.  Thoen C, Lobue P, de Kantor I. The importance of Mycobacterium bovis as a 
zoonosis. Vet Microbiol. 2006 Feb 25;112(2–4):339–45.  
18.  Samuelle C. Livestock sector in Morocco. Bord Bia Ir Food Board [Internet]. 2014 
[cited 2015 Oct 2]; Available from: 
http://www.bordbia.ie/industry/manufacturers/insight/alerts/Pages/LivestocksectorinMo
rocco.aspx?year=2014&wk=28 
19.  Yahyaoui Azami H, Ducrotoy M, Bouslikhane M, Hattendorf J, Thrusfield M, Conde-
Alvarez R, et al. The prevalence of ruminant brucellosis and bovine tuberculosis in Sidi 
Kacem area in Morocco. Press. 2016;  
20.  FAO. Principales réalisations depuis l’ouverture de la Représentation de la FAO à 
Rabat en 1982. 2011 Juillet.  
21.  Tuberculose bovine [Internet]. 2016 [cited 2016 Mar 1]. Available from: 
http://www.onssa.gov.ma/fr/index.php?option=com_content&view=article&id=181&Ite
mid=122 
22.  Müller B, Dürr S, Alonso S, Hattendorf J, Laisse CJM, Parsons SDC, et al. Zoonotic 
Mycobacterium bovis-induced tuberculosis in humans. Emerg Infect Dis. 2013 
Jun;19(6):899–908.  
23.  Pérez-Guerrero L, Milián-Suazo F, Arriaga-Díaz C, Romero-Torres C, Escartín-
Chávez M. [Molecular epidemiology of cattle and human tuberculosis in Mexico]. 
Salud Pública México. 2008 Aug;50(4):286–91.  
24.  Oloya J, Opuda-Asibo J, Kazwala R, Demelash AB, Skjerve E, Lund A, et al. 
Mycobacteria causing human cervical lymphadenitis in pastoral communities in the 
Karamoja region of Uganda. Epidemiol Infect. 2008 May;136(5):636–43.  
25.  Pérez-Lago L, Navarro Y, García-de-Viedma D. Current knowledge and pending 
challenges in zoonosis caused by Mycobacterium bovis: a review. Res Vet Sci. 2014 
Oct;97 Suppl:S94–100.  
26.  Smith NH, Kremer K, Inwald J, Dale J, Driscoll JR, Gordon SV, et al. Ecotypes of the 
Mycobacterium tuberculosis complex. J Theor Biol. 2006 Mar 21;239(2):220–5.  
27.  Smith NH, Gordon SV, de la Rua-Domenech R, Clifton-Hadley RS, Hewinson RG. 
Bottlenecks and broomsticks: the molecular evolution of Mycobacterium bovis. Nat 
Rev Microbiol. 2006 Sep;4(9):670–81.  
28.  Brosch R, Gordon SV, Marmiesse M, Brodin P, Buchrieser C, Eiglmeier K, et al. A new 
evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci 
U S A. 2002 Mar 19;99(6):3684–9.  
29.  Mostowy S, Cousins D, Brinkman J, Aranaz A, Behr MA. Genomic deletions suggest a 
phylogeny for the Mycobacterium tuberculosis complex. J Infect Dis. 2002 Jul 
1;186(1):74–80.  
90 
 
30.  Ingen J van, Zwaan R de, Dekhuijzen R, Boeree M, Soolingen D van. Region of 
Difference 1 in Nontuberculous Mycobacterium Species Adds a Phylogenetic and 
Taxonomical Character. J Bacteriol. 2009 Sep 15;191(18):5865–7.  
31.  Teklu T, Belyhun Y, Tesfaye S, Medhin G. Trends of tuberculosis and HIV infections 
between 2004 and 2008 in Wolaita Sodo, southern Ethiopia. Ethiop Med J. 2012 
Jan;50(1):1–11.  
32.  Biet F, Boschiroli ML, Thorel MF, Guilloteau LA. Zoonotic aspects of Mycobacterium 
bovis and Mycobacterium avium-intracellulare complex (MAC). Vet Res. 2005 
Jun;36(3):411–36.  
33.  Diguimbaye-Djaibe C, Hilty M, Ngandolo R, Mahamat HH, Pfyffer GE, Baggi F, et al. 
Mycobacterium bovis isolates from tuberculous lesions in Chadian zebu carcasses. 
Emerg Infect Dis. 2006;12(5):769–771.  
34.  Ngandolo BNR, Müller B, Diguimbaye-Djaïbe C, Schiller I, Marg-Haufe B, Cagiola M, 
et al. Comparative assessment of fluorescence polarization and tuberculin skin testing 
for the diagnosis of bovine tuberculosis in Chadian cattle. Prev Vet Med. 
2009;89(1):81–89.  
35.  Malla B, Stucki D, Borrell S, Feldmann J, Maharjan B, Shrestha B, et al. First Insights 
into the Phylogenetic Diversity of Mycobacterium tuberculosis in Nepal. PLoS ONE 
[Internet]. 2012 Dec 26 [cited 2016 Jan 13];7(12). Available from: 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530561/ 
36.  Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, et al. 
Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for 
diagnosis and epidemiology. J Clin Microbiol. 1997 Apr;35(4):907–14.  
37.  SITVIT WEB - M. tuberculosis genotyping WorldWide Database Online Consultation : 
Description [Internet]. 2016 [cited 2016 Jan 13]. Available from: http://www.pasteur-
guadeloupe.fr:8081/SITVIT_ONLINE/tools.jsp 
38.  Mycobacterium bovis molecular typing database [Internet]. 2016 [cited 2016 Jan 13]. 
Available from: http://www.mbovis.org/ 
39.  Hunter PR, Gaston MA. Numerical index of the discriminatory ability of typing systems: 
an application of Simpson’s index of diversity. J Clin Microbiol. 1988 Nov 
1;26(11):2465–6.  
40.  Müller B, Steiner B, Bonfoh B, Fané A, Smith NH, Zinsstag J. Molecular 
characterisation of Mycobacterium bovis isolated from cattle slaughtered at the 
Bamako abattoir in Mali. BMC Vet Res. 2008;4(1):1.  
41.  Sanou A, Tarnagda Z, Kanyala E, Zingué D, Nouctara M, Ganamé Z, et al. 
Mycobacterium bovis in Burkina Faso: epidemiologic and genetic links between 
human and cattle isolates. PLoS Negl Trop Dis. 2014;8(10):e3142.  
42.  Gumi B, Schelling E, Berg S, Firdessa R, Erenso G, Mekonnen W, et al. Zoonotic 
transmission of tuberculosis between pastoralists and their livestock in South-East 
Ethiopia. EcoHealth. 2012 Jun;9(2):139–49.  
43.  Sahraoui N, Müller B, Guetarni D, Boulahbal F, Yala D, Ouzrout R, et al. Molecular 
characterization of Mycobacterium bovis strains isolated from cattle slaughtered at two 
abattoirs in Algeria. BMC Vet Res. 2009;5:4.  
91 
 
44.  Lamine-Khemiri H, Martínez R, García-Jiménez WL, Benítez-Medina JM, Cortés M, 
Hurtado I, et al. Genotypic characterization by spoligotyping and VNTR typing of 
Mycobacterium bovis and Mycobacterium caprae isolates from cattle of Tunisia. Trop 
Anim Health Prod. 2014 Feb;46(2):305–11.  
45.  Navarro Y, Romero B, Copano MF, Bouza E, Domínguez L, de Juan L, et al. Multiple 
sampling and discriminatory fingerprinting reveals clonally complex and 
compartmentalized infections by M. bovis in cattle. Vet Microbiol. 2015 Jan 
30;175(1):99–104.  
46.  Tsao K, Robbe-Austerman S, Miller RS, Portacci K, Grear DA, Webb C. Sources of 
bovine tuberculosis in the United States. Infect Genet Evol. 2014 Dec;28:137–43.  
47.  Rodriguez-Campos S, Aranaz A, Juan L de, Sáez-Llorente JL, Romero B, Bezos J, et 
al. Limitations of Spoligotyping and Variable-Number Tandem-Repeat Typing for 
Molecular Tracing of Mycobacterium bovis in a High-Diversity Setting. J Clin Microbiol. 
2011 Sep 1;49(9):3361–4.  
48.  Matos F, Cunha MV, Canto A, Albuquerque T, Amado A, Botelho A. Snapshot of 
Mycobacterium bovis and Mycobacterium caprae Infections in Livestock in an Area 
with a Low Incidence of Bovine Tuberculosis. J Clin Microbiol. 2010 Nov 
1;48(11):4337–9.  
49.  Chang J-R, Chen Y-Y, Huang T-S, Huang W-F, Kuo S-C, Tseng F-C, et al. Clonal 
Expansion of Both Modern and Ancient Genotypes of Mycobacterium tuberculosis in 
Southern Taiwan. PLoS ONE. 2012 Aug 24;7(8):e43018.  
50.  Malama S, Johansen TB, Muma JB, Mwanza S, Djønne B, Godfroid J. Isolation and 
molecular characterization of Mycobacterium bovis from Kafue lechwe (Kobus leche 
kafuensis) from Zambia. Trop Anim Health Prod. 2014 Jan;46(1):153–7.  
51.  Shimizu E, Macías A, Paolicchi F, Magnano G, Zapata L, Fernández A, et al. 
Genotyping Mycobacterium bovis from cattle in the Central Pampas of Argentina: 
temporal and regional trends. Mem Inst Oswaldo Cruz. 2014 Apr;109(2):236–45.  
52.  Rodríguez S, Bezos J, Romero B, de Juan L, Álvarez J, Castellanos E, et al. 
Mycobacterium caprae infection in livestock and wildlife, Spain. Emerg Infect Dis. 
2011;17(3):532–535.  
53.  Müller B, Hilty M, Berg S, Garcia-Pelayo MC, Dale J, Boschiroli ML, et al. African 1, an 
epidemiologically important clonal complex of Mycobacterium bovis dominant in Mali, 
Nigeria, Cameroon, and Chad. J Bacteriol. 2009;191(6):1951–1960.  
54.  Berg S, Garcia-Pelayo MC, Müller B, Hailu E, Asiimwe B, Kremer K, et al. African 2, a 
clonal complex of Mycobacterium bovis epidemiologically important in East Africa. J 
Bacteriol. 2011;193(3):670–678.  
55.  Tschopp R, Hattendorf J, Roth F, Choudhoury A, Shaw A, Aseffa A, et al. Cost 
estimate of bovine tuberculosis to Ethiopia. In: One Health: The Human-Animal-
Environment Interfaces in Emerging Infectious Diseases [Internet]. Springer; 2012 
[cited 2016 May 19]. p. 249–268. Available from: 
http://link.springer.com/chapter/10.1007/82_2012_245 
56.  Tschopp R, Schelling E, Hattendorf J, Young D, Aseffa A, Zinsstag J. Repeated cross-
sectional skin testing for bovine tuberculosis in cattle kept in a traditional husbandry 
system in Ethiopia. Vet Rec. 2010;167(7):250–256.  
92 
 
57.  Abakar F, Yahyaoui Azami H, Justus Bless P, Crump L, Lohmann P, Laager M, et al. 
Transmission Dynamics and Elimination Potential of Zoonotic Tuberculosis in 
Morocco. Press. 2016;  
 
 
 
 
 
 
 
93 
 
VI. Transmission dynamics and elimination potential of zoonotic 
tuberculosis in Morocco 
 
Mahamat Fayiz Abakar(1,2,3)■, Hind Yahyaoui Azami(2,3,4)■*, Philipp Justus Bless(2,3), Lisa 
Crump(2,3), Petra Lohmann(2,3), Mirjam Laager(2,3), Nakul Chitnis(2,3), Jakob Zinsstag(2,3)* 
 
 
1)Institut de Recherches en Elevage pour le Développement, BP 433, N’Djaména, Chad 
2)Swiss Tropical and Public Health Institute, PO Box, CH-4002 Basel, Switzerland 
3)University of Basel, Basel, Switzerland 
4)Institut Agronomique et Vétérinaire Hassan II, Rabat, Morocco 
■ These authors contributed equally to the paper. 
Published in PloS NTD 
  
*Corresponding authors: hind.yahyaoui-azami@unibas.ch and jakob.zinsstag@unibas.ch  
  
94 
 
Abstract: 
Bovine tuberculosis (BTB) is an endemic zoonosis in Morocco caused by 
Mycobacterium bovis, which infects many domestic animals and is transmitted to 
humans through consumption of raw milk or from contact with infected animals. The 
prevalence of BTB in Moroccan cattle is estimated at 18 %, and 33 % at the 
individual and the herd level respectively, but the human M. bovis burden needs 
further clarification. The current control strategy based on test and slaughter should 
be improved through local context adaptation taking into account a suitable 
compensation in order to reduce BTB prevalence in Morocco and decrease the 
disease burden in humans and animals.  
A compartmental deterministic mathematical model for BTB transmission in cattle 
and humans was established to provide a broader understanding of BTB, in 
particular regarding transmission to humans. Differential equations were used to 
establish the different pathways between the compartments for cattle and humans. 
Scenarios of test and slaughter were simulated for the effects on BTB prevalence in 
cattle and humans. Simulation of test and slaughter interventions led to a decline of 
BTB prevalence depending on the proportion of testing (p). The time to freedom from 
disease (individual animal prevalence of less than one in a thousand) ranged from 75 
years for p = 20% to 12 years for p = 100%. For p > 60% the time to elimination was 
less than 20 years. The cumulated cost was largely stable: for p values higher than 
40 %, cost ranged from 1.47 to 1.87 billion Euros with a time frame of 12 to 44 years 
to reach freedom from disease. This analysis informs Moroccan bovine tuberculosis 
control policy regarding time frame, range of cost and levels of intervention. Further 
research is needed to clarify the national human-bovine tuberculosis ratio in 
Morocco.  
Key words: Bovine tuberculosis, Mycobacterium bovis, transmission 
modelling, Morocco, disease elimination, cattle 
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Author summary  
Tuberculosis is a disease of humans and animals which mainly affects the lungs but 
can also manifest in other organs. A variety of tuberculosis bacteria cause the 
disease and are usually transmitted through air, i.e. inhalation of aerosols. Bovine 
tuberculosis (BTB) occurs predominantly among domestic cattle, and wild animals 
are an important reservoir for transmission. Humans are usually infected with BTB 
through contaminated dairy products or close contact with cattle. While BTB has 
been eliminated in cattle and human populations of most high-income countries, it is 
still a major health threat in low- and middle-income countries. In Morocco, the 
disease frequently occurs in cattle and poses a health risk for humans. An effective 
intervention to reduce BTB among domestic cattle and reduce the risk to humans is 
slaughter of cattle which test positive for the disease. We simulated BTB in the 
Moroccan cattle and human populations using a disease transmission model. We 
assessed effects of test and slaughter in regard to elimination of disease in cattle and 
humans and estimated the associated costs with the model. The time to elimination 
of disease depended on the number of cattle tested. The disease could be eliminated 
in cattle within 32 years if 40% of Moroccan cattle are tested annually and infected 
individuals are slaughtered or within 13 years if at least 90% of the cattle population 
is tested. The total costs for the time periods until elimination ranged from 1.55 billion 
Euros for testing and slaughter at 50% to 1.48 billion Euros at 90%. These results 
can be used as an estimate for planning BTB control policy in Morocco with regard to 
time frames and associated costs. 
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Introduction 
Bovine tuberculosis (BTB) is a zoonotic bacterial infection caused by Mycobacterium 
bovis. It belongs to a group of well-known and newer mycobacteria, together with 
Mycobacterium tuberculosis, all of which derive from a common ancestor forming the 
Mycobacterium tuberculosis complex (MTBC) (1-4). M. bovis is capable of infecting a 
broad range of hosts, including ruminants (predominantly domestic cattle), humans 
and other primates (5-10). The wide host range makes BTB highly relevant to 
conservation projects and difficult to eliminate where wildlife reservoirs are involved, 
for instance, badgers (Meles meles) in the United Kingdom (11, 12). 
Bovine tuberculosis infection in cattle is a chronic disease which affects first the 
lymph nodes and then the lungs from weeks to decades later because transmission 
between cattle occurs predominantly through aerosol inhalation (13-16). The 
transmission rate is increased by risk factors such as high herd density and intensive 
breeding (17). The disease can also be manifested in other organs, for example, 
mammary tissue, and the gastrointestinal or urinary tract (18). Pseudo-vertical 
transmission from cows to suckling calves through infected milk has been described 
(19). Factors like a long survival period for the microbes in manure and soil and close 
contact between animals, for example around water sources, also contribute to 
increase risk of infection (20, 21). In humans, contaminated dairy products are 
considered to be the main source of BTB infection, usually resulting in extra-
pulmonary infection such as lymphadenitis (22-24). These patients are missed by 
thoracic radiographic screening and the resulting diagnostic cascade (25). Aerosol 
cattle-to-human transmission can occur during close contact with infected animals, 
posing an occupational risk, especially for pastoralists and farmers (2, 26). Infection 
risks linked to local cultural practices, for instance consumption of fresh blood, are 
reviewed by Daborn (27). There is evidence that human patients can transmit BTB to 
animals, and human to human transmission occurs (28, 29). 
There is a bottleneck in detecting human BTB cases because the routine diagnostic 
protocols were developed for patients with pulmonary tuberculosis, as caused by M. 
tuberculosis. Tuberculosis (TB) and BTB cannot be distinguished on the basis of 
clinical symptoms, radiography or histopathology (30). Glycerol-containing 
Löwenstein-Jensen medium, the long-time gold standard for TB culture, inhibits the 
growth of M. bovis, thereby increasing the number of undetected cases (31). New 
molecular diagnostic tools, for example spoligotyping, and even whole genome 
sequencing have been developed for M. bovis detection (32, 33). Although they 
require enhanced laboratory infrastructure and personnel training which are not 
currently available in some developing countries, these new techniques offer promise 
for epidemiological research, control and adequate treatment, particularly since M. 
bovis is resistant to pyrazinamide, one of the first-line antibiotics for TB treatment 
(34). 
Morocco is transitioning from extensive pastoralist livestock and dairy production to 
more intensified production due to increasing demands for dietary protein by a 
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growing human population (35). The shift in agricultural practice and increased use of 
high-producing Holstein cattle in place of local breeds may have an impact on BTB 
epidemiology and contribute to a higher prevalence (36). The official national control 
program in Morocco is currently based on a test and slaughter scheme. However, 
large-scale application remains challenging because testing is not mandatory, and 
the proposed compensation, ranging from 470 Euro for local breeds to 980 Euro for 
improved breeds, is considered lower than market value. 
In Morocco, BTB is an endemic zoonosis in livestock. Even though the predominant 
livestock species in Morocco are sheep and goats, cattle remain of major importance. 
The most recent national survey, conducted in 2004, showed an individual cattle 
prevalence of 18% and a herd prevalence of 33% (37). This prevalence remained 
similar in the individual level (18%), while the herd prevalence increased (56%) in a 
2012 pilot study of 1’200 cattle using the tuberculin skin test (38). Since 2000, the 
health risk of tuberculosis in Morocco has been addressed through a national TB 
program funded by the Ministry of Health in collaboration with the World Health 
Organization (WHO). In 2014, TB caused 2’800 deaths in Morocco (39), and human 
tuberculosis had a relatively high incidence, with 36’000 new cases (106 cases per 
100’000 inhabitants) (40). These data do not appear to differentiate between M. 
tuberculosis and M. bovis infection. A recent meta-analysis estimated the median 
proportion of human BTB among all TB cases in 13 African countries at 2.8%, with a 
range of 0-37.7% (41).  National prevalence data from a range of countries worldwide 
were summarized in a 2014 review; in Mexico up to 13% of all TB cases are 
reportedly due to BTB, while in the United States it is only 1.4% (42). In Morocco, 
Bendadda et al. reported M. bovis prevalence of 17.8% among drug resistant TB 
isolates from 200 human sputum samples (43). 
In the early 20th century, the prevalence in German cattle herds was 90% (44), with 
25-80% in other European states and only 2-10% in the US (45). In most 
industrialized countries, the health risk and economic loss from M. bovis were 
considerably reduced or eliminated through strict test-and-slaughter and meat 
inspection protocols for cattle, along with the implementation of milk pasteurization 
and financial compensation of farmers (45). Using a similar control strategy, 
Switzerland eradicated BTB in 1960 (46). In most developing countries where the 
disease is endemic, such measures are not feasible due to financial constraints, 
particularly for farmer compensation, and inadequate veterinary services (47). 
Alternatives for BTB endemic countries to reduce the health and economic risk 
related to the disease must be sought.  
Although cost estimation is difficult due to immense local variability in production 
parameters and prices (48), the global economic loss due to BTB is thought to be 
about 3 billion USD annually (49). In cattle, the disease has a significant economic 
impact, through an increased death rate and decreased milk and meat production, 
draft power and fertility (50). Modelling approaches have been used, mainly for 
developing countries, to estimate different parameters and factors related to BTB. 
Previous publications on the economics of BTB focus mainly on the cost of disease 
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and control efforts. Analyses of the profitability of control efforts are very scarce (51). 
A study on the economics of BTB in Africa showed higher losses in intensive dairy 
systems in peri-urban areas of Ethiopia when compared to extensive pastoral 
production systems in rural areas but did not include the cost to public health (48). 
Zinsstag et al presented a simplified framework for a model of animal to human 
transmission in which transmission between cattle and from cattle to humans is 
considered (51). This model allows the simulation of different scenarios over 5-10 
years, with and without intervention, where the measurable outcome is prevalence in 
humans and in cattle. The economic analysis further delineates broader issues such 
as inter-sectorial contributions from agricultural and public health or private 
households affected by BTB.  
Interventions to reduce health and economic risks, such as those related to BTB, are 
non-linear processes. Although, statistical versions of compartmental models have 
been used for many years to analyze different types of health interventions, 
mathematical modeling represents an alternative approach which provides a broader 
understanding, especially regarding disease transmission to humans. This paper 
presents a mathematical model of BTB transmission from cattle to humans in order to 
estimate the disease cost and simulate potential interventions in Moroccan cattle. 
Materials and methods 
Epidemiological data collection 
Annual data on cattle numbers are estimated using data routinely collected by the 
Ministry of Agriculture and reported to veterinary services. Our model considered 
these data from 1995 to 2013. In the transmission model, the cattle population was 
not stratified by age and sex. We used a tuberculin prevalence of 18% for cattle, as 
reported in the most recent national survey (2003) [33]. A similar prevalence was 
noted in a smaller study performed in 2012 in Sidi Kacem, Morocco (38). 
Model 
A schematic diagram of the model is depicted in Figure 6.1 and the variables and 
parameters are described in Table 6.1 and Table 6.2, respectively. 
The cattle population is divided into three mutually exclusive compartments 
consisting of susceptible cattle (SC), exposed cattle with latent BTB which are 
positive to the tuberculin test, without showing gross visible lesions (EC) and infected 
cattle with active BTB showing tuberculosis lesions (IC). Those parameters were 
estimated based on Ngandolo et al 2009 (52). The total cattle population (NC) at time 
t is: 
NC(t) = SC(t) + EC(t) + IC(t)   (1) 
The human population consists of four mutually exclusive compartments: susceptible 
humans (SH), exposed humans with latent BTB reacting to the Mantoux test (EH), 
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infected humans with active BTB (IH) and humans recovered from BTB with 
temporary immunity (RH). The total human population (NH) at time t is: 
NH(t) = SH(t) + EH(t) + IH(t) + RH(t)    (2) 
 
Figure VI.1. Schematic diagram of the BTB cattle-human transmission 
model for Morocco 
The susceptible cattle population (SC(t)) increases through birth (at a rate bC) and 
decreases through exposure to BTB (at a rate (Ic/Nc)βC) and  mortality (at a rate µC). 
Exposure to BTB is assumed to be frequency dependent. According to Bernues (53), 
the rate bC decreases by 5% for exposed cattle with latent BTB (EC(t)) and for 
infected cattle with active BTB (IC(t)), such that: 
݀ܵ஼
݀ݐ ൌ ܾ஼ܵ஼ ൅ ൫0.95 ൈ ܾ஼ሺܧ஼ ൅ ܫ஼ሻ൯ െ ߚ஼
ܫ஼ܵ஼
஼ܰ
െ μ஼ܵ஼				ሺ3ሻ 
The population of exposed cattle with latent BTB (EC(t)) is generated through 
infection of susceptible cattle with BTB (at a rate βC) and decreased through the 
development of active BTB (at a rate αC) and through mortality (at a rate µC). 
Consequently: 
݀ܧ஼
݀ݐ ൌ ߚ஼
ܫ஼ܵ஼
஼ܰ
െ ߙ஼ܧ஼ െ μ஼ܧ஼			ሺ4ሻ 
Similarly, the infected cattle population with active BTB (IC(t)) is generated through 
the development of active BTB among exposed cattle with latent BTB (at a rate αC) 
and decreased through mortality (at a rate µC): 
݀ܫ஼
݀ݐ ൌ ߙ஼ܧ஼ െ μ஼ܫ஼				ሺ5ሻ 
For simplicity, no additional mortality rate due to BTB is assumed for the cattle and 
human populations in the model. 
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Table VI.1. Description of the variables of the BTB model for Morocco 
Variable Interpretation 
SC Population of susceptible cattle 
EC Population of exposed cattle with latent BTB 
IC Population of infected cattle with active BTB 
SH Population of susceptible humans 
EH Population of exposed humans with latent BTB 
IH Population of infected humans with active BTB 
RH Population of humans recovered from BTB 
The susceptible human population (SH(t)) increases through birth (at a rate bH) and 
through recovered humans becoming susceptible again (at a rate δC). The population 
decreases through exposure to BTB from cattle with active BTB (at a rate βH) and 
through natural mortality (at a rate µC). For the susceptible human population, the 
exposure (both direct (aerosol) and indirect (milk) transmission) to BTB from cattle 
with active BTB is assumed to be frequency dependent and proportional to the 
number of infected cattle (IC): 
݀ܵு
݀ݐ ൌ ܾுܰு ൅ ߜுܴு െ ߚு
ܫ஼ܵு
஼ܰ
െ μுܵு					ሺ6ሻ 
Human to human transmission is assumed to be negligible. The population of 
exposed humans with latent BTB (EH(t)) is generated through infection of susceptible 
humans with BTB (at a rate βH) and decreased through the development of active 
BTB (at a rate αH) and through natural mortality (at a rate µH): 
݀ܧு
݀ݐ ൌ ߚ஼
ܫ஼ܵு
஼ܰ
െ ߙுܧு െ μுܧு						ሺ7ሻ 
The infected human population with active BTB (IH(t)) is generated by the 
development of active BTB among exposed humans with latent BTB (at a rate αH) 
and decreased by recovery of humans with active BTB (at a rate γH) and by natural 
mortality (at a rate µH): 
݀ܫு
݀ݐ ൌ ߙுܧு െ ߛுܫு െ μுܫு						ሺ8ሻ 
The population of humans recovered from BTB is generated through the recovery of 
humans with active BTB (at a rate γH) and decreased through humans becoming 
susceptible to BTB again (at a rate δH) and through natural mortality (at a rate µH), so 
that: 
ܴ݀ு
݀ݐ ൌ ߛுܫு െ ߜுܴு െ μுܴு					ሺ9ሻ 
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Table VI.2. Description of the parameters of the BTB model for Morocco 
Parameter Interpretation 
bC Birth rate of cattle 
βC Cattle to cattle transmission rate 
µC Mortality rate of cattle 
αC Inverse of cattle incubation period 
bH Birth rate of humans 
βH Cattle to human transmission rate 
µH Natural mortality rate of humans 
αH Inverse of human incubation period 
δH Loss of immunity in humans 
 
Values for variables and parameters of the model 
Variable starting values 
The most recent estimate (2013) for the cattle population in Morocco is 3’173’000 
(NC), of which 18% [95% CI: 16.5%-20.3%] are tuberculin skin test positive. The 
initial values of the three compartments IC, EC and SC were calculated such that the 
pre-intervention endemic equilibrium of the model equals the prevalence of 18% 
(Supporting information 1). This yield: 
ܫ஼ ൌ ߙ௖߮஼ߙ஼ ൅ ܾ஼ െ ሺܾ஼ െ ݎ௕ܾ஼ሻ߮ ஼ܰ					ሺ10ሻ 
ܧ஼ ൌ ൬߮஼ െ ܫ஼஼ܰ൰ ஼ܰ						ሺ11ሻ 
ܵ஼ ൌ ஼ܰ െ ܧ஼ െ ܫ஼					ሺ12ሻ 
The human population of Morocco in 2013 is estimated to be 33’008’150 individuals 
(54). The estimated number of people with active TB is 43’000 (prevalent cases) (40). 
In Africa, a median of 2.8% of all human TB cases are caused by BTB (41). Between 
5 and 10% (mean 7.5%) of TB-exposed people will develop active TB during their 
lifetime (55). Based on these estimates the starting values of IH, EH, RH and SH are 
calculated as (Table 6.3): 
ܫு ൌ ߙு߮ுߙு ൅ ߜு ൅ ܾு ܰு				ሺ13ሻ 
ܧு ൌ ൬߮ െ ܫுܰு൰ ுܰ					ሺ14ሻ 
ܵு ൌ ுܰ െ ܧு െ ܫு			ሺ15ሻ 
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Table VI.3. Initial values for the BTB cattle-human transmission model 
Variable Starting value 
SC 2’601’860
EC 79'610
IC 491'529
SH 33'006'946
EH 784
IH 420
Parameter values 
The average lifespan of the Moroccan cattle is 6 years which yields a death rate of 
ߤ஼ ൌ 0.167. Form data on cattle populations (Yahyaoui H., unpublished data, Dec. 
2015) using least squares the birth rate was estimated as ܾ஼ ൌ 0.177. 
From the UN World Population Prospects we calculated the birth rate bH and death 
rate µH in humans (54). Although BTB bacteria are not completely eliminated from 
treated humans (56, 57) it is nevertheless assumed, for the sake of simplicity, that all 
successfully treated humans are recovered and become susceptible again within a 
period of 6 months. 
The cattle to cattle transmission rate, βC, and the cattle to human transmission rate, 
βH, were estimated from the pre-intervention endemic equilibrium (Supporting 
Information 2). The model was implemented using MATLAB® (MathWorks, Natick, 
MA) (Table 6.4).  
Table VI.4. Parameters of the BTB cattle-human transmission model assuming a 
stable prevalence (endemic stability) 
Parameter Baseline value (year-1)  Source 
bC 0.177 [0.121 - 0.274] Yahayoui H., unpublished data, 
Dec. 2015 
βC 0.249 [10.244 - 0.255] Estimated from the endemic 
prevalence in cattle 
µC 0.167 [0.111 -  0.333] (58) 
αC 1.083 [0.5 – 1.667] (1) 
Se 0.438 [0.057 – 0.819] (52) 
Sp 0.894 [0.842 – 0.946] (52) 
bH 0.0229  (54) 
βH 0.00015  Estimated from the endemic 
prevalence in humans 
µH 0.0063  (54) 
αH 1.083   
δH 2  (59) 
The reproductive number of the transmission between cattle R0 was computed as:  
ܴ଴ ൌ ߙ ∗ ߚሺߙ ൅ ߤሻߤ 			ሺ18ሻ
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Sensitivity analysis of model 
A sensitivity analysis of the model recalculated the change of prevalence if individual 
parameters varied from baseline over 30 years.  
Simulation and cost of interventions 
Although Morocco has a test and slaughter policy for the control of BTB, it is currently 
not effectively implemented. The BTB transmission model was used to estimate the 
effect of the proportion of tested and slaughtered tuberculin positive animals on the 
duration to reach freedom from disease, achieving an individual animal prevalence of 
less than one in a thousand tested animals (<1/1000) according to the standards of 
the World Organization for Animal Health (OIE) (60). The proportion of tested and 
slaughtered animals was simulated by removing 10-100 % of the exposed (Ec) and 
infectious cattle (Ic) per year from the herd. The control reproductive number Rc 
including the test and slaughter intervention as proportion p with a test of sensitivity 
se was computed as: 
ܴ௖ ൌ ߙ ∗ ߚሺߙ ൅ ߤ ൅ ݏ݁ ∗ ݌ሻሺߤ ൅ ݏ݁ ∗ ݌ሻ						ሺ17ሻ 
The associated costs were estimated in a summaric way, assuming an incremental 
cost of comparative intradermal or interferon gamma (BOVIGAM®) testing of 3 Euro 
per animal. The cost of compensation at 80% of the market value varies from 470 
Euro for local breeds to 970 Euro for improved breeds (61). For the current 
estimation of the cost of BTB elimination in Morocco, we used a single value of 500 
Euro of compensation per slaughtered animal. The cumulated costs of elimination 
were discounted by an annual discount rate of 5% and expressed as net present 
value (NPV). Models run with and without interventions were simulated using data 
from 2013 onwards. 
The OIE recommended cut-off for SICTT interpretation is 4 mm, however, many 
studies showed that a severe cut-off of 2 mm increased the sensitivity of the test (62, 
63), without affecting the specificity compared to the recommended cut-off (64). 
Consequently, we decided to consider both 2mm and 4 mm cut-offs in the model, 
and to compare the respective results. The present model considered both options of 
SICTT cut-off at 2mm and 4mm.  
Results 
Model properties 
The reproductive ratio of the cattle to cattle transmission of bovine tuberculosis 
without intervention was 1.325. For the total cost, the birth rate of cattle bc was the 
most sensitive parameter influencing the dynamics of BTB transmission (Figure 6.2). 
High birth rate values lead to an increased cattle population yielding higher costs for 
elimination. For the time to elimination, the sensitivity of the test was the most 
sensitive parameter. Low test sensitivity (i.e. with cut-off at 4mm) leads to low 
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detection of infected animals and therefore less culling which leads to a longer time 
to elimination. 
 
Figure VI.2. PRCC sensitivity analysis of total cost (left) and time to elimination 
(right) on parameter values 
The simulation of a test and slaughter intervention led to a decline in BTB prevalence 
depending on the proportion p of testing (Figure 6.3). The time to elimination, i.e. the 
time to reach an individual animal prevalence of less than one in a thousand, ranged 
from 75 years for p = 20% to 12 years for p =100%. For values of p > 60%, the time 
to elimination was below 20 years (Figure 6.3). The reproductive number decreased 
rapidly below one with an increasing proportion test and slaughter p (Figure 6.4). 
With 60% testing and culling, the prevalence of exposed and active human cases 
BTB decreased from 3.5 per 1'000’000 to less than 1 in 1'000’000 at the time of 
freedom from disease after 20 years (Figure 6.5).  
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Figure VI.3. Prevalence of tuberculin positive cattle depending on the 
proportion of test and slaughter between 0 and 1 (in steps of 0.1) with 
sensitivity and specificity of the 4mm cutoff test (left) and the 2mm cuttoff 
test (right) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure VI.4. Relationship between reproductive number and proportion of 
test and slaughter for the 4mm cutoff test and the 2 mm cutoff test 
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Figure VI.5. Relationship between human prevalence and proportion of test 
and slaughter 
Cost of test and slaughter intervention 
The cost of test and slaughter depends on the percentage p of test and slaughter 
(Table 6.5). Lower p results in lower cumulated costs but longer time until elimination. 
The cumulated cost is remarkably stable for p values higher than 0.2, ranging 
between 1.47 to 1.87 billion Euros within a time range of 12 to 32 years to reach 
freedom from disease. The cumulated cost of BTB test and slaughter intervention 
and the time to elimination were lower using 2mm cut-off of SICTT compared to the 
4mm cut-off (Figure 6.6). 
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Table VI.5. Relationship of proportion of animals included in test and slaughter and 
the cumulated cost and time freedom from disease (Individual animal prevalence 
<1/1000) 
Proportion 
of 
 test and 
slaughter p 
Cumulated cost 
of control in 
Euro* 
(4mm Test) 
Time to reach 
freedom from disease 
in years 
(4mm Test) 
Cumulated cost 
of control in 
Euro* 
(2mm Test) 
Time to reach 
freedom from disease 
in years 
(2mm Test) 
0   > 100  > 100
0.1   > 100 > 100
0.2   > 100 1.87 * 10^9  75
0.3   > 100 1.68 * 10^9  44
0.4  > 100 1.60 * 10^9  32
0.5   > 100 1.55 * 10^9  25
0.6   > 100 1.53 * 10^9  20
0.7     1.99 * 10^9  82 1.51 * 10^9  17
0.8      1.94 * 10^9  69 1.49 * 10^9  15
0.9      1.90 * 10^9  59 1.48 * 10^9  13
1    1.84 * 10^9  51 1.47 * 10^9  12
 
 
 
Figure VI.6. Total Cost of the interventions that reach elimination for 
different proportions of tested animals and 2mm cutoff test (yellow) and 
4mm cut off test (blue) 
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Discussion and Conclusions 
This manuscript presents the first cattle to cattle and cattle to human compartmental 
deterministic mathematical model. Differential equations were used to describe 
different pathways within and between compartments at human and animal level. 
Sensitivity analysis of the model has been used to determine the most sensitive 
parameter. Additionally, different scenarios of test and culling interventions were 
simulated by considering different proportions of tested population per year (p).  
Model properties 
To our knowledge this is the first model describing cattle to cattle and cattle to human 
transmission of BTB, although an African buffalo-human model has been published 
(65). Time series similar to those for brucellosis in Mongolia (66) are unfortunately 
not available but the available data allows for a parameterization under the 
assumption of endemic stability similar to Ethiopia (67). The estimated reproductive 
number of 1.325 is in the range for both low risk areas (R0= 0.6-1.4) and high risk 
areas (R0= 1.3-1.9) reported for the United Kingdom (68) but is lower than the 1.7-2.2 
reported by Bekara et al. for France (69). Using a sensitivity analysis, the birth rate of 
cattle (bc) was determined to be the most sensitive parameter of the model. 
A key challenge in this model was to distinguish between exposed and infected cattle 
because the diagnostic test utilized was the intradermal tuberculin test. We used the 
proportion of cattle with active TB (13.5%) among cattle tested positive by tuberculin 
skin test, as reported by Ngandolo et al (52), to calculate the number of infected 
cattle. We did not address the sensitivity of tuberculin testing or within herd 
transmission because there is no data available on validation of tuberculin testing in 
Morocco or on within herd BTB transmission in Moroccan husbandry systems.  
Further microbiological data is required to better describe BTB prevalence in humans 
in Morocco. Patients treated for active BTB do not completely clear all organisms 
from their body, with some bacteria persisting in bone marrow (56). Therefore, in 
contrast to our model, humans do not become completely susceptible again but 
technically are subject to re-infection (57). We argue that this has only a minor impact 
on total human BTB prevalence, but re-infection should be considered to refine the 
model. 
Risk exposure of animals and humans to BTB could change according to sex and 
age groups. Because our model does not take into account such stratification, 
specific results for age groups were not provided. 
Test and slaughter intervention 
BTB prevalence was found to reach less than one per thousand in less than 20 years 
when the proportion of tested cattle was above 30%. The annual cost for this 
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potential intervention was nearly 78 million Euros. Intervention in cattle was found to 
impact the prevalence of human TB due to M. bovis, which decreased from 5 per 
10’000 to 1 per 10’000 after 17 years. 
The economic assessment presented here is preliminary, and a detailed cost and 
cost-effectiveness analysis will be published separately. However, our analysis 
informs Moroccan bovine tuberculosis control policy on the time horizon, range of 
cost and optimal levels of intervention. An effective control programme will depend on 
the human resources and technical and logistical capacity of the veterinary services 
to implement testing and slaughtering of animals. If the proportion of cattle subjected 
to test and slaughter was greater than 60%, freedom from disease would be reached 
in less than 20 years. Our model simulates the removal of individual animals rather 
than whole herds. Past experience in Europe has shown that whole herd removal is 
critical for effective elimination in low prevalence situations (46). In addition, a herd 
based model of the Moroccan cattle population could potentially lead to a lower 
intervention cost, as it is more realistic.  
A recalculation of the intervention cost taking into account stratification by breed, sex 
and age should be undertaken, as it could lead to a different cost estimation of BTB 
control strategy.  
Shortage of human resources should be considered for intervention planning, a 
maximum of 40% cull rate might be feasible; however, it would be costly in view of 
current Moroccan economic situation. One may think that test and slaughter 
implementation would lead to a reduction in cattle population and its by-product. But 
on the other hand, the increased import of cattle from other countries, with enhanced 
control measures, could maintain the current population density. In the meantime, as 
dairy products are provided mostly from highly controlled farms where BTB has a 
very low prevalence, we could argue that milk production would not be significantly 
affected.  
Towards One Health 
The WHO includes BTB amongst the seven neglected zoonoses which are perceived 
to be severe threats to public health (1). Further molecular epidemiology 
investigations in Morocco are needed in order to clarify local and national human 
BTB/TB ratios. To reach this goal, closer collaboration, at the national and 
international level, between the human and animal health sectors through a One 
Health approach is highly recommended. Operations in these two sectors remain 
largely independent in Morocco. Communication must be enhanced to establish a 
One Health approach, which has proven efficacy in health service delivery and 
potential  for economic savings in zoonosis control (70, 71). 
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Abstract 
In Morocco, cattle production is one of the most important components of the 
agricultural economy. The development of this sector is faced by many problems, like 
poor infrastructure, lack of services and climate change, in addition to infectious 
diseases like bovine tuberculosis. Bovine tuberculosis is a chronic zoonosis caused  
by M. bovis, which has the ability to infect a wide range of animals, as well as 
humans  
The first objective of this study is to develop a demographic model for the cattle 
population of Morocco based on real data. The second objective is to estimate the 
cost of BTB to the Moroccan economy, considering the losses in the animal sector. 
In order to reach the objectives, a deterministic model was conceptualized in Vensim 
considering 5 age classes for females and 3 age classes for males. One year was 
considered as a time step. In addition, using the matrix model, cattle population was 
simulated for 18 years. 
The productivity losses triggered by BTB (5%) were estimated for 18 years, applying 
Leslie matrix with and without BTB. An endemic stable state of 18% was considered 
for this estimation. Cattle Moroccan population was compared with and without the 
disease, and the loss in term of animal numbers was then calculated. The number of 
cattle lost due to BTB was then transformed into monetary value. The total amount 
lost due to BTB in 18 years, considering the productivity loss is 913 Million Euro. 
The present working paper present the first BTB cost estimation for Morocco. The 
analysis presented here is preliminary; a complete analysis will be done for the full 
paper. 
The cost estimation of BTB is an important step, which will contribute to the advocacy 
of BTB control to decision makers. In addition, the inclusion of the societal cost of 
human health of BTB into the total cost estimation will constitute a strong argument to 
promote the animal-human collaboration in order to control and eliminate BTB in 
Morocco using a One Health approach 
Keywords: Morocco, Cattle population, Deterministic model, Matrix model, 
Cost of BTB 
  
118 
 
 
Introduction 
In Morocco, cattle production is one of the most important components of the 
agricultural economy; it generates 35 milliards of Moroccan Dirhams (MAD) (1 Euro =  
10.87 MAD, (1)) per year which represents more than 44% of the agricultural product. 
This sector contributes heavily to the development of the Moroccan economy by 
generating many job opportunities, more than 2.5 million persons work in the animal 
production sector. The development of this sector is faced by many problems, like 
poor infrastructure, lack of services and climate change. A large number of Moroccan 
small farmers follow the ambitious “Plan Maroc vert” (PMV), using an integrated and 
global approach towards sustainable social and ecological development. This 
program has multiple objectives, as to increase the animal production aiming at the  
production of 5 million tons of milk by 2020 (2). 
While the livestock production system is growing in Morocco, cattle are facing many 
infectious diseases which cause economic losses. Some of these diseases, e.g. 
bovine tuberculosis are zoonotic and cause a human health burden in addition.  
Bovine tuberculosis is a chronic zoonosis caused  by M. bovis, which has the ability 
to infect a wide range of animals, as well as humans (3). Even though, the 
preferential host of M. bovis is cattle (4), M. bovis have been described in several 
wildlife hosts like the badger (Meles meles), and the Possum (Trichosurus vulpecula) 
(5). In Morocco, M. bovis have been recently described in wild boar (6), however, 
there is still no strong evidence about the exact role of wild boar in BTB transmission 
and persistence in Morocco. 
M. bovis can be transmitted between animals through the inhalation of aerosols and 
the ingestion of contaminated feed (7), while the transmission to humans is possible 
via the contact with infected cattle in addition to the consumption of unpasteurized 
milk and milk products (8). 
The net growth rate of a population is the difference between the per capita birth and 
mortality rates. In a demographic matrix model a projection matrix P is multiplied with 
a population vector V composed of age and sex classes as V(t+1) = P x V(t). The 
composition of the population is in equilibrium if the relative proportions of the age 
and sex classes are stable. V is then an Eigenvector of P and the dominant 
Eigenvalue of P represents the net growth rate of the population (9). A mathematical 
model is a representation of “reality” (10). Deterministic models of a population using 
differential equations represent the flow of individuals between different age and sex 
classes which are considered as compartments. Per capita birth and survival rates 
constitute the elements of the projection matrix of a matrix model(11).In this way 
cattle populations can simulated as a set of coupled differential equations or as a 
matrix model. (10). The simulation of cattle populations provides the backbone to 
animal health economic assessments, aiming at providing a framework of concepts, 
119 
 
procedures and data to support the decision making process in optimizing animal 
health management. It actually deals with quantifying the financial effects of animal 
diseases, develop methods for optimizing decisions when animals, herds or 
populations are affected, in addition to determining the costs and benefits of disease 
control measures (12) 
Bovine tuberculosis is a zoonosis which affects livestock industry, public health 
sector and wildlife reservoir. BTB has also indirect effects on trade restrictions in 
endemic countries. Tourism and other areas of public and private interest may also 
be affected indirectly by BTB infection.  
BTB affects cattle productivity, it causes a decrease in milk and meat production, in 
addition to a fertility reduction, it could also causes unknown indirect consequences 
for the whole ecosystem and economic activities by affecting wildlife (13). 
Cattle productivity losses due to BTB were for the first time investigated by Meisinger 
et al. in 1969 (14) and afterwards by Denes et al in 1986 (15) and by Bernues et al in 
1997(16). Actually, all the studies investigating quantified effects of BTB on livestock 
were conducted in developed countries (13). Considering those studies, the milk 
production loss due to BTB was estimated to range from 10% to 12% of total milk 
yield. Total meat production loss (losses due to emergency or illness slaughter + 
losses triggered by the normal slaughtering and routine meat inspection) were 
estimated to range between 6% and 12%. A replacement loss of 15% in infected 
animals was registered. In addition BTB have been shown to cause 5% decrease in 
fertility. An estimation of the losses caused by BTB per animal per year have shown 
1/5 calf loss, and 1/5 replacement loss in infected animals.  
The quantification of BTB burden by its cost calculation is not well investigated, it has 
been performed for some countries, such as Turkey (17) and Argentina (18), and 
more recently Ethiopia (19). Although, the cost of the control of BTB requires further 
assessments, Zinsstag et al (13) summarized economic studies on BTB control. It 
was then emphasized that benefit-cost analysis are very scarce. A model cost benefit 
analysis was performed in Canada, and showed an extreme high Benefit-cost ratio of 
33/1. Similar studies were also performed in the USA, and found to be cost effective 
(20). While in the United Kingdom (UK), the opinions are contradictory, Sheehy et al 
in 1991 performed a benefit-cost analysis, and showed that the UK BTB control 
program is cost beneficial, it is to be highlighted that the benefit from preserving 
international market access was included in the analysis (21). On the other hand 
Power and Watts found that BTB control was not profitable when the control of 
badgers was included in the analysis (22). More recently, an analysis of the current 
costs spend on BTB control showed that BTB control in the UK is not effective and 
not profitable. The authors argue that even the public health benefit is negligible 
provided the mandatory pasteurization of milk (23). In Ethiopia, the cost of BTB 
ranged from 75.2 Million USD to 358 Million USD in the urban area, where the 
prevalence of BTB is higher, while the cost ranged from 500’000 to 4.9 million USD 
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for the rural area, where BTB prevalence is lower. The cost analysis of BTB in 
Ethiopia concluded that the control of BTB is not one of the priorities considering the 
financial component and the expensive control intervention required (24). However, 
these analyses did not take into account the cost to human health. 
The prevalence of BTB among human TB has been reviewed by Muller et al in 61 
countries, for whom the data is available so far. Overall median proportions of 
zoonotic TB observed were 2.8% in Africa, and 1.4% outside of Africa (25). In 
addition, WHO declared that M. bovis is responsible for 3.1% of all TB cases in 
humans (26). 
Cost analysis and cost-effectiveness studies investigating the cost of different 
treatments and diagnostic strategies relative to human TB have been much 
performed, mostly in the developed countries (27–32). In addition, studies 
investigating direct costs of human TB were performed as well, in the USA, the cost 
of TB patient considering direct costs which are mainly covered by public sector, in 
addition to the loss in productivity was estimated to 17’000 USD for non-MDR 
patients, 134’000 USD for MRD patients and 430’000 for XDR patients (33). In 
Germany MDR and XDR TB patients cost were 82150 Euros, and 108733 
respectively (34). In developing countries, the cost of human TB patients is much 
lower than the cost in developed countries; actually, in Uganda, the cost of the 
disease for one human TB patient ranges from 391 USD to 911 USD considering 
community-based care and hospital-based strategy respectively (35). In Zambia the 
cost of human TB from the patient perspective was found to be 25 USD (48% of the 
patient median monthly income) (36). Considering the direct and indirect costs 
triggered by TB, the cost of TB for the household in rural area in Nigeria was found to 
be 592 USD (37% of the median annual household income) (37). The cost of TB 
considering directly observed treatment in Brazil is 336 USD for the patients and 726 
USD for the facility, direct and indirect costs were also considered (38). 
Recently, cattle to cattle and cattle to human transmission model was developed for 
Morocco, Using this model, the cost of BTB elimination was estimated between 1.87 
to 1.48 billion Euro with a time frame of 13 to 20 years to reach freedom from 
disease. This model showed also the positive impact of a BTB intervention in cattle 
on the zoonotic human TB prevalence (39). 
Objectives: 
The first objective of this study is was develop a demographic model for the cattle 
population of Morocco based on real data. The second objective was to estimate the 
cost of BTB to the Moroccan economy, considering the losses in the animal sector. 
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Materials/Methods 
Overview of Moroccan cattle population  
Cattle production in Morocco has an important role in the national economy; it 
participated to more than 50% of the national red meat supplying and almost 90% of 
Moroccan milk supplying (40). Statistics of cattle population are managed by the 
statistical section of the ministry of Agriculture; this data is reported to the veterinary 
services. We considered in our study data from 1995 to 2013. The Moroccan cattle 
population is composed in majority of cows aged from 3 to 9 years. The growth rate 
of cattle population from 1995 to 2013 is on average 1.017 with a minimum of 0.905 
and a maximum of 1.097. 
Moroccan cattle are composed of local breeds, pure imported breeds (represented in 
more than 80% by Holstein breed) and crossbreeds between local and imported 
called ameliorated breeds. The cattle population in Morocco in the 1970’s was 
composed in majority of local breed. After the implementation of the milk program In 
1975 and the meat program in 1978, Morocco began  large scale  importation of 
European breeds (Holstein in majority). In this way the Moroccan cattle herd 
experienced a transition dominantly local breeds (4 different Moroccan local breeds), 
to almost an equilibrium between the local breeds and the improved breed (pure and 
crossed) (40). 
According to the data between 1995 and 2013, the birth rate ranged from 31% to 
36% with an average of 32%. According to the livestock management service, the 
mortality of the calves is 8%, while it’s 4% for heifers and 2% for cows. The milk 
production is variable and depends from many factors like the age and the breed of 
the cow, e.g.: the imported breeds have a higher milk production than the local 
breeds (41).  
Cost analysis  
Animal health 
Losses triggered by BTB in the animal production were analyzed. Bovine tuberculosis 
caused losses in the milk production, a decrease in fertility, in addition to losses in 
the carcass weight and the meat and entrails condemned in the slaughterhouse. 
No studies are available for Morocco estimating specific losses in milk and in fertility. 
Consequently, we will consider in our analysis, estimations from previous studies, 
which will be validated by Moroccan experts. 
As a preliminary analysis, we considered the decrease in productivity caused by 
BTB. After the implementation of the Moroccan cattle population model using Vensim 
(42) and a Leslie Matrix, the population was compared with and without BTB, the 
fertility affected by BTB prevalence was calculated as following: 
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Fertility (with BTB) = Fertility (without BTB) * (1-(BTB prevalence*reduction in the 
parameter)) (24) 
The differences between the number of cattle of the population without and with BTB 
were calculated. Using estimated values of the prices of cattle considering sex and 
age categories, the total amount lost because of BTB for 18 years was estimated.  
Human health:  
Bovine tuberculosis has also a human health burden, the exact human burden of M. 
bovis in Morocco is not yet known, however, a study performed on MRD tuberculosis 
patients showed a prevalence of 17.8% of M. bovis, we could though consider the 
proportion of MDR patients among the total TB cases in order to calculate a potential 
prevalence of M. bovis among human TB cases in Morocco. 
The cost of the human burden of BTB will then be estimated considering the societal 
cost of a human TB patient (public and private costs), and the proportion of M. bovis 
among the overall human TB patients. 
In order to estimate the societal cost of human TB for the patient and the hospital; 
first, we conducted a socio economic survey with human TB patients in Rabat 
hospital (Appendix 1), considering direct and indirect costs of TB. The survey had 
several parts: 1) socio demographic information, 2) M. bovis related risk factors, 3) 
expenses triggered by the disease, and 4) socio-economic consequences related to 
the disease. Second we conducted an individual interview with the head of the 
financial service in order to estimate the cost of TB patients for the hospital, 
considering that human TB treatment is free in Morocco. It is to be highlighted that 
the total amount spent by the hospital for each patient includes the direct and indirect 
costs (staff salaries, external charges). 
A total of 112 surveys were conducted, a detailed analysis will follow afterwards. The 
survey will provide the following information for each TB patient: 
 Amount spent by the patient before the hospitalization 
 Amount spent by the patient during the hospitalization (direct costs) 
 Amount spent by the patient during the hospitalization (indirect costs) 
 Amount of the money spent by the hospital 
 Hospitalization period 
 Invalidity period 
 Socio economic status 
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Results 
Model 
Data from 1995 to 2013 were used for the model; data of the years 1997, 1999, 
2006, 2010 and 2012 were extrapolated from the year before and after. Using data 
from 2008 to 2013 (Table 1) the proportion of slaughtered cattle was calculated using 
the cattle meat production, the average carcass weight as given by the national data 
(43).  
Table VII.1. Cattle meat production and the proportion of slaughtered cattle (2208-
2013) (44) 
Year Cattle meat production (T) 
Number of 
slaughtered cattle 
(av=220 Kg) 
Total cattle 
population 
Proportion of 
slaughtered cattle (%)
2008 180000 818’182 2‘814‘000 29
2009 190000 863’636 2‘545‘300 34
2010 192000 872’727 2‘791‘650 31
2011 194000 881’818 3‘038‘000 29
2012 197000 895’455 3‘105‘500 29
2013 198000 900’000 3‘173‘000 28
An average proportion of 30% of the total Moroccan cattle population is slaughtered 
per year (Table 7.1). This proportion was applied to the total cattle population from 
1995 to 2007 in order to have a total slaughtered population. 
Deterministic model  
The deterministic model was conceptualized in Vensim (42) considering 5 age 
classes for females (calves, heifers, primipara, cow and old cow) and 3 age classes 
for males (Male calf, Young bull and bull), for each category we considered the birth 
rate, the slaughtered rate, and the transition rate from the previous compartment 
(Figure7.1). For every age and sex class a differential equation was written, ignoring 
density dependence.. In our model we used a time step of one year. The parameters 
and the variables used in the model are presented in Table 7.2 and 7.3, with their 
respective units and values. 
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Figure VII.1. Schematic diagram for Moroccan cattle population model 
The total cattle population Pc is divided to 8 age and sex compartments, female 
calves (Cf), Heifer (H), Primipara (P), Cow (C), Old cow (Co), Male calf (Cm), Young 
bull (By), Bull (B). At a time (t), the total population will be: 
Pc(t)= Cf (t)+H(t)+P(t)+C(t)+ Co (t)+ Cm (t) + By (t) +B (t)  (1) 
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Table VII.2. Interpretation and value of the parameters used in the model as starting 
values for the optimization 
Parameters  Interpretation  Value Unit Source 
bcf birth rate female calves 0.375 1/Year Calculated from data 
bcm birth rate male calves 0.375 1/Year Calculated from data 
µcf mortality rate female calves 0.08 1/Year (41) 
µh mortality rate heifer 0.04 1/Year (41) 
µp mortality rate primipara 0.03 1/Year Assumption 
µc mortality rate cow 0.02 1/Year (41) 
µco mortality rate old cow 0.05 1/Year Assumption 
µcm mortality rate male calves 0.08 1/Year (41) 
µby mortality rate young bulls 0.03 1/Year Assumption 
µb mortality rate bulls 0.03 1/Year Assumption 
Scf slaughter rate female calves 0 1/Year Assumption 
Sh slaugther rate heifer 0 1/Year Assumption 
Sp slaugther rate primipara 0.01 1/Year Assumption 
Sc slaugther rate cow 0.2 1/Year Assumption 
Sco slaugther rate old cow 0.8 1/Year Assumption 
Scm slaughter rate male calves 0.1 1/ Year Assumption 
Sby slaughter rate young bulls 0.8 1/Year Assumption 
Sb slaughter rate bulls 0.95 1/Year Assumption 
Tpc primipara to cow rate 1 1/Year Calculated from data 
Tcco cow to old cow rate 1/6 1/Year Calculated from data 
Tcby calf to young bull rate 1 1/Year Calculated from data 
Tbyb young bull to bull rate 0.5 1/Year Calculated from data 
Table VII.3. Interpretation and unit of the compartment variables considered in the 
model 
Variables Interpretation Unit Cattle number 
(1995) 
Source 
Cf Female calves Animal 363’337 National statistics_Morocco 
H Heifer Animal 172’107 National statistics_Morocco 
P Primipara Animal 191’230 National statistics_Morocco 
C Cow Animal 1’070’888 National statistics_Morocco 
Co Old Cow Animal 114’738 National statistics_Morocco 
Cm Mal calf Animal 340’548 National statistics_Morocco 
By Young bull Animal 207’792 National statistics_Morocco 
B Bull Animal 28’860 National statistics_Morocco 
Pc Total population Animal 2’489’500 National statistics_Morocco 
The differential equations below represent the number of animals per compartment 
considering the animals in the other compartments and the different parameters: 
Female calves 
dCf/dt=bcf *(P+C+Co)-(Cf*Tcfh)-mcf-Scf    (2) 
Heifers 
dH/dt= (Cf*Tcfh)-(H*Thp)-mh-Sh    (3) 
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Primipara 
dP/dt= (H*Thp)-(P*Tpc)-mp -Sp   (4) 
Cow 
dC/dt=(P* Tpc)-mc-Sc    (5) 
Old cow  
dCo/dt= (C*Tcco)-mco-Sco   (6) 
Male calf 
dCm/dt=bm*(P+C+Co)-(Cm*Tcmby)-mcm-Scm   (7) 
Young bull 
dBy/dt= (Cm*Tcmby) -(By*Tbyb)-mby-Sby   (8) 
Bull 
dB/dt=(By*Tbyb)-mb-Sb  (9) 
Optimization and implementation of the Matrix model 
Several calibrations were performed using Vensim (42), Similarly to Zinsstag et al 
(45), the Powell nonlinear maximum-likelihood optimization algorithm was used to fit 
the model to the data (46). Parameters were optimized on the basis of the goodness-
of-fit, called ‘‘payoff’’ in Vensim software. The payoff compares the log likelihood of 
the current model with the log likelihood of a perfect model. The best model is the 
one with smallest payoff. The parameters from the best calibration were used for the 
Leslie matrix.  
Using the parameters optimized by Vensim, we implemented the model using Leslie 
matrix as described above.  
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Table VII.4. Cattle productivity parameters used in the projection matrix 
Parameter Central value 
Fertility rate for female 0.376
Fertility rate for male 0.344
Survival female calves 0.517
Survival heifers 0.531
Survival primipara 1
Survival cows 0.28
Inverse years as cow 0.83
Inverse years as old cow 0.5
Survival male calves 0.39
Survival young bulls 0.01
Inverse years as young bulls 0.5
Inverse years as bulls 0.84
Using the matrix model, cattle population was simulated for 18 years, the results 
obtained were compared to the official national data (Figure 7.2). 
 
Figure VII.2. . Comparison between Moroccan total and slaughtered cattle 
population from national official data and data simulated using the 
deterministic model 
The productivity losses triggered by BTB were estimated for 18 years, taking as a 
starting date 1995, and applying Leslie matrix with and without BTB (considering 5 % 
loss in productivity). An endemic stable state of 18% was considered for this 
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estimation. Cattle Moroccan population was compared with and without the disease, 
and the loss in term of animal numbers was then calculated. The number of cattle 
lost due to BTB was then transformed into monetary value, considering the average 
value of animals in every sex and age category. For the final paper, the discounting 
of monetary value will be included. 
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Table VII.5. Loss due to BTB considering the price of the animals by sex and age 
Animal 
categories Price_Min Price_Max
Average price 
(MAD) 
Loss_Due to BTB 
(MAD) 
Loss_Due to 
BTB (Euro) 
Female calve 5‘000 8‘000 6‘500 101‘273‘580 9‘316‘797
Heifer 15‘000 20‘000 17‘500 134‘065‘153 12‘333‘501
Primipara 15‘000 20‘000 17‘500 67‘559‘147 6‘215‘193
Cow 20‘000 28‘000 24‘000 390‘059‘951 35‘884‘080
Old cow 8‘000 15‘000 11‘500 90‘212‘701 8‘299‘237
Male calf 5‘000 8‘000 6‘500 92‘859‘054 8‘542‘691
Young bull 15‘000 20‘000 17‘500 176‘120‘398 16‘202‘428
Bull 20‘000 28‘000 24‘000 10‘430‘432 959‘561
Total 1‘062‘580‘416 97‘753‘488
Table 7.5 shows the different prices of the different categories of cattle (Marhaben A., 
Personal communication, 2016), in addition to the respective loss due to BTB. The 
asset value of the living animals lost due to BTB in year 18 is 98 Million Euro (1 
Euro=10.87 MAD). 
The estimation of the cumulated losses triggered by BTB in milk production and 
carcass weight will be estimated in the same way for the final paper. Milk yield data 
and average carcass weight by sex and age are needed to complete the cost 
analysis. 
Discussion and conclusion: 
The present working paper present the first BTB cost estimation for Morocco. The 
analysis presented here is preliminary; a complete analysis will be done for the full 
paper. Here we considered only the effect of the loss of fertility triggered by BTB on 
the asset value of the living cattle population. Deterministic and Matrix models were 
used in order to create the demographic model of the Moroccan cattle population, the 
cost of BTB considering the loss in productivity was estimated to be 98 Million Euro in 
a the year 18. The current optimization of the deterministic model in Vensim will be 
confirmed using a matrix model MATLAB®.  
The cost estimation of BTB is an important step, which will contribute to the advocacy 
of BTB control to decision makers. In addition, the inclusion of the societal cost of 
human health of BTB into the total cost estimation will constitute a strong argument to 
promote the animal-human collaboration in order to control and eliminate BTB in 
Morocco using a One Health approach. 
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VIII. Discussion 
The present thesis has 4 components, we first investigated the prevalence of BTB 
in Sidi Kacem area of Morocco, and afterwards, we conducted a molecular 
characterization of BTB isolated from two slaughterhouses in Morocco. In parallel, a 
transmission model for animal-human BTB was realized, followed by a cost estimate 
of bovine tuberculosis to the livestock sector. The results shown by the present thesis 
constitutes a step forward in the control of BTB in Morocco; those results will be used 
for the advocacy of BTB control in Morocco. The results will be disseminated through 
trans-disciplinary meetings including all the stakeholders in order to enhance the 
collaboration and the One health approach in Morocco.  
In Sidi Kacem in Morocco, 1201 cattle were screened for BTB using SICTT, the 
prevalence found, when compared to the last national prevalence study performed in 
2004, highlighted likely an endemic stable state (20.4% in 2012 vs. 18% in 2004). 
The slight difference could be due to the study area, which could also explain the 
higher herd prevalence (56% in 2012 vs. 33% in 2004). Even if the BTB prevalence 
found in Morocco is higher than that registered in Niger (101) and in Tanzania (95), 
and lower than BTB prevalence in Mozambique (94) and in Zambia (102), the 
endemic stable state registered in Morocco is similar to other African countries. 
The test used in the prevalence study was the SCITT. In Morocco, the legislation 
requires the use of SITT first, and SCITT is used as confirmatory test. In the 
prevalence study, we decided to use the SCITT directly because of logistic matters 
and to enhance the specificity of the test. Gamma interferon tests have been already 
used in African settings (190,191), and it could be a good alternative to the SCITT in 
Morocco to encounter the logistic problems with the SICTT, as the interferon gamma 
test does not require a second visit (192,193). 
Using a random effect model, univariate and multivariate analysis were used in 
order to perform the statistical analysis of the individual risk factors. Consequently, 
risk factors that showed significantly higher risk for BTB were identified. Cross-breeds 
showed a higher risk for BTB compared with the local breed; this could be explained 
by the higher susceptibility of the cross-breeds to BTB, but needs further studying on 
the effects of management density of animals. In addition cross-breeds are usually 
kept in larger herd sizes, in intensive or semi-intensive livestock production systems 
(LPS), under irrigated rearing systems, which are also factors associated with higher 
risk of BTB. The previous risk factors have already been linked to higher BTB risk in 
other settings; in Ethiopia, where intensive livestock production system has shown a 
higher risk for BTB, with a higher prevalence registered in intensive farms (urban 
area) in contrast to the rural area which is characterized by extensive LPS (126,127). 
On the other hand, similarly to our results, the local breed showed a lower risk for 
BTB, as already described in Mozambique (94). 
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The livestock production sector in Morocco is quickly growing, due to the 
ambitious “plan Maroc vert” launched in 2008 in addition to increasing consumption 
of animal protein in Morocco. Consequently, the livestock production systems are 
moving towards the intensified and irrigation rearing systems. Those factors, when 
applied in small to medium herds, with limited means, may have adverse 
consequences, like a confined environment, with limited access to sun and fresh air, 
factors that enhance the transmission of mycobacteria between animals and 
promotes its persistence in the environment. This is in contrast to extensive rearing 
systems that allow good access to fresh air and sun.  
The prevalence of visible BTB lesions in the slaughterhouses of Rabat and El 
Jadida was 3.7 %, similar to that reported in Algeria (3.6%) (194). The relatively low 
prevalence of proven M. bovis infection found in the abattoirs has to be interpreted 
with caution. Firstly, the abattoir prevalence reflects more the prevalence in young 
bulls and old cows rather than the whole population. Secondly, not all granuloma 
yielded a bacteriological isolate, hence the true prevalence may be much higher than 
the one observed. Overall, our findings reflect rather the epidemiological situation of 
a low level endemic transmission similar to other African countries rather than the 
one of a peri-urban intensive system (55,56).  
Surprisingly, no non-tuberculous mycobacteria was found, while in the African 
context, among slaughterhouse gross visible lesions, 3.3 % in Mali (40), and 9 % in 
Burkina Fasso (41) were confirmed as non-tuberculous mycobacteria. Additional 
studies in Chad showed the isolation of NTM slaughterhouse gross visible lesions 
(33,34). Further molecular analysis with increased sample size and for other 
slaughterhouses will provide further input in regard to the proportion of non-
tuberculous mycobacteria in Morocco 
The molecular characterization using deletion typing and spoligotyping of 
Moroccan BTB isolates showed 43 different spoligotype patterns, of which 33 were 
already reported in other countries, mostly in Europe. The existence of European 
spoligotypes in Morocco could be explained by importation of cattle from European 
countries to Morocco. This element should be considered for a future control 
strategy, especially in the last stages of the strategy, to prevent a re-increase of the 
prevalence. In addition, the first introduction of BTB to Morocco is suggested to occur 
between 1913 and 1950 by the importation in the thirties of European cattle breeds 
and the introduction of new management systems (195). The fact that Moroccan M. 
bovis has similar spoligotype patterns as European once could be a consequence of 
this introduction, however, Morocco continue to import cattle from Europe.  
On the other hand, spoligotypes of African 1 and African 2 clonal complexes were 
not reported among our characterized isolates. Considering the localization of African 
1 and African 2 in West Central Africa and East Africa respectively, we would 
conclude that the Sahara could be considered as a potential efficient barrier 
preventing the introduction of BTB to Morocco from West-Central and East Africa. 
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Additionally, ten new spoligotypes were reported and submitted to the M. bovis 
database, where they were given new reference numbers.  
More research is needed to further characterize the ongoing transmission 
patterns of bovine tuberculosis in view of the development of a locally adapted 
elimination strategy of bovine tuberculosis in Morocco (57). In addition, more 
molecular characterization is needed to investigate the strains circulating in the south 
and the north of Morocco. Whole genome sequencing could also be useful to gain 
insight about Moroccan BTB strains, although to date, almost no data is available for 
whole genome sequences of M. bovis in Africa. An overall study considering different 
countries from Africa would have an added value and give more information about 
the transmission dynamics of BTB in Africa, and the links between BTB in different 
African countries. 
Co-evolution scenarios have been realized for human TB, to understand the co-
evolution of MTBC in regard to the human evolution. It was suggested then that 
MTBC has been able to adapt to changing in human population and that there is a 
co-evolution of MTBC with anatomically modern humans for tens of thousands years 
(Comas et al. 2013). Similarly, a study interested in the co-evolution of MTBC in 
regard to cattle population will provide an understanding of the origin of M. bovis, and 
the respective co-evolution, this could bring an understanding of the dynamics of M. 
bovis. 
Collaboration between African countries for BTB molecular investigation is likely 
to provide a better understanding of the past evolution of the disease. This 
understanding could contribute to build more adapted control strategies. An African 
collaboration could also be efficient for mutual lesson learning, recommendations 
from different African countries could be bring together and adapted to each context. 
The illegal trade of animal from other African countries to Morocco is a crucial 
point, which will impact the success of a potential control strategy, this element 
should be rigorously controlled for a most efficient and sustainable BTB control and 
elimination intervention. Moreover, in Morocco, a big issue facing disease control, 
especially zoonosis control is the informal trade of diary and meat products. This 
informal sector is difficult to control, and it is also a key element to consider for a 
future BTB control strategy. 
The identification of the Moroccan cattle is big step that Moroccan veterinary 
services started a year ago. In the USA, the application of animal traceability is 
challenging for the abattoir surveillance (114). The identification of the total cattle 
population will contribute positively into the success and the sustainability of a 
potential BTB elimination intervention in Morocco, and will provide better abattoir 
surveillance. 
An efficient identification of the Moroccan cattle population could contribute to the 
control of the illegal trade of animals inside the country, and also with neighboring 
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countries. In addition, Milk and meat informal trade constitutes a risky behavior, 
which promotes the possible transmission of M. bovis to humans. The control of the 
informal ways of milk and meat trade in Morocco should be preferentially performed 
before the implementation of any control or elimination control strategies.  
Cattle to cattle and cattle to human compartmental deterministic mathematic 
model was elaborated for Morocco. The reproductive number was subsequently 
calculated to be 1.325, in the range of both low risk areas (R0= 0.6-1.4) and high risk 
areas (R0=1.3-1.9) as previously reported in the United Kingdom (196), however, it 
was lower than the R0  (1.7-2.2) reported in France (197). Using a senstivity analysis, 
, the birth rate of cattle bc was the most sensitive parameter for the total cost, 
influencing the dynamics of BTB transmission. High birth rate values lead to an 
increased cattle population yielding higher costs for elimination. For the time to 
elimination, the sensitivity of the test was the most sensitive parameter. Low test 
sensitivity (i.e. with cut-off at 4mm) leads to low detection of infected animals and 
therefore less culling which leads to a longer time to elimination. 
In addition, a preliminary economic assessment of the cost of a potential BTB 
intervention in Morocco was performed. It was found that the cost of the intervention 
depends on the percentage of test and slaughter (the annual coverage). The 
cumulated cost was remarkably stable for coverage values higher than 40%, ranging 
from 1.47 and 1.87 billion Euros within a time frame 12 to 44 years to reach freedom 
from disease. Shortage of human resources should be considered for intervention 
planning, a maximum of 40% cull rate might be feasible; however, it would be costly 
in view of current Moroccan economic situation. 
More parameters should be considered in the model in order to further refine it, 
e.g., re-infection of human TB recovered patients was not considered in the model. In 
addition, further molecular characterization of the BTB/TB ratio in human patients in 
Morocco is needed in order to be able to quantify the BTB human burden.  
The transmission model allowed us to investigate the link between BTB 
intervention in animals and the prevalence of human TB due to M. bovis. With 40 % 
coverage of test and slaughter, the prevalence of exposed and active human cases 
due to M. bovis decreased from 5 per 10’000 to less than 1 in 10’000 at the time of 
freedom from disease after 17 years. 
The OIE recommended cut-off for SICTT interpretation is 4 mm, however, many 
studies showed that a severe cut-off of 2 mm increased the sensitivity of the test 
(198,199), without affecting the specificity compared to the recommended 4 mm cut-
off (200). The two cut offs were compared using the model. The cumulated cost of 
BTB test and slaughter intervention and the time to elimination were lower using 
2mm cut-off of SICTT compared to the 4mm cut-off. 
Considering the economic situation of Morocco as a middle income country, BTB 
intervention remains unaffordable. In developing countries, as well as in Morocco, 
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BTB is a neglected problem, the limited financial and human resources available are 
mainly engaged in the control of other highly contagious diseases and parasitic 
diseases. The only BTB control measure which is applied in Morocco is the 
slaughterhouse inspection of cattle and condemnation of animals (or organs) with 
BTB suspicious lesions, a measure which remains inadequate for efficient BTB 
control. In order to deal with this problem, collaboration between the private milk 
industry and the public veterinary services may be useful to launch a BTB control and 
elimination program. The milk industry in Morocco, in addition to the meat industry, 
will benefit from the elimination of BTB. 
Deterministic and matrix models were used to perform a preliminary cost analysis 
of BTB considering the losses in productivity. The amount of 98 Million Euro was 
found to be the asset value lost due to BTB in the year 18 years, with an endemic 
stable prevalence of 18%. 
The optimization of the demographic model using MATLAB will provide a useful 
and efficient tool for livestock management in Morocco. The conceptualized and 
optimized model could be used for the estimation of the cost of infectious disease for 
the Moroccan livestock, in addition to the estimation of the cost of potential disease 
control strategies. 
One health approaches have shown their efficiency in many settings. In Chad, a 
OH health approach was used in a vaccination campaign for both pastoralists and 
their animals which led to a reduction of the cost by 15% (175,176). In addition, an 
intervention can become highly cost effective when costs are shared between 
different sectors respective to their benefits (201). In Morocco, human and animal 
health experts have been introduced to the OH approach; however, the collaboration 
between the two sectors is currently at a very low level. Moreover, almost no 
communication exists between the ministries of Health and of Agriculture. In order to 
enhance the communication and collaboration between the two ministries, many 
meetings should be held, and a trans-disciplinary (TD) approach could be useful.  
Considering that the implementation of BTB control strategy should be motivated 
by both public health issues and the economic losses triggered. Trans-disciplinary 
approach is an efficient way to set up a beneficial dialogue between different 
disciplines, and bring them to work together and collaborate. The benefit from an 
efficient collaboration between the two sectors should be highlighted using examples 
from other countries, or models from Morocco, showing the effect of animal 
interventions in the prevalence of human zoonosis. Zinsstag et al demonstrated, 
using brucellosis, rabies and influenza examples, that zoonosis control intervention 
could become cost efficient when the societal component is considered (179). The 
results of the present thesis could be used as advocacy elements during the TD 
meetings with human health, animal health experts and decision makers in Morocco. 
A potential way to enhance the collaboration between the two sectors would be to 
set up a common project between human and animal health experts, where all the 
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partners are actively and commonly leading the project actions. The establishment of 
sustainable collaborations between the veterinary services and the human health 
sector could be an efficient way to bring the two sectors together and promote one 
health approach in Morocco. 
In addition, considering the animal health sector in Morocco, contact between 
livestock keepers, local authorities and veterinary services is characterized by 
mistrust by the owners. While a solid and sustainable control program cannot be 
achieved without the contribution of all the stakeholders, and although the local 
population is considered as a substantial stakeholder, we have to start from the 
bottom and roll-out an adapted awareness program to make the local population 
aware about the necessity of a national control program. Awareness campaigns have 
been shown to be cost-effective and beneficial in order to enhance disease 
awareness among the population. Besides, a better awareness of the disease is key 
element for an effective application n and sustainability of control and elimination 
strategies (120,121). 
The implementation of an awareness stainable strategy in Morocco for several 
zoonoses in Tandem could contribute to a better acceptance of the control strategies 
by the population afterwards. In a long term, health education could contribute to the 
Modification of some risky cultural behaviors like the consumption of unpasteurized 
milk and traditional milk product. 
In Morocco, the application of BTB elimination strategy is a long term goal, as it is 
not logistically and financially feasible currently. Bovine tuberculosis control 
measures are almost inexistent, expect from the abattoir surveillance. Consequently, 
further spread of the disease is possible in the future, with potential increase in the 
prevalence. In the meanwhile, some measures could be implemented like the control 
of illegal trade of cattle product in Morocco, and a better management of cattle 
movement.  
IX. Perspectives and identified research needs 
In order to reach a deeper understanding of molecular epidemiology of BTB in 
Morocco, further molecular investigations, are needed in other Moroccan 
slaughterhouses. In addition, information regarding BTB strains in the north and 
south of Morocco is not available so far. 
 Furthermore, new molecular techniques such as whole genome sequencing are 
needed to clarify more the potential links between Moroccan BTB strains and those 
of Europe and other African countries. 
 Collaboration with the other African countries, especially the neighboring countries 
for a deep investigation of BTB dynamics in Africa and the co-evolution of BTB in 
regard to cattle will provide a better understanding of BTB in Africa. 
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 The results provided by the present thesis could be used to launch TD meetings 
with all the stakeholders involved in BTB problem in Morocco. Meetings in small level 
could be first performed, before to set up a national TD seminar, in collaboration with 
all the stakeholders.  
In order to deal with the problem of unaffordability of BTB elimination intervention 
in Morocco, possible public-private collaborations for BTB control in Morocco have to 
be identified and explored. 
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X. Appendix 
Appendix 1: Questionnaire for TB patients 
Coût direct et indirect de la tuberculose humaine 
Publique cible : Patients tuberculeux hospitalisés 
1. Identification:………………………………………………………..Code … 
1.1.  Nom du patient…………………………………………………………………… 
1.2.  N° de tel :……………………………… …………………………………………. 
1.3.  Lieu de l’enquête :…………………………………………………………………… 
1.4.  Date d’enquête : ......./……../..….. 
1.5.  Nom de l’enquêteur : 
……………………………………………………………………..  
2. Informations sociodémographiques 
2.1.  Sexe :  Féminin  Masculin 
2.2.  Age (ans) :  
2.3.  Occupation 
(s)…………………………………………………………………………….. 
2.4.  Secteur d’activité:     Public           Privé 
2.5.  Etat civil:  Célibataire  Marié  Divorcé   Veuf 
2.6.  Niveau d’instruction :  (1. Aucun, 2. Ecole coranique, 3 Primaire, 4 Secondaire, 5 
Supérieur) 
2.7.  Adresse: (Ville/Village / Commune / 
Province)……………..……….…………………… 
……………………………………………………………………………………………… 
2.8.  Etes-vous indépendant financièrement :  Oui Non 
2.8.1  Si Non, de qui dépendez-vous :………………………………………………. 
2.8.2.  Si oui,  
2.8.2.1.  Revenu mensuel moyen ? (en 
Dhs)………………………………………… 
2.8.2.2.  Combien de personnes vivent dans votre foyer ? , dont à votre 
charge…… 
2.8.2.3.  Parmi les personnes vivant dans votre maison combien sont : 
  Enfants scolarisés  
  Enfants non scolarisés  
  Personnes âgées de plus de 60 ans . 
  Adultes sans emploi  
  Invalides (incapables de travailler)  
  Actifs   
Domaines d’activité Revenu moyen (en Dhs) 
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2.9. Description du foyer: 
Rural  Urbain  
Habitat traditionnel (terre battue)  Appartement  
Habitat moderne (briques et béton)  Maison individuelle  
Baraque en tôle  Baraque en tôle (bidonville)  
Collectif (plusieurs familles)  Collectif  
Individuel  Individuel  
Superficie approximative   Superficie approximative  
Nb. pièces habitables  Nb. pièces habitables  
Commentaires :…………………………… 
………………………………………………….
Commentaires :………………………………. 
………………………..................................................
 
3. Connaissance et perception de la maladie par le patient 
3.8.  Quel est l’origine de la tuberculose selon 
vous ?................................................... 
........................................................................................................................................
... 
3.9.  Quels sont les voies de transmission de la tuberculose selon vous ? 
 Contact  Utilisation des mêmes ustensiles de cuisine  
 Autres (à 
préciser) …………………………………………………………………….. 
 
4. Informations sur les facteurs d’exposition à M. bovis 
4.8.  Distance entre la maison et les locaux d’élevage : 
4.8.1.  Même bâtiment……………………….…....…..mètres 
4.8.2.  Bâtiments différent…………………………….mètres 
4.9.  Consommation du lait cru / produits laitiers à base de 
lait cru 
 Oui  Non 
4.10. Contact avec un élevage de bovins  Oui  Non 
4.10.1.  Cadre professionnel   Oui  Non 
4.10.2.  Cadre ménager  Oui  Non 
4.10.3.  Occasionnellement   Oui  Non 
4.11.  Consommation de viande du circuit informel  Oui  Non 
4.12.  Consommation du lait provenant du colporteur/laiterie  Oui  Non 
5.  Facteurs de susceptibilité :  
5.1.  Consommation de : 
5.1.1.  La cigarette          Oui  Non 
5.1.2.  La drogue            Oui  Non 
5.2.  Autres maladies : 
5.2.1.  Diabète                      Oui  Non 
5.2.2.  Insuffisance rénale     Oui  Non 
5.2.3.  Problèmes cardiaques  Oui  Non 
 
6.  Information sur la maladie 
6.1.  Quand est-ce que vous avez été diagnostiqué de la tuberculose : …./…../…. 
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6.2.  Combien de docteurs/guérisseurs avez-vous consulté avant de commencer le 
traitement antituberculeux :  
Intervalle Durée  Médecin 
/Guérisseur
(M/G) 
Frais 
Transport
(Dhs) 
Frais 
Consultations 
(Dhs) 
Frais de 
médication
(Dhs) 
Apparition de 
symptômes et 1ère 
consultation 
     
1ère et 2ème 
consultation 
     
2ère et 3ème 
consultation 
     
      
Déduire intervalle  Apparition de symptômes – suspicion de tuberculose: 
……………… 
Déduire intervalle  Suspicion de tuberculose – confirmation: …………………………… 
 
6.3.  Date d’hospitalisation :…../…../….. ; Date probable de sortie : …../…../….. 
6.4.  Quelle est, selon vous le type de tuberculose que vous avez? (appellation 
vernaculaire) 
………………………………………………………………………………………………. 
6.5.  Le type de tuberculose selon le médecin traitant : 
………………………………………………………………………………………………. 
6.6.  Les coûts engagés depuis le diagnostic jusqu’à présent : 
Phase Coûts associés (Dhs) 
Avant diagnostic Après diagnostic 
Diagnostic   
Traitement à l’hôpital   
Traitement au foyer   
Convalescence   
Après la maladie   
Accompagnateur   
6.7.  Avez-vous eu une récidive / récurrence :  Oui  Non 
6.8.  Si oui, 
6.8.1.  Combien cela vous a coûté (en Dhs):…………………………………………. 
6.8.2.  Est-ce qu’il y a eu un changement au niveau de votre travail et/ou votre 
revenu à cause de la maladie :  Oui  Non 
6.8.3.  Si oui, préciser…………………………………………………………………… 
6.8.4.  Variation du revenu du à ce changement (en 
%):……………………………….. 
6.9.  Autres personnes de la famille ou de l’entourage immédiat ayant fait la 
tuberculose après vous ? Oui Non 
6.10.  Si oui, combien de personnes en milieu familial  et en milieu 
professionnel  
 
7.  Conséquences socio-économiques 
7.1.  Combien de personnes par jours vous rendaient elles visitent à l’hôpital :  
7.2.  La distance moyenne parcourue par ces personnes pour venir à l’hôpital : 
……………………………………………………………..………km/personne 
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7.3.  Période d’invalidité en rapport avec la maladie  (en 
mois) :………………………. 
7.4.  Avez-vous chargé quelqu’un pour assurer vos activités professionnelles 
pendant votre hospitalisation :  Oui  Non 
7.5. Si oui : 
7.5.1.  Quelles activités :…………………………………………………………..…… 
7.5.2.  Combien ceci vous a coûté par 
mois ?………………………………………….… 
7.6.  Est-ce que votre revenu a baissé depuis que vous êtes malade :  Oui  
Non 
7.7.  Est-ce que vous vous êtes senti victime d’une stigmatisation à cause de votre 
maladie ? 
  De la part des amis                                                                   Oui  Non 
  De la part de la famille                                                             Oui  Non 
  De la part des collègues                                                           Oui  Non 
7.8.  La maladie a-t-elle causé des problèmes conjugaux                      Oui  
Non 
Si oui: 
  Problèmes mineurs                                                                  Oui  Non 
  Problèmes majeures                                                                  Oui  Non 
  Séparation temporaire                                                              Oui  Non 
  Séparation définitive (divorce)                           .                    Oui  Non 
Conséquences liées à ces problèmes :…………………………………………………. 
…………………………………………………………………………………………………
…………………………………………………………………………………………………
………………………………………………………………... 
Lieux de l’enquête: Hôpital My Youssef, Rabat ; Hôpital XXXX, Kenitra ; CHU 
Ibn Rochd, Casablanca. 
Equipe de recherche : 
  Pr. Mohammed Bouslikhne, Pr. Jaouad Berrada, Dr. Yahyaoui Azami Hind 
(Institut Agronomique et Vétérinaire Hassan II, Rabat, Maroc. 
  Pr. Fouad Sghrouchni (Institut National d’Hygiene, Rabat, Maroc) 
  Pr. Jamal Eddine Bourekkadi (Hôpital My Youssef, Rabat, Maroc) 
  Pr. Kamal Marhoum El filali (CHU Ibn Rochd, Casablanca, Maroc) 
  Pr Jakob Zinsstag, Dr. Jan Hattendorf (Institut Tropicale et de Santé Publique, 
Université de Bâle, Suisse) 
  Pr. Alexandra Shaw (AP Consultants, UK) 
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Appendix 3: Supporting information 2 
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Appendix 4: Field and laboratory pictures 
 
Survey with the household keeper in Sidi Kacem-Morocco 
 
 
Blood sampling a goat in Sidi Kacem-Morocco 
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Tuberculin skin test investigation in Sidi kacem-Morocco 
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SCITT reaction in a female cattle in Sidi Kacem 
 
Bovine tuberculosis granuloma from the abattoir of Rabat 
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Spoligotyping membrane-Tuberculosis laboratory-Swiss TPH 
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